|
Cayman Islands
|
| |
6770
|
| |
N/A
|
|
|
(State or Other Jurisdiction of
Incorporation or Organization) |
| |
(Primary Standard Industrial
Classification Code Number) |
| |
(I.R.S. Employer
Identification Number) |
|
|
James C. Lin
Miranda So Davis Polk & Wardwell LLP c/o 18th Floor, The Hong Kong Club Building 3A Chater Road, Central Hong Kong +852 2533-3300 |
| |
Brandon J. Bortner
Steve L. Camahort Paul Hastings LLP 2050 M Street NW Washington, D.C. 20036 (202) 551-1720 |
|
| Large accelerated filer ☐ | | | Accelerated filer ☐ | |
| Non-accelerated filer ☒ | | | Smaller reporting company ☒ | |
| | | | Emerging growth company ☒ | |
|
☐ Exchange Act Rule 13e-4(i)
(Cross-Border Issuer Tender Offer) |
| |
☐ Exchange Act Rule 14d-1(d)
(Cross-Border Third-Party Tender Offer) |
|
| | | | By Order of the DSAC Board of Directors | |
| | | |
Manoj Jain
Chairman |
|
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 6 | | | |
| | | | 9 | | | |
| | | | 31 | | | |
| | | | 31 | | | |
| | | | 31 | | | |
| | | | 32 | | | |
| | | | 33 | | | |
| | | | 36 | | | |
| | | | 36 | | | |
| | | | 37 | | | |
| | | | 38 | | | |
| | | | 38 | | | |
| | | | 38 | | | |
| | | | 39 | | | |
| | | | 40 | | | |
| | | | 40 | | | |
| | | | 40 | | | |
| | | | 42 | | | |
| | | | 43 | | | |
| | | | 43 | | | |
| | | | 43 | | | |
| | | | 44 | | | |
| | | | 44 | | | |
| | | | 45 | | | |
| | | | 48 | | | |
| | | | 49 | | | |
| | | | 50 | | | |
| | | | 52 | | | |
| | | | 54 | | | |
| | | | 54 | | | |
| | | | 54 | | | |
| | | | 55 | | | |
| | | | 55 | | | |
| | | | 73 | | | |
| | | | 98 | | | |
| | | | 100 | | | |
| | | | 105 | | | |
| | | | 105 | | | |
| | | | 105 | | | |
| | | | 105 | | | |
| | | | 106 | | | |
| | | | 106 | | | |
| | | | 106 | | | |
| | | | 106 | | | |
| | | | 106 | | | |
| | | | 106 | | |
| | |
Page
|
| |||
| | | | 107 | | | |
| | | | 109 | | | |
| | | | 109 | | | |
| | | | 109 | | | |
| | | | 110 | | | |
| | | | 110 | | | |
| | | | 111 | | | |
| | | | 111 | | | |
| | | | 112 | | | |
| | | | 112 | | | |
| | | | 112 | | | |
| | | | 113 | | | |
| | | | 113 | | | |
| | | | 113 | | | |
| | | | 115 | | | |
| | | | 115 | | | |
| | | | 123 | | | |
| | | | 125 | | | |
| | | | 128 | | | |
| | | | 130 | | | |
| | | | 131 | | | |
| | | | 131 | | | |
| | | | 133 | | | |
| | | | 136 | | | |
| | | | 136 | | | |
| | | | 136 | | | |
| | | | 137 | | | |
| | | | 137 | | | |
| | | | 137 | | | |
| | | | 138 | | | |
| | | | 138 | | | |
| | | | 141 | | | |
| | | | 141 | | | |
| | | | 141 | | | |
| | | | 141 | | | |
| | | | 141 | | | |
| | | | 141 | | | |
| | | | 143 | | | |
| | | | 143 | | | |
| | | | 143 | | | |
| | | | 144 | | | |
| | | | 144 | | | |
| | | | 145 | | | |
| | | | 145 | | | |
| | | | 146 | | | |
| | | | 146 | | | |
| | | | 146 | | | |
| | | | 146 | | | |
| | | | 147 | | | |
| | | | 147 | | | |
| | | | 147 | | |
| | |
Page
|
| |||
| | | | 148 | | | |
| | | | 148 | | | |
| | | | 148 | | | |
| | | | 150 | | | |
| | | | 152 | | | |
| | | | 153 | | | |
| | | | 153 | | | |
| | | | 154 | | | |
| | | | 154 | | | |
| | | | 154 | | | |
| | | | 155 | | | |
| | | | 155 | | | |
| | | | 155 | | | |
| | | | 155 | | | |
| | | | 155 | | | |
| | | | 157 | | | |
| | | | 157 | | | |
| | | | 157 | | | |
| | | | 158 | | | |
| | | | 158 | | | |
| | | | 159 | | | |
| | | | 159 | | | |
| | | | 159 | | | |
| | | | 159 | | | |
| | | | 163 | | | |
| | | | 165 | | | |
| | | | 165 | | | |
| | | | 165 | | | |
| | | | 165 | | | |
| | | | 166 | | | |
| | | | 166 | | | |
| | | | 167 | | | |
| | | | 167 | | | |
| | | | 167 | | | |
| | | | 169 | | | |
| | | | 170 | | | |
| | | | 170 | | | |
| | | | 170 | | | |
| | | | 171 | | | |
| | | | 171 | | | |
| | | | 171 | | | |
| | | | 171 | | | |
| | | | 171 | | | |
| | | | 171 | | | |
| | | | 173 | | | |
| | | | 174 | | | |
| | | | 187 | | | |
| | | | 187 | | | |
| | | | 187 | | | |
| | | | 187 | | | |
| | | | 188 | | | |
| | | | 188 | | |
| | |
Page
|
| |||
| | | | 188 | | | |
| | | | 190 | | | |
| | | | 191 | | | |
| | | | 191 | | | |
| | | | 192 | | | |
| | | | 192 | | | |
| | | | 193 | | | |
| | | | 193 | | | |
| | | | 193 | | | |
| | | | 193 | | | |
| | | | 193 | | | |
| | | | 194 | | | |
| | | | 195 | | | |
| | | | 195 | | | |
| | | | 195 | | | |
| | | | 195 | | | |
| | | | 196 | | | |
| | | | 197 | | | |
| | | | 197 | | | |
| | | | 197 | | | |
| | | | 198 | | | |
| | | | 198 | | | |
| | | | 200 | | | |
| | | | 200 | | | |
| | | | 200 | | | |
| | | | 201 | | | |
| | | | 202 | | | |
| | | | 203 | | | |
| | | | 205 | | | |
| | | | 206 | | | |
| | | | 206 | | | |
| | | | 207 | | | |
| | | | 207 | | | |
| | | | 208 | | | |
| | | | 208 | | | |
| | | | 208 | | | |
| | | | 208 | | | |
| | | | 209 | | | |
| | | | 209 | | | |
| | | | 210 | | | |
| | | | 211 | | | |
| | | | 211 | | | |
| | | | 211 | | | |
| | | | 212 | | | |
| | | | 212 | | | |
| | | | 215 | | | |
| | | | 217 | | | |
| | | | 223 | | | |
| | | | 224 | | | |
| | | | 227 | | |
| | |
Page
|
| |||
| | | | 227 | | | |
| | | | 227 | | | |
| | | | 227 | | | |
| | | | 227 | | | |
| | | | 229 | | | |
| | | | 230 | | | |
| | | | 232 | | | |
| | | | 232 | | | |
| | | | 232 | | | |
| | | | 235 | | | |
| | | | 235 | | | |
| | | | 236 | | | |
| | | | 236 | | | |
| | | | 237 | | | |
| | | | 241 | | | |
| | | | 241 | | | |
| | | | 242 | | | |
| | | | 242 | | | |
| | | | 242 | | | |
| | | | 242 | | | |
| | | | 243 | | | |
| | | | 243 | | | |
| | | | 243 | | | |
| | | | 244 | | | |
| | | | 244 | | | |
| | | | 244 | | | |
| | | | 255 | | | |
| | | | 257 | | | |
| | | | 257 | | | |
| | | | 261 | | | |
| | | | 261 | | | |
| | | | 262 | | | |
| | | | 262 | | | |
| | | | 264 | | | |
| | | | 264 | | | |
| | | | 264 | | | |
| | | | 265 | | | |
| | | | 265 | | | |
| | | | 265 | | | |
| | | | 266 | | | |
| | | | 267 | | | |
| | | | 268 | | | |
| | | | 268 | | | |
| | | | 270 | | | |
| | | | 272 | | | |
| | | | 272 | | | |
| | | | 273 | | | |
| | | | 276 | | | |
| | | | 276 | | | |
| | | | 277 | | | |
| | | | 283 | | | |
| | | | 283 | | |
| | |
Page
|
| |||
| | | | 284 | | | |
| | | | 284 | | | |
| | | | 286 | | | |
| | | | 286 | | | |
| | | | 287 | | | |
| | | | 288 | | | |
| | | | 289 | | | |
| | | | 290 | | | |
| | | | 290 | | | |
| | | | 291 | | | |
| | | | 291 | | | |
| | | | 291 | | | |
| | | | 291 | | | |
| | | | 292 | | | |
| | | | 294 | | | |
| | | | 295 | | | |
| | | | F-1 | | | |
| | | | A-1 | | | |
| | | | B-1 | | | |
| | | | C-1 | | | |
| | | | D-1 | | | |
| | | | E-1 | | | |
| | | | F-1 | | | |
| | | | G-1 | | | |
| | | | H-1 | | |
| | |
Assuming
No Redemptions |
| |
Assuming
50% Redemptions |
| |
Assuming Maximum
Redemptions |
| |||||||||||||||||||||||||||
| | |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| ||||||||||||||||||
DSAC Shareholders | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Public shares owned by public shareholders
|
| | | | 13,500,000 | | | | | | 10.6% | | | | | | 6,750,000 | | | | | | 5.3% | | | | | | — | | | | | | — | | |
Public shares owned by the Sponsor(1)(2)
|
| | | | 4,000,000 | | | | | | 3.1% | | | | | | 10,750,000 | | | | | | 8.4% | | | | | | 17,500,000 | | | | | | 13.7% | | |
Initial shares
|
| | | | 4,375,000 | | | | | | 3.4% | | | | | | 4,375,000 | | | | | | 3.4% | | | | | | 4,375,000 | | | | | | 3.4% | | |
PIPE shares
|
| | | | 10,000,000 | | | | | | 7.8% | | | | | | 10,000,000 | | | | | | 7.8% | | | | | | 10,000,000 | | | | | | 7.8% | | |
| | |
Assuming
No Redemptions |
| |
Assuming
50% Redemptions |
| |
Assuming Maximum
Redemptions |
| |||||||||||||||||||||||||||
| | |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| ||||||||||||||||||
FiscalNote Stockholders | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Class A Shares(3)(4) | | | | | 87,561,867 | | | | | | 68.4% | | | | | | 87,561,867 | | | | | | 68.4% | | | | | | 87,561,867 | | | | | | 68.4% | | |
Class B Shares(5) | | | | | 8,491,491 | | | | | | 6.6% | | | | | | 8,491,491 | | | | | | 6.6% | | | | | | 8,491,491 | | | | | | 6.6% | | |
Total | | | | | 127,928,359 | | | | | | 100.0% | | | | | | 127,928,359 | | | | | | 100.0% | | | | | | 127,928,359 | | | | | | 100.0% | | |
|
| | |
Assuming No
Redemptions of Public Shares |
| |
Maximum
Redemptions of Public Shares(1) |
| ||||||
FiscalNote Co-Founders
|
| | | | 64.0% | | | | | | 64.0% | | |
Other FiscalNote Stockholders
|
| | | | 26.4% | | | | | | 26.4% | | |
DSAC shareholders
|
| | | | 6.6% | | | | | | 6.6%(1) | | |
PIPE Investors
|
| | | | 3.0% | | | | | | 3.0% | | |
Total
|
| | | | 100.0% | | | | | | 100.0% | | |
(in millions)
|
| |
Assuming No
Redemptions |
| |
Assuming
Maximum Redemptions |
| ||||||
Sources | | | | | | | | | | | | | |
Proceeds from Trust Account(1)
|
| | | $ | 175 | | | | | $ | 175 | | |
Private Placement(2)
|
| | | | 100 | | | | | | 100 | | |
Sponsor Equity
|
| | | | 44 | | | | | | 44 | | |
FiscalNote Shareholder Rollover(5)
|
| | | | 1,000 | | | | | | 1,000 | | |
Total Sources
|
| | | $ | 1,318 | | | | | $ | 1,318 | | |
Uses | | | | | | | | | | | | | |
FiscalNote Shareholder Rollover(5)
|
| | | $ | 1,000 | | | | | $ | 1,000 | | |
Debt Paydown(3)
|
| | | | 127 | | | | | | 127 | | |
Sponsor Equity Rollover
|
| | | | 44 | | | | | | 44 | | |
Cash to Balance Sheet(3)
|
| | | | 118 | | | | | | 118 | | |
Estimated Fees & Expenses(4)
|
| | | | 30 | | | | | | 30 | | |
Total Uses
|
| | | $ | 1,318 | | | | | $ | 1,318 | | |
| | |
Nine months ended
September 30, 2021 |
| |
For the Period From
August 28,2020 (inception) through September 30, 2020 |
| |
Year ended
December 31, 2020 |
| |||||||||
| | |
(Unaudited)
|
| |
(Unaudited)
|
| | |||||||||||
Income Statement Data: | | | | | | | | | | | | | | | |||||
Loss from operations
|
| | | $ | (3,356) | | | | | $ | — | | | | | $ | (672) | | |
Net income (loss)
|
| | | $ | 7,956 | | | | | $ | — | | | | | $ | (9,091) | | |
Weighted average shares outstanding of common stock subject of redemption, basic and diluted
|
| | | | 17,500,000 | | | | | $ | — | | | | | | 8,536,585 | | |
Basic and diluted net income (loss) per share subject to redemption
|
| | | $ | 0.36 | | | | | $ | — | | | | | $ | (0.70) | | |
Weighted average shares outstanding of common stock, basic and diluted
|
| | | | 4,375,000 | | | | | | 4,375,000 | | | | | | 4,375,000 | | |
Basic and diluted net income (loss) per share
|
| | | $ | 0.36 | | | | | $ | (0.01) | | | | | $ | (0.70) | | |
Balance Sheet Data (at period end): | | | | | | | | | | | | | | | |||||
Investments held in Trust Account
|
| | | $ | 175,084 | | | | | | | | | | | $ | 175,031 | | |
Total assets
|
| | | $ | 175,564 | | | | | | | | | | | $ | 176,232 | | |
Total liabilities
|
| | | $ | 18,667 | | | | | | | | | | | $ | 27,290 | | |
Common stock subject to possible redemption
|
| | | $ | 175,000 | | | | | | | | | | | $ | 175,000 | | |
Total stockholders’ equity
|
| | | $ | (18,103) | | | | | | | | | | | $ | (26,058) | | |
(In thousands, except shares and per share data)
|
| |
Nine months ended September 30,
|
| |
Year ended December 31,
|
| ||||||||||||||||||
|
2021
|
| |
2020
|
| |
2020
|
| |
2019
|
| ||||||||||||||
| | |
(Unaudited)
|
| |
(Unaudited)
|
| | | ||||||||||||||||
Income Statement Data: | | | | | | | | | | | | | | | | | | | | | | | | | |
Revenue
|
| | | $ | 58,450 | | | | | $ | 48,510 | | | | | $ | 65,157 | | | | | $ | 65,870 | | |
Operating loss
|
| | | $ | (39,307) | | | | | $ | (19,597) | | | | | $ | (28,966) | | | | | $ | (29,125) | | |
Net loss
|
| | | $ | (88,462) | | | | | $ | (37,972) | | | | | $ | (51,272) | | | | | $ | (33,335) | | |
Loss per share – basic and diluted
|
| | | $ | (24.83) | | | | | $ | (3.67) | | | | | $ | (8.74) | | | | | $ | (4.82) | | |
Balance Sheet Data (at period end): | | | | | | | | | | | | | | | | | | | | | | | | | |
Total assets
|
| | | $ | 360,682 | | | | | $ | 264,748 | | | | | $ | 280,106 | | | | | $ | 243,120 | | |
Long-term debt
|
| | | $ | 289,464 | | | | | $ | 211,769 | | | | | $ | 211,968 | | | | | $ | 155,427 | | |
Total liabilities
|
| | | $ | 373,183 | | | | | $ | 280,643 | | | | | $ | 272,373 | | | | | $ | 225,480 | | |
Temporary equity
|
| | | $ | 469,805 | | | | | $ | 203,613 | | | | | $ | 238,963 | | | | | $ | 206,972 | | |
Total stockholders’ deficit
|
| | | $ | (482,306) | | | | | $ | (219,508) | | | | | $ | (231,230) | | | | | $ | (189,332) | | |
| | |
Pro Forma Combined
(Assuming No Redemptions and Maximum Redemptions) |
| |
Pro Forma Combined
(Assuming No Redemptions and Maximum Redemptions) |
| ||||||
|
For the nine months
ended September 30, 2021 |
| |
For the year ended
December 31, 2020 |
| ||||||||
Summary Unaudited Pro Forma Condensed Combined Statement
of Operations Data |
| | | | | | | | | | | | |
Revenue
|
| | | $ | 58,450 | | | | | $ | 65,157 | | |
Operating loss
|
| | | $ | (44,557) | | | | | $ | (34,673) | | |
Net loss
|
| | | $ | (29,703) | | | | | $ | (95,922) | | |
Loss per share – basic and diluted
|
| | | $ | (0.23) | | | | | $ | (0.75) | | |
Weighted-average shares outstanding – basic and diluted
|
| | | | 127,928,359 | | | | | | 127,928,359 | | |
| | |
Duddell
(Historical) |
| |
FiscalNote
(Historical) |
| |
Combined
Pro Forma |
| |
FiscalNote
Pro forma per share data(2) |
| ||||||||||||
|
Assuming No
Redemptions and Maximum Redemptions |
| |
Assuming No
Redemptions and Maximum Redemptions |
| ||||||||||||||||||||
As of and for the nine months ended September 30, 2021 (Unaudited)
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Book value per share(1)(2)
|
| | | $ | (4.14) | | | | | $ | (39.05) | | | | | $ | 2.62 | | | | | $ | 3.16 | | |
Weighted average shares outstanding of DSAC ordinary shares subject to redemption, basic and diluted
|
| | | | 17,500,000 | | | | | | N/A | | | | | | N/A | | | | | | N/A | | |
Weighted average shares outstanding of ordinary shares, basic and diluted
|
| | | | 4,375,000 | | | | | | 12,351,464 | | | | | | N/A | | | | | | 96,053,359 | | |
Weighted average shares of New FiscalNote Class A and Class B common stock outstanding – basic and diluted
|
| | | | N/A | | | | | | N/A | | | | | | 127,928,359 | | | | | | N/A | | |
Basic and diluted net income (loss) per share,
DSAC ordinary shares subject to redemption |
| | | $ | 0.36 | | | | | | N/A | | | | | | N/A | | | | | | N/A | | |
Basic and diluted net income (loss) per share,
ordinary shares |
| | | $ | 0.36 | | | | | $ | (24.83) | | | | | | N/A | | | | | $ | — | | |
Net income (loss) per share, New FiscalNote
Class A and B – basic and diluted |
| | | | N/A | | | | | | N/A | | | | | $ | (0.23) | | | | | | N/A | | |
As of and for the year ended December 31, 2020
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Book value per share(1)(2)
|
| | | $ | 1.14 | | | | | $ | (24.28) | | | | | | N/A | | | | | | N/A | | |
Weighted average shares outstanding of DSAC ordinary shares subject to redemption, basic and diluted
|
| | | | 8,536,585 | | | | | | N/A | | | | | | N/A | | | | | | N/A | | |
Weighted average shares outstanding of ordinary shares, basic and diluted
|
| | | | 4,375,000 | | | | | | 9,521,927 | | | | | | N/A | | | | | | N/A | | |
Weighted average shares of New FiscalNote Class A and Class B common stock outstanding – basic and diluted
|
| | | | N/A | | | | | | N/A | | | | | | 127,928,359 | | | | | | N/A | | |
Basic and diluted net income (loss) per share,
DSAC ordinary shares subject to redemption |
| | | $ | (0.70) | | | | | | N/A | | | | | | N/A | | | | | | N/A | | |
Basic and diluted net income (loss) per share,
ordinary shares |
| | | $ | (0.70) | | | | | $ | (8.74) | | | | | | N/A | | | | | $ | — | | |
Net income (loss) per share, New FiscalNote
Class A and B – basic and diluted |
| | | | N/A | | | | | | N/A | | | | | $ | (0.75) | | | | | | N/A | | |
| |
THE DSAC BOARD HAS UNANIMOUSLY DETERMINED THAT THE BUSINESS COMBINATION PROPOSAL AND THE OTHER PROPOSALS TO BE PRESENTED AT THE SPECIAL MEETING ARE ADVISABLE AND IN THE BEST INTERESTS OF THE DSAC SHAREHOLDERS AND RECOMMENDS THAT YOU VOTE “FOR” EACH OF THE PROPOSALS DESCRIBED ABOVE.
|
| |
| | |
CY 2022E
TEV / Revenue |
|
Legal Tech Companies (Median)
|
| |
8.8 x
|
|
Information Services Companies (Median)
|
| |
19.5x
|
|
Vertical Software Companies (Median)
|
| |
19.2x
|
|
Company Ticker
|
| |
Company
Name |
| |
Equity
Value |
| |
Total
Enterprise Value |
| |
Revenue Estimates
|
| | |||||||||||||||||||||||
|
2021
|
| |
2022
|
| |
2023
|
| | ||||||||||||||||||||||||||||
Core Comps | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
LZ-US
|
| | LegalZoom | | | | $ | 5,338 | | | | | $ | 5,685 | | | | | $ | 571 | | | | | $ | 691 | | | | | $ | 853 | | | | ||
LAW-US
|
| | CS Disco | | | | | 3,250 | | | | | | 3,204 | | | | | | 104 | | | | | | 137 | | | | | | 182 | | | | ||
INTA-US
|
| | Intapp | | | | | 1,755 | | | | | | 2,137 | | | | | | 215 | | | | | | 244 | | | | | | 288 | | | | ||
Info Services | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
MSCI-US
|
| | MSCI | | | | | 53,230 | | | | | | 55,201 | | | | | | 1,977 | | | | | | 2,184 | | | | | | 2,414 | | | | ||
CSGP-US
|
| | CoStar | | | | | 33,342 | | | | | | 30,798 | | | | | | 1,947 | | | | | | 2,266 | | | | | | 2,716 | | | | ||
ZI-US
|
| | ZoomInfo | | | | | 27,362 | | | | | | 28,150 | | | | | | 674 | | | | | | 868 | | | | | | 1,133 | | | | ||
TYL-US
|
| | Tyler | | | | | 22,256 | | | | | | 23,569 | | | | | | 1,529 | | | | | | 1,823 | | | | | | 2,040 | | | | ||
Vertical Software | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
PLTR-US
|
| | Palantir | | | | | 51,016 | | | | | | 48,887 | | | | | | 1,480 | | | | | | 1,904 | | | | | | 2,446 | | | | ||
VEEV-US
|
| | Veeva | | | | | 48,811 | | | | | | 46,721 | | | | | | 1,793 | | | | | | 2,135 | | | | | | 2,537 | | | | ||
AVLR-US
|
| | Avalara | | | | | 15,914 | | | | | | 15,300 | | | | | | 652 | | | | | | 805 | | | | | | 998 | | | | ||
PCOR-US
|
| | Procore | | | | | 12,545 | | | | | | 11,576 | | | | | | 489 | | | | | | 600 | | | | | | 737 | | | | ||
GWRE-US
|
| | Guidewire | | | | | 10,221 | | | | | | 9,603 | | | | | | 743 | | | | | | 786 | | | | | | 869 | | | | ||
NCNO-US
|
| | nCino | | | | | 7,320 | | | | | | 6,970 | | | | | | 255 | | | | | | 314 | | | | | | 398 | | | | ||
DCT-US
|
| |
Duck Creek
|
| | | | 4,070 | | | | | | 3,720 | | | | | | 268 | | | | | | 314 | | | | | | 373 | | | | ||
ALKT-US
|
| | Alkami | | | | | 2,678 | | | | | | 2,365 | | | | | | 146 | | | | | | 184 | | | | | | 230 | | | | ||
Median
|
| | | | | | | 12,545 | | | | | | 11,576 | | | | | | 652 | | | | | | 786 | | | | | | 869 | | | | | |
Average
|
| | | | | | | 19,940 | | | | | | 19,592 | | | | | | 856 | | | | | | 1,017 | | | | | | 1,214 | | | | | |
| | |
FY21E
|
| |
Long-term
scale (expected) |
| ||||||
Gross Margin
|
| | | | 82% | | | | | | ~88% | | |
Sales & Marketing Expenses
|
| | | | 31% | | | | | | ~20% | | |
Research & Development Expenses
|
| | | | 25% | | | | | | ~13% | | |
| | |
FY21E
|
| |
Long-term
scale (expected) |
| ||||||
Editorial Expenses
|
| | | | 20% | | | | | | ~12% | | |
General & Administrative Expenses
|
| | | | 27% | | | | | | ~12% | | |
EBITDA Margin
|
| | | | (21)% | | | | | | ~30% | | |
(in millions)
|
| |
Assuming No
Redemption |
| |
Assuming
Maximum Redemption |
| ||||||
Sources | | | | | | | | | | | | | |
Proceeds from Trust Account(1)
|
| | | $ | 175 | | | | | $ | 175 | | |
Private Placement(2)
|
| | | | 100 | | | | | | 100 | | |
Sponsor Equity
|
| | | | 44 | | | | | | 44 | | |
FiscalNote Shareholder Rollover(5)
|
| | | | 1,000 | | | | | | 1,000 | | |
Total Sources
|
| | | $ | 1,318 | | | | | $ | 1,318 | | |
Uses | | | | | | | | | | | | | |
FiscalNote Shareholder Rollover(5)
|
| | | $ | 1,000 | | | | | $ | 1,000 | | |
Debt Paydown(3)
|
| | | | 127 | | | | | | 127 | | |
Sponsor Equity Rollover
|
| | | | 44 | | | | | | 44 | | |
Cash to Balance Sheet(3)
|
| | | | 118 | | | | | | 118 | | |
Estimated Fees & Expenses(4)
|
| | | | 30 | | | | | | 30 | | |
Total Uses
|
| | | $ | 1,318 | | | | | $ | 1,318 | | |
Individual
|
| |
Entity
|
| |
Entity’s Business
|
| |
Affiliation
|
|
Manoj Jain | | | Maso Capital Partners Ltd | | | Financial Services | | |
Co-Chief Investment Officer and Co-Founder
|
|
Sohit Khurana | | | Maso Capital Partners Ltd | | | Financial Services | | |
Co-Chief Investment Officer and Co-Founder
|
|
Allan Finnerty | | | Maso Capital Partners Ltd | | | Financial Services | | | Chief Operating Officer and Co-Founder | |
Marc Holtzman | | |
Bank of Kigali
CBZ Holdings TTEC Astana Financial Services Authority |
| |
Financial Services
Financial Services Technology Financial Services |
| |
Chairman
Chairman Non-executive Director Non-executive Director |
|
Bradford Allen | | |
VAUNT
Clean Earth Acquisition Corp. |
| |
Entertainment
Special Purpose Acquisition Company |
| |
Chairman
Director |
|
Mark Derrick Collier | | |
Sigma Pensions Ltd
Assupol Group Holdings Assupol Life Actis Golf BV |
| |
Financial Services
Financial Services Financial Services Financial Services |
| |
Chairman
Non-executive Director Non-executive Director Non-executive Director |
|
Advisory Governing Documents Proposal
|
| |
DSAC Current Charter
|
| |
Proposed Charter
|
|
Advisory Proposal A — Changes in Share Capital
|
| | Under the Current Charter, the capital of DSAC is 201,000,000, divided into (a) 180,000,000 Class A Ordinary Shares, par value $0.0001 per share, and 20,000,000 Class B Ordinary Shares, par value $0.0001 per share, and (b) 1,000,000 Preference Shares, par value $0.0001 per share. | | | Under the Proposed Charter, New FiscalNote will be authorized to issue 1,809,000,000 shares of capital stock, consisting of (a) 1,700,000,000 shares of New FiscalNote Class A common stock, par value $0.0001 per share and 9,000,000 shares of New FiscalNote Class B common stock, par value $0.0001 per share, and (b) 100,000,000 shares of preferred stock, par value $0.0001 per share. | |
Advisory Proposal B — Voting Rights of Common Stock
|
| | Under the Current Charter, the holders of DSAC Class A Ordinary Shares, DSAC Class B Ordinary Shares, and DSAC Preference Shares are entitled to cast one (1) vote for each such share. | | |
Under the Proposed Charter, (i) at all meetings of stockholders and on all matters properly submitted to a vote of stockholders of New FiscalNote generally, (A) holders of New FiscalNote Class A common stock will be entitled to cast one (1) vote per share of New FiscalNote Class A common stock and (B) holders of New FiscalNote Class B common stock will be entitled to cast twenty-five (25) votes per share of New FiscalNote Class B common stock.
(ii) to amend the Proposed Charter or approve any change of control transaction, an affirmative vote of the holders of two-thirds (2/3) of the outstanding shares of Class A common stock and Class B
|
|
Advisory Governing Documents Proposal
|
| |
DSAC Current Charter
|
| |
Proposed Charter
|
|
| | | | | | common stock, voting together as a single class | |
Advisory Proposal C — Required Vote to Change Number of Directors
|
| | The Current Charter provides that the number of directors on the DSAC Board shall be fixed from time to time by Ordinary Resolution (as defined in the Current Charter), and unless such numbers are fixed as aforesaid, shall be no less than one (1) and the maximum shall be unlimited. | | | Subject to the rights of holders of any series of preferred stock to elect directors, the number of directors constituting the New FiscalNote Board shall be fixed from time to time by the New FiscalNote Board; provided, that unless otherwise approved by the Requisite Stockholder Consent, the number of the directors shall be no less than five (5) and shall not exceed twelve (12). | |
Advisory Proposal D — Share Authorization
|
| | Under the Current Charter, DSAC’s share capital may be increased by Ordinary Resolution, to be divided into shares of such classes and amount, as the resolution shall prescribe | | | Under the Proposed Charter, the number of authorized shares of New FiscalNote Class A common stock, New FiscalNote Class B common stock and New FiscalNote preferred stock may be increased or decreased by the affirmative vote of the holders of shares representing a majority of the voting power of all of the outstanding shares of capital stock of New FiscalNote entitled to vote thereon, except the number of authorized shares may not be decreased below the number of shares thereof then outstanding or, in the case of the New FiscalNote Class A common stock, the number of shares of New FiscalNote Class A common stock reserved for issuance upon conversion of all outstanding shares of New FiscalNote Class B common stock | |
Advisory Proposal E — Other Changes in Connection with Adoption of Proposed Charter
|
| | The current charter includes various provisions relating to DSAC’s status as a blank check company prior to the consummation of a business combination. | | | Under the Proposed Charter, New FiscalNote (i) will adopt Delaware as the exclusive forum for certain stockholder litigation and the federal district courts of the United States as the exclusive forum for certain other stockholder litigation, in each case unless New FiscalNote expressly consents in writing to the selection of an alternative forum, and (ii) remove certain provisions related to DSAC’s status as a blank check company | |
Advisory Governing Documents Proposal
|
| |
DSAC Current Charter
|
| |
Proposed Charter
|
|
| | | | | | that will no longer be applicable upon consummation of the Business Combination. | |
Advisory Governing Documents Proposal F — Authorization of an amendment to the Proposed Charter in order to change the corporate name of “Duddell Street Acquisition Corp.” to “FiscalNote Holdings, Inc.” | | |
The current charter designates the corporate name of DSAC as “Duddell Street Acquisition Corp.”
|
| |
Change name to “FiscalNote Holdings, Inc.” upon consummation of the Business Combination.
|
|
Name and Position
|
| |
Dollar Value
($) |
| |
Number of
Shares |
| ||||||
All current executive officers as a group
|
| | | $ | | | | | | | | | |
All current directors who are not executive officers as a group
|
| | | | — | | | | | | — | | |
All employees, including all current officers who are not executive officers, as a group
|
| | | | — | | | | | | — | | |
| | |
Assuming No Redemptions
|
| |
Assuming Maximum
Redemptions |
| ||||||||||||||||||
| | |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| ||||||||||||
DSAC Shareholders | | | | | | | | | | | | | | | | | | | | | | | | | |
Public shares owned by public shareholders
|
| | | | 13,500,000 | | | | | | 10.6% | | | | | | — | | | | | | — | | |
Public shares owned by the Sponsor(1)(2)
|
| | | | 4,000,000 | | | | | | 3.1% | | | | | | 17,500,000 | | | | | | 13.7% | | |
Initial shares
|
| | | | 4,375,000 | | | | | | 3.4% | | | | | | 4,375,000 | | | | | | 3.4% | | |
PIPE shares
|
| | | | 10,000,000 | | | | | | 7.8% | | | | | | 10,000,000 | | | | | | 7.8% | | |
FiscalNote Stockholders | | | | | | | | | | | | | | | | | | | | | | | | | |
Class A Shares(3)(4)
|
| | | | 87,561,867 | | | | | | 68.4% | | | | | | 87,561,867 | | | | | | 68.4% | | |
Class B Shares(5)
|
| | | | 8,491,491 | | | | | | 6.6% | | | | | | 8,491,491 | | | | | | 6.6% | | |
Total
|
| | | | 127,928,359 | | | | | | 100.0% | | | | | | 127,928,359 | | | | | | 100.0% | | |
| | |
Shares of
FiscalNote |
| |
Conversion
ratio |
| |
Shares of New
FiscalNote |
| |||||||||
FiscalNote common stock converted to New FiscalNote Class A
Shares |
| | | | 7,791,173 | | | | | | 1.206 | | | | | | 9,397,152 | | |
FiscalNote preferred shares
|
| | | | 39,250,698 | | | | | | 1.206 | | | | | | 47,341,368 | | |
FiscalNote options and RSUs
|
| | | | 4,041,422 | | | | | | 1.206 | | | | | | 4,874,473 | | |
FiscalNote warrants
|
| | | | 382,504 | | | | | | 1.206 | | | | | | 461,349 | | |
FiscalNote shares from convertible debt(a)
|
| | | | 25,173,112 | | | | | | 1.206 | | | | | | 30,361,998 | | |
Fully diluted Class A FiscalNote shares outstanding at Closing
|
| | | | 76,638,909 | | | | | | 1.206 | | | | | | 92,436,340 | | |
Less: FiscalNote options and RSUs outstanding
|
| | | | (4,041,422) | | | | | | 1.206 | | | | | | (4,874,473) | | |
Class A Common Stock of New FiscalNote issued to FiscalNote Stockholders
|
| | | | 72,597,487 | | | | | | 1.206 | | | | | | 87,561,867 | | |
Class B Common Stock of New FiscalNote issued to FiscalNote Stockholders
|
| | | | 7,040,290 | | | | | | 1.206 | | | | | | 8,491,491 | | |
| | |
Duddell
(Historical) |
| |
FiscalNote
(Historical) |
| |
Pro Forma
Transaction Adjustments (Assuming No Redemption and Maximum Redemptions) |
| |
Note
|
| |
Combined
Pro Forma (Assuming No Redemptions and Maximum Redemptions) |
| |||||||||||||||
Current Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 99 | | | | | $ | 35,722 | | | | | $ | 175,084 | | | | |
|
3a
|
| | | | $ | 160,551 | | |
| | | | | | | | | | | | | | | | | 100,000 | | | | |
|
3b
|
| | | | | | | |
| | | | | | | | | | | | | | | | | (50,000) | | | | |
|
3h
|
| | | | | | | |
| | | | | | | | | | | | | | | | | (48,913) | | | | |
|
3i
|
| | | | | | | |
| | | | | | | | | | | | | | | | | (7,377) | | | | |
|
3k
|
| | | | | | | |
| | | | | | | | | | | | | | | | | (28,897) | | | | |
|
3l
|
| | | | | | | |
| | | | | | | | | | | | | | | | | (15,167) | | | | |
|
3n
|
| | | | | | | |
Restricted cash
|
| | | | — | | | | | | 842 | | | | | | — | | | | | | | | | | | | 842 | | |
Accounts receivable, net
|
| | | | — | | | | | | 9,024 | | | | | | — | | | | | | | | | | | | 9,024 | | |
Costs capitalized to obtain revenue
contracts, net |
| | | | — | | | | | | 2,359 | | | | | | — | | | | | | | | | | | | 2,359 | | |
Prepaid expenses and other current assets
|
| | | | 381 | | | | | | 4,899 | | | | | | (1,178) | | | | |
|
3l
|
| | | | | 4,102 | | |
Total current assets
|
| | | | 480 | | | | | | 52,846 | | | | | | 123,552 | | | | | | | | | | | | 176,878 | | |
Property and equipment, net
|
| | | | — | | | | | | 7,653 | | | | | | — | | | | | | | | | | | | 7,653 | | |
Capitalized software costs, net
|
| | | | — | | | | | | 6,562 | | | | | | — | | | | | | | | | | | | 6,562 | | |
Noncurrent costs capitalized to obtain revenue contracts, net
|
| | | | — | | | | | | 1,872 | | | | | | — | | | | | | | | | | | | 1,872 | | |
Goodwill
|
| | | | — | | | | | | 175,684 | | | | | | — | | | | | | | | | | | | 175,684 | | |
Intangible assets, net
|
| | | | — | | | | | | 116,065 | | | | | | — | | | | | | | | | | | | 116,065 | | |
Investments and cash held in Trust Account
|
| | | | 175,084 | | | | | | — | | | | | | (175,084) | | | | |
|
3a
|
| | | | | — | | |
Total assets
|
| | | $ | 175,564 | | | | | $ | 360,682 | | | | | $ | (51,532) | | | | | | | | | | | $ | 484,714 | | |
Liabilities, temporary equity and stockholders’
equity (deficit) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Short-term debt and current maturities of long-term debt
|
| | | $ | — | | | | | $ | 9,350 | | | | | $ | — | | | | | | | | | | | $ | 9,350 | | |
Accounts payable
|
| | | | 1,607 | | | | | | 2,675 | | | | | | — | | | | | | | | | | | | 4,282 | | |
Accrued payroll
|
| | | | — | | | | | | 3,747 | | | | | | — | | | | | | | | | | | | 3,747 | | |
Accrued expenses
|
| | | | 1,387 | | | | | | 4,861 | | | | | | — | | | | | | | | | | | | 6,248 | | |
Deferred revenue, current portion
|
| | | | — | | | | | | 27,650 | | | | | | — | | | | | | | | | | | | 27,650 | | |
Customer deposits
|
| | | | — | | | | | | 1,647 | | | | | | — | | | | | | | | | | | | 1,647 | | |
Other current liabilities
|
| | | | — | | | | | | 6,298 | | | | | | — | | | | | | | | | | | | 6,298 | | |
Total current liabilities
|
| | | | 2,994 | | | | | | 56,228 | | | | | | — | | | | | | | | | | | | 59,222 | | |
Long-term debt, net of current maturities
|
| | | | — | | | | | | 289,464 | | | | | | (103,646) | | | | |
|
3g
|
| | | | | 53,595 | | |
| | | | | | | | | | | | | | | | | (69,398) | | | | |
|
3h
|
| | | | | — | | |
| | | | | | | | | | | | | | | | | (48,933) | | | | |
|
3i
|
| | | | | — | | |
| | | | | | | | | | | | | | | | | (8,576) | | | | |
|
3j
|
| | | | | | | |
| | | | | | | | | | | | | | | | | (5,316) | | | | |
|
3k
|
| | | | | | | |
Deferred tax liabilities
|
| | | | — | | | | | | 4,670 | | | | | | — | | | | | | | | | | | | 4,670 | | |
Deferred revenue, net of current portion
|
| | | | — | | | | | | 799 | | | | | | — | | | | | | | | | | | | 799 | | |
Deferred rent
|
| | | | — | | | | | | 8,505 | | | | | | — | | | | | | | | | | | | 8,505 | | |
Sublease loss liability, noncurrent portion
|
| | | | — | | | | | | 3,657 | | | | | | — | | | | | | | | | | | | 3,657 | | |
Lease incentive liability, net of current
portion |
| | | | — | | | | | | 4,572 | | | | | | — | | | | | | | | | | | | 4,572 | | |
Deferred underwriting commissions
|
| | | | 6,125 | | | | | | — | | | | | | (6,125) | | | | |
|
3l
|
| | | | | — | | |
Derivative warrant liabilities
|
| | | | 9,548 | | | | | | — | | | | | | — | | | | | | | | | | | | 9,548 | | |
Other noncurrent liabilities
|
| | | | — | | | | | | 5,288 | | | | | | — | | | | | | | | | | | | 5,288 | | |
Total liabilities
|
| | | | 18,667 | | | | | | 373,183 | | | | | | (241,994) | | | | | | | | | | | | 149,856 | | |
Commitments and Contingencies | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | |
Duddell
(Historical) |
| |
FiscalNote
(Historical) |
| |
Pro Forma
Transaction Adjustments (Assuming No Redemption and Maximum Redemptions) |
| |
Note
|
| |
Combined
Pro Forma (Assuming No Redemptions and Maximum Redemptions) |
| |||||||||||||||
Class A ordinary shares; 17,500,000 shares
subject to possible redemption at $10.00 per share at September 30, 2021 |
| | | | 175,000 | | | | | | — | | | | | | (175,000) | | | | |
|
3d
|
| | | | | — | | |
Redeemable, convertible preferred stock
|
| | | | — | | | | | | 469,805 | | | | | | (469,805) | | | | |
|
3f
|
| | | | | — | | |
Stockholders’ equity (deficit)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock
|
| | | | — | | | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at September 30, 2021
|
| | | | — | | | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Class A ordinary shares, $0.0001 par value;
180,000,000 shares authorized; none issued and outstanding at September 30, 2021 |
| | | | — | | | | | | — | | | | | | 1 | | | | |
|
3b
|
| | | | | 12 | | |
| | | | | | | | | | | | | | | | | — | | | | |
|
3c
|
| | | | | | | |
| | | | | | | | | | | | | | | | | 2 | | | | |
|
3d
|
| | | | | | | |
| | | | | | | | | | | | | | | | | 9 | | | | |
|
3m
|
| | | | | | | |
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 4,375,000 shares issued and outstanding at September 30, 2021
|
| | | | — | | | | | | — | | | | | | — | | | | |
|
3c
|
| | | | | 1 | | |
| | | | | | | | | | | | | | | | | 1 | | | | |
|
3m
|
| | | | | | | |
Additional paid-in capital
|
| | | | — | | | | | | — | | | | | | 99,999 | | | | |
|
3b
|
| | | | | 868,510 | | |
| | | | | | | | | | | | | | | | | 174,998 | | | | |
|
3d
|
| | | | | | | |
| | | | | | | | | | | | | | | | | (18,103) | | | | |
|
3e
|
| | | | | | | |
| | | | | | | | | | | | | | | | | 469,805 | | | | |
|
3f
|
| | | | | | | |
| | | | | | | | | | | | | | | | | 119,525 | | | | |
|
3g
|
| | | | | | | |
| | | | | | | | | | | | | | | | | 36,291 | | | | |
|
3h
|
| | | | | | | |
| | | | | | | | | | | | | | | | | 9,455 | | | | |
|
3j
|
| | | | | | | |
| | | | | | | | | | | | | | | | | (23,450) | | | | |
|
3l
|
| | | | | | | |
| | | | | | | | | | | | | | | | | (10) | | | | |
|
3m
|
| | | | | | | |
Accumulated other comprehensive loss
|
| | | | — | | | | | | (609) | | | | | | — | | | | | | | | | | | | (609) | | |
Accumulated deficit
|
| | | | (18,103) | | | | | | (481,697) | | | | | | 18,103 | | | | |
|
3e
|
| | | | | (533,056) | | |
| | | | | | | | | | | | | | | | | (15,879) | | | | |
|
3g
|
| | | | | | | |
| | | | | | | | | | | | | | | | | (16,893) | | | | |
|
3h
|
| | | | | | | |
| | | | | | | | | | | | | | | | | 20 | | | | |
|
3i
|
| | | | | | | |
| | | | | | | | | | | | | | | | | (879) | | | | |
|
3j
|
| | | | | | | |
| | | | | | | | | | | | | | | | | (2,061) | | | | |
|
3k
|
| | | | | | | |
| | | | | | | | | | | | | | | | | (500) | | | | |
|
3l
|
| | | | | | | |
| | | | | | | | | | | | | | | | | (15,167) | | | | |
|
3n
|
| | | | | | | |
Total Stockholders’ equity (deficit)
|
| | | | (18,103) | | | | | | (482,306) | | | | | | 835,267 | | | | | | | | | | | | 334,858 | | |
Liabilities, temporary equity and stockholders’
equity (deficit) |
| | | $ | 175,564 | | | | | $ | 360,682 | | | | | $ | (51,532) | | | | | | | | | | | $ | 484,714 | | |
|
| | |
Duddell
(Historical) |
| |
FiscalNote
(Historical) |
| |
Pro Forma
Adjustments (Assuming No Redemption and Maximum Redemptions) |
| |
Note
|
| |
Combined
Pro Forma (Assuming No Redemptions and Maximum Redemptions) |
| |||||||||||||||
Revenues | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Subscription
|
| | | | — | | | | | | 53,098 | | | | | | — | | | | | | | | | | | | 53,098 | | |
Advisory, advertising and other
|
| | | | — | | | | | | 5,352 | | | | | | — | | | | | | | | | | | | 5,352 | | |
Total revenues
|
| | | | — | | | | | | 58,450 | | | | | | — | | | | | | | | | | | | 58,450 | | |
Operating expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cost of revenues
|
| | | | — | | | | | | 14,664 | | | | | | — | | | | | | | | | | | | 14,664 | | |
Research and development
|
| | | | — | | | | | | 17,671 | | | | | | — | | | | | | | | | | | | 17,671 | | |
Sales and marketing
|
| | | | — | | | | | | 21,258 | | | | | | — | | | | | | | | | | | | 21,258 | | |
Editorial
|
| | | | — | | | | | | 10,967 | | | | | | — | | | | | | | | | | | | 10,967 | | |
General and administrative
|
| | | | 3,356 | | | | | | 25,184 | | | | | | 1,894 | | | | |
|
4d
|
| | | | | 30,434 | | |
Amortization of intangible assets
|
| | | | — | | | | | | 6,651 | | | | | | — | | | | | | | | | | | | 6,651 | | |
Loss on sublease
|
| | | | — | | | | | | 1,362 | | | | | | — | | | | | | | | | | | | 1,362 | | |
Total operating expenses
|
| | | | 3,356 | | | | | | 97,757 | | | | | | 1,894 | | | | | | | | | | | | 103,007 | | |
Operating loss
|
| | | | (3,356) | | | | | | (39,307) | | | | | | (1,894) | | | | | | | | | | | | (44,557) | | |
Interest expense, net
|
| | | | — | | | | | | (46,102) | | | | | | 43,345 | | | | |
|
4b
|
| | | | | (2,757) | | |
Change in fair value of warrant and derivative liabilities
|
| | | | 11,258 | | | | | | (9,406) | | | | | | 9,406 | | | | |
|
4c
|
| | | | | 11,258 | | |
Other expense
|
| | | | — | | | | | | (384) | | | | | | — | | | | | | | | | | | | (384) | | |
Interest earned on investments held in Trust Account
|
| | | | 54 | | | | | | — | | | | | | (54) | | | | |
|
4a
|
| | | | | — | | |
Net income (loss) before income taxes and loss on equity method investment
|
| | | | 7,956 | | | | | | (95,199) | | | | | | 50,803 | | | | | | | | | | | | (36,440) | | |
Benefit for income taxes
|
| | | | — | | | | | | 6,737 | | | | | | — | | | | |
|
4h
|
| | | | | 6,737 | | |
Net income (loss)
|
| | | | 7,956 | | | | | | (88,462) | | | | | | 50,803 | | | | | | | | | | | | (29,703) | | |
Other comprehensive loss, net of tax
|
| | | | — | | | | | | (546) | | | | | | — | | | | | | | | | | | | (546) | | |
Total comprehensive income (loss)
|
| | | $ | 7,956 | | | | | $ | (89,008) | | | | | $ | 50,803 | | | | | | | | | | | $ | (30,249) | | |
Weighted average shares outstanding of ordinary shares subject to redemption, basic and diluted
|
| | | | 17,500,000 | | | | | | | | | | | | | | | | | | | | | | | | | | |
Basic and diluted net income per share, ordinary shares subject to redemption
|
| | | $ | 0.36 | | | | | | | | | | | | | | | | | | | | | | | | | | |
Weighted average shares outstanding of ordinary shares, basic and diluted
|
| | | | 4,375,000 | | | | | | 12,351,464 | | | | | | | | | | | | | | | | | | 127,928,359 | | |
Basic and diluted net income (loss) per share, ordinary shares
|
| | | $ | 0.36 | | | | | $ | (24.83) | | | | | | | | | | | | | | | | | $ | (0.23) | | |
| | |
Duddell
(Historical) |
| |
FiscalNote
(Historical) |
| |
Pro Forma
Adjustments (Assuming No Redemption and Maximum Redemptions) |
| |
Note
|
| |
Combined
Pro Forma (Assuming No Redemptions and Maximum Redemptions) |
| |||||||||||||||
Revenues | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Subscription
|
| | | | — | | | | | | 60,002 | | | | | | — | | | | | | | | | | | | 60,002 | | |
Advertising and other
|
| | | | — | | | | | | 5,155 | | | | | | — | | | | | | | | | | | | 5,155 | | |
Total revenues
|
| | | | — | | | | | | 65,157 | | | | | | — | | | | | | | | | | | | 65,157 | | |
Operating expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cost of revenues
|
| | | | — | | | | | | 12,621 | | | | | | — | | | | | | | | | | | | 12,621 | | |
Research and development
|
| | | | — | | | | | | 15,122 | | | | | | — | | | | | | | | | | | | 15,122 | | |
Sales and marketing
|
| | | | — | | | | | | 21,559 | | | | | | — | | | | | | | | | | | | 21,559 | | |
Editorial
|
| | | | — | | | | | | 14,303 | | | | | | — | | | | | | | | | | | | 14,303 | | |
General and administrative
|
| | | | 672 | | | | | | 20,740 | | | | | | 4,535 | | | | |
|
4d
|
| | | | | 26,447 | | |
| | | | | | | | | | | | | | | | | 500 | | | | |
|
4g
|
| | | | | | | |
Amortization of intangible assets
|
| | | | — | | | | | | 7,345 | | | | | | — | | | | | | | | | | | | 7,345 | | |
Loss on debt extinguishment
|
| | | | — | | | | | | 2,433 | | | | | | — | | | | | | | | | | | | 2,433 | | |
Total operating expenses
|
| | | | 672 | | | | | | 94,123 | | | | | | 5,035 | | | | | | | | | | | | 99,830 | | |
Operating loss
|
| | | | (672) | | | | | | (28,966) | | | | | | (5,035) | | | | | | | | | | | | (34,673) | | |
Interest expense, net
|
| | | | — | | | | | | (31,829) | | | | | | 28,712 | | | | |
|
4b
|
| | | | | (53,976) | | |
| | | | | | | | | | | | | | | | | (35,692) | | | | |
|
4e
|
| | | | | | | |
| | | | | | | | | | | | | | | | | (15,167) | | | | |
|
4f
|
| | | | | | | |
Change in fair value of warrant and derivative liabilities
|
| | | | (7,980) | | | | | | 8,346 | | | | | | (8,346) | | | | |
|
4c
|
| | | | | (7,980) | | |
Financing cost – derivative warrant liabilities
|
| | | | (470) | | | | | | — | | | | | | — | | | | | | | | | | | | (470) | | |
Other expense
|
| | | | — | | | | | | (177) | | | | | | — | | | | | | | | | | | | (177) | | |
Interest earned on investments held in Trust Account
|
| | | | 31 | | | | | | — | | | | | | (31) | | | | |
|
4a
|
| | | | | — | | |
Net loss before income taxes and loss on
equity method investment |
| | | | (9,091) | | | | | | (52,626) | | | | | | (35,559) | | | | | | | | | | | | (97,276) | | |
Benefit for income taxes
|
| | | | — | | | | | | (1,435) | | | | | | — | | | | |
|
4h
|
| | | | | (1,435) | | |
Net loss before loss on equity method investment
|
| | | | (9,091) | | | | | | (51,191) | | | | | | (35,559) | | | | | | | | | | | | (95,841) | | |
Loss on equity method investment
|
| | | | — | | | | | | (81) | | | | | | — | | | | | | | | | | | | (81) | | |
Net loss
|
| | | | (9,091) | | | | | | (51,272) | | | | | | (35,559) | | | | | | | | | | | | (95,922) | | |
Other comprehensive loss, net of
tax |
| | | | — | | | | | | 91 | | | | | | — | | | | | | | | | | | | 91 | | |
Total comprehensive loss
|
| | | $ | (9,091) | | | | | $ | (51,181) | | | | | $ | (35,559) | | | | | | | | | | | $ | (95,831) | | |
Weighted average shares outstanding of ordinary shares subject to redemption, basic and diluted
|
| | | | 8,536,585 | | | | | | | | | | | | | | | | | | | | | | | | | | |
Basic and diluted net income per share, ordinary shares subject to redemption
|
| | | $ | (0.70) | | | | | | | | | | | | | | | | | | | | | | | | | | |
Weighted average shares outstanding of ordinary shares, basic and diluted
|
| | | | 4,375,000 | | | | | | 9,521,927 | | | | | | | | | | | | | | | | | | 127,928,359 | | |
Basic and diluted net loss per share, ordinary shares
|
| | | $ | (0.70) | | | | | $ | (8.74) | | | | | | | | | | | | | | | | | $ | (0.75) | | |
| | |
For the nine months ended
September 30, 2021 |
| |
For the year ended
December 31, 2020 |
| ||||||
|
Pro Forma Combined
(Assuming No Redemption and Maximum Redemption) |
| |
Pro Forma Combined
(Assuming No Redemption and Maximum Redemption) |
| ||||||||
Pro forma net loss attributable to common shareholders – basic and diluted
|
| | | $ | (29,703) | | | | | $ | (88,744) | | |
Weighted average shares outstanding – basic and diluted
|
| | | | 127,928,359 | | | | | | 127,928,359 | | |
Pro Forma Loss Per Share – basic and diluted
|
| | | $ | (0.23) | | | | | $ | (0.75) | | |
Pro Forma Weighted Average Shares – Basic and Diluted | | | | | | | | | | | | | |
Public shares
|
| | | | 17,500,000 | | | | | | 17,500,000 | | |
Initial shares
|
| | | | 4,375,000 | | | | | | 4,375,000 | | |
PIPE shares
|
| | | | 10,000,000 | | | | | | 10,000,000 | | |
Class A Shares
|
| | | | 87,561,867 | | | | | | 87,561,867 | | |
Class B Shares
|
| | | | 8,491,491 | | | | | | 8,491,491 | | |
Total Pro Forma Weighted Average Shares – basic and diluted
|
| | | | 127,928,359 | | | | | | 127,928,359 | | |
Name
|
| |
Age
|
| |
Position
|
|
Manoj Jain | | |
43
|
| | Chief Executive Officer, Co-Chief Investment Officer and Chairman of the Board of Directors | |
Sohit Khurana | | |
48
|
| | President, Chief Risk Officer and Director | |
Allan Finnerty | | |
49
|
| | Chief Financial Officer | |
Marc Holtzman | | |
61
|
| | Director | |
Bradford Allen | | |
65
|
| | Director | |
Mark Derrick Collier | | |
67
|
| | Director | |
| | |
Nine months ended
September 30, 2021 |
| |
Year ended
December 31, 2020 |
| ||||||
| | | (Unaudited) | | | | | | | | | ||
Income Statement Data: | | | | | | | | | | | | | |
Loss from operations
|
| | | $ | (3,356) | | | | | $ | (672) | | |
Net income (loss)
|
| | | $ | 7,956 | | | | | $ | (9,091) | | |
Weighted average shares outstanding of common stock subject of redemption, basic and diluted
|
| | | | 17,500,000 | | | | | | 8,536,585 | | |
Basic and diluted net income per share subject to redemption
|
| | | $ | 0.36 | | | | | $ | (0.70) | | |
Weighted average shares outstanding of common stock, basic and diluted
|
| | | | 4,375,000 | | | | | | 4,375,000 | | |
Basic and diluted net income (loss) per share
|
| | | $ | 0.36 | | | | | $ | (0.70) | | |
Balance Sheet Data (at period end): | | | | | | | | | | | | | |
Investments held in Trust Account
|
| | | $ | 175,084 | | | | | $ | 175,031 | | |
Total assets
|
| | | $ | 175,564 | | | | | $ | 176,232 | | |
Total liabilities
|
| | | $ | 18,667 | | | | | $ | 27,290 | | |
Common stock subject to possible redemption
|
| | | $ | 175,000 | | | | | $ | 175,000 | | |
Total stockholders’ equity
|
| | | $ | (18,103) | | | | | $ | (26,058) | | |
(In thousands, except shares and per share data)
|
| |
Nine months ended September 30,
|
| |
Year ended December 31,
|
| ||||||||||||||||||
|
2021
|
| |
2020
|
| |
2020
|
| |
2019
|
| ||||||||||||||
| | |
(Unaudited)
|
| |
(Unaudited)
|
| | | | | | | | | | | | | ||||||
Income Statement Data: | | | | | | | | | | | | | | | | | | | | | | | | | |
Revenue
|
| | | $ | 58,450 | | | | | $ | 48,510 | | | | | $ | 65,157 | | | | | $ | 65,870 | | |
Operating loss
|
| | | $ | (39,307) | | | | | $ | (19,597) | | | | | $ | (28,966) | | | | | $ | (29,125) | | |
Net loss
|
| | | $ | (88,462) | | | | | $ | (37,972) | | | | | $ | (51,272) | | | | | $ | (33,335) | | |
Loss per share – basic and diluted
|
| | | $ | (24.83) | | | | | $ | (3.67) | | | | | $ | (8.74) | | | | | $ | (4.82) | | |
Balance Sheet Data (at period end): | | | | | | | | | | | | | | | | | | | | | | | | | |
Total assets
|
| | | $ | 360,682 | | | | | $ | 264,748 | | | | | $ | 280,106 | | | | | $ | 243,120 | | |
Long-term debt
|
| | | $ | 289,464 | | | | | $ | 211,769 | | | | | $ | 211,968 | | | | | $ | 155,427 | | |
Total liabilities
|
| | | $ | 373,183 | | | | | $ | 280,643 | | | | | $ | 272,373 | | | | | $ | 225,480 | | |
Temporary equity
|
| | | $ | 469,805 | | | | | $ | 203,613 | | | | | $ | 238,963 | | | | | $ | 206,972 | | |
Total shareholders’ deficit
|
| | | $ | (482,306) | | | | | $ | (219,508) | | | | | $ | (231,230) | | | | | $ | (189,332) | | |
| | |
September 30,
|
| |
December 31,
|
| ||||||||||||||||||
(in thousands)
|
| |
2021
|
| |
2020
|
| |
2020
|
| |
2019
|
| ||||||||||||
Annual Recurring Revenue
|
| | | $ | 60,400 | | | | | $ | 55,900 | | | | | $ | 56,000 | | | | | $ | 56,100 | | |
| | |
Nine months ended September 30,
|
| |
Year ended December 31,
|
| ||||||||||||||||||
| | |
2021
|
| |
2020
|
| |
2020
|
| |
2019
|
| ||||||||||||
Net Revenue Retention
|
| | | | 95.4% | | | | | | 92.2% | | | | | | 90% | | | | | | (a) | | |
|
For the Three Months Ended
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
|
September 30,
2021 |
| |
June 30,
2021 |
| |
March 31,
2021 |
| |
December 31,
2020 |
| |
September 30,
2020 |
| |
June 30,
2020 |
| |
March 31,
2020 |
| |
December 31,
2019 |
| |
September 30,
2019 |
| ||||||||||||||||||||||||
|
99%
|
| | | | 101% | | | | | | 96% | | | | | | 97% | | | | | | 99% | | | | | | 98% | | | | | | 95% | | | | | | 98% | | | | | | 97% | | |
| | |
Nine months ended
September 30, |
| |
Change 2021 vs. 2020
|
| ||||||||||||||||||
(in thousands)
|
| |
2021
|
| |
2020
|
| |
$
|
| |
%
|
| ||||||||||||
Revenues: | | | | | | | | | | | | | | | | | | | | | | | | | |
Subscription
|
| | | $ | 53,098 | | | | | $ | 44,717 | | | | | $ | 8,381 | | | | | | 19% | | |
Advisory, advertising, and other
|
| | | | 5,352 | | | | | | 3,793 | | | | | | 1,559 | | | | | | 41% | | |
Total revenues
|
| | | | 58,450 | | | | | | 48,510 | | | | | | 9,940 | | | | | | 20% | | |
Operating expenses: | | | | | | | | | | | | | | | | | | | | | | | | | |
Costs of revenues
|
| | | | 14,664 | | | | | | 9,811 | | | | | | 4,853 | | | | | | 49% | | |
Research and development
|
| | | | 17,671 | | | | | | 11,304 | | | | | | 6,367 | | | | | | 56% | | |
Sales and marketing
|
| | | | 21,258 | | | | | | 15,612 | | | | | | 5,646 | | | | | | 36% | | |
Editorial
|
| | | | 10,967 | | | | | | 10,929 | | | | | | 38 | | | | | | 0% | | |
General and administrative
|
| | | | 25,184 | | | | | | 14,944 | | | | | | 10,240 | | | | | | 69% | | |
Amortization of intangibles
|
| | | | 6,651 | | | | | | 5,507 | | | | | | 1,144 | | | | | | 21% | | |
Loss on sublease
|
| | | | 1,362 | | | | | | — | | | | | | 1,362 | | | | | | 100% | | |
Total operating expenses
|
| | | | 97,757 | | | | | | 68,107 | | | | | | 29,650 | | | | | | 44% | | |
Loss from operations
|
| | | | (39,307) | | | | | | (19,597) | | | | | | (19,710) | | | | | | 101% | | |
Interest expense, net
|
| | | | 46,102 | | | | | | 22,483 | | | | | | 23,619 | | | | | | 105% | | |
Change in fair value of warrant and derivative liabilities
|
| | | | 9,406 | | | | | | (4,159) | | | | | | 13,565 | | | | | | 326% | | |
Other (income) expense
|
| | | | 384 | | | | | | 152 | | | | | | 232 | | | | | | 153% | | |
Net loss before income taxes and loss on equity method investment
|
| | | | (95,199) | | | | | | (38,073) | | | | | | (57,126) | | | | | | 150% | | |
Benefit for income taxes
|
| | | | (6,737) | | | | | | (182) | | | | | | (6,555) | | | | | | nm | | |
Net loss before loss on equity method investment
|
| | | | (88,462) | | | | | | (37,891) | | | | | | (50,571) | | | | | | 133% | | |
Loss on equity method investment
|
| | | | — | | | | | | (81) | | | | | | 81 | | | | | | (100)% | | |
Net loss
|
| | | $ | (88,462) | | | | | $ | (37,972) | | | | | $ | (50,490) | | | | | | 133% | | |
| | |
Nine months ended September 30,
|
| |
Change 2021 vs. 2020
|
| ||||||||||||||||||
(in thousands)
|
| |
2021
|
| |
2020
|
| |
$
|
| |
%
|
| ||||||||||||
North America
|
| | | $ | 52,433 | | | | | $ | 47,308 | | | | | $ | 5,125 | | | | | | 11% | | |
Europe
|
| | | | 5,307 | | | | | | 1,120 | | | | | | 4,187 | | | | | | 374% | | |
Asia
|
| | | | 307 | | | | | | 82 | | | | | | 225 | | | | | | 274% | | |
Australia
|
| | | | 403 | | | | |
|
—
|
| | | | | 403 | | | | | | 100% | | |
Total revenues
|
| | | $ | 58,450 | | | | | $ | 48,510 | | | | | $ | 9,940 | | | | | | 20% | | |
| | |
Year ended December 31,
|
| |
Change 2020 vs. 2019
|
| ||||||||||||||||||
(in thousands)
|
| |
2020
|
| |
2019
|
| |
$
|
| |
%
|
| ||||||||||||
Revenues: | | | | | | | | | | | | | | | | | | | | | | | | | |
Subscription
|
| | | $ | 60,002 | | | | | $ | 56,969 | | | | | $ | 3,033 | | | | | | 5% | | |
Advertising and other
|
| | | | 5,155 | | | | | | 8,901 | | | | | | (3,746) | | | | | | (42)% | | |
Total revenues
|
| | | | 65,157 | | | | | | 65,870 | | | | | | (713) | | | | | | (1)% | | |
Operating expenses: | | | | | | | | | | | | | | | | | | | | | | | | | |
Cost of revenues
|
| | | | 12,621 | | | | | | 13,193 | | | | | | (572) | | | | | | (4)% | | |
Research and development
|
| | | | 15,122 | | | | | | 14,810 | | | | | | 312 | | | | | | 2% | | |
Sales and marketing
|
| | | | 21,559 | | | | | | 21,817 | | | | | | (258) | | | | | | (1)% | | |
Editorial
|
| | | | 14,303 | | | | | | 15,367 | | | | | | (1,064) | | | | | | (7)% | | |
General and administrative
|
| | | | 20,740 | | | | | | 16,675 | | | | | | 4,065 | | | | | | 24% | | |
Amortization of intangibles
|
| | | | 7,345 | | | | | | 7,304 | | | | | | 41 | | | | | | 1% | | |
Loss on sublease
|
| | | | — | | | | | | 5,829 | | | | | | (5,829) | | | | | | (100)% | | |
Loss on debt extinguishment
|
| | | | 2,433 | | | | | | — | | | | | | 2,433 | | | | | | 100% | | |
Total operating expenses
|
| | | | 94,123 | | | | | | 94,995 | | | | | | (872) | | | | | | (1) | | |
Loss from operations
|
| | | | (28,966) | | | | | | (29,125) | | | | | | 159 | | | | | | (1)% | | |
Interest expense, net
|
| | | | 31,829 | | | | | | 22,940 | | | | | | 8,889 | | | | | | 39% | | |
Change in fair value of warrant and derivative liabilities
|
| | | | (8,346) | | | | | | 49 | | | | | | (8,395) | | | | | | nm | | |
Other (income) expense
|
| | | | 177 | | | | | | (22) | | | | | | 199 | | | | | | nm | | |
Net loss before income taxes and loss on equity method investment
|
| | | | (52,626) | | | | | | (52,092) | | | | | | (534) | | | | | | 1% | | |
Benefit from income taxes
|
| | | | (1,435) | | | | | | (18,824) | | | | | | 17,389 | | | | | | (92)% | | |
Net loss before loss on equity method investment
|
| | | | (51,191) | | | | | | (33,268) | | | | | | (17,923) | | | | | | 54% | | |
Loss on equity method investment
|
| | | | (81) | | | | | | (67) | | | | | | (14) | | | | | | 21% | | |
Net loss
|
| | | $ | (51,272) | | | | | $ | (33,335) | | | | | $ | (17,937) | | | | | | 54% | | |
| | |
Year ended December 31,
|
| |
Change 2021 vs. 2020
|
| ||||||||||||||||||
(in thousands)
|
| |
2020
|
| |
2019
|
| |
$
|
| |
%
|
| ||||||||||||
North America
|
| | | $ | 63,360 | | | | | $ | 64,714 | | | | | $ | (1,354) | | | | | | (2)% | | |
Europe
|
| | | | 1,574 | | | | | | 1,156 | | | | | | 418 | | | | | | 36% | | |
Asia
|
| | | | 223 | | | | | | — | | | | | | 223 | | | | | | 100% | | |
Total revenues
|
| | | $ | 65,157 | | | | | $ | 65,870 | | | | | $ | (713) | | | | | | (1)% | | |
| | |
Nine months ended September 30,
|
| |
Year ended December 31,
|
| ||||||||||||||||||
(in thousands)
|
| |
2021
|
| |
2020
|
| |
2020
|
| |
2019
|
| ||||||||||||
Subscription revenue
|
| | | $ | 53,098 | | | | | $ | 44,717 | | | | | $ | 60,002 | | | | | $ | 56,969 | | |
Deferred revenue adjustment
|
| | | | 1,533 | | | | | | — | | | | | | — | | | | | | — | | |
Adjusted subscription revenue
|
| | | | 54,631 | | | | | | 44,717 | | | | | | 60,002 | | | | | | 56,969 | | |
Advisory, advertising, and other revenue
|
| | | | 5,352 | | | | | | 3,793 | | | | | | 5,155 | | | | | | 8,901 | | |
Total adjusted revenues
|
| | | $ | 59,983 | | | | | $ | 48,510 | | | | | $ | 65,157 | | | | | $ | 65,870 | | |
| | |
Nine months ended September 30,
|
| |
Year ended December 31,
|
| ||||||||||||||||||
(in thousands)
|
| |
2021
|
| |
2020
|
| |
2020
|
| |
2019
|
| ||||||||||||
Adjusted revenues
|
| | | $ | 59,983 | | | | | $ | 48,510 | | | | | $ | 65,157 | | | | | $ | 65,870 | | |
Costs of revenue
|
| | | | (14,664) | | | | | | (9,811) | | | | | | (12,621) | | | | | | (13,193) | | |
Amortization of intangible assets
|
| | | | 4,077 | | | | | | 2,364 | | | | | | 2,862 | | | | | | 3,242 | | |
Adjusted gross profit
|
| | | $ | 49,396 | | | | | $ | 41,063 | | | | | $ | 55,398 | | | | | $ | 55,919 | | |
Adjusted gross profit margin
|
| | | | 82% | | | | | | 85% | | | | | | 85% | | | | | | 85% | | |
| | |
Nine months ended September 30,
|
| |
Year ended December 31,
|
| ||||||||||||||||||
(in thousands)
|
| |
2021
|
| |
2020
|
| |
2020
|
| |
2019
|
| ||||||||||||
Net loss
|
| | | $ | (88,462) | | | | | $ | (37,972) | | | | | $ | (51,272) | | | | | $ | (33,335) | | |
Benefit from income taxes
|
| | | | (6,737) | | | | | | (182) | | | | | | (1,435) | | | | | | (18,824) | | |
Depreciation and amortization
|
| | | | 11,598 | | | | | | 8,697 | | | | | | 11,509 | | | | | | 11,516 | | |
Interest expense, net
|
| | | | 46,102 | | | | | | 22,483 | | | | | | 31,829 | | | | | | 22,940 | | |
EBITDA
|
| | | | (37,499) | | | | | | (6,974) | | | | | | (9,369) | | | | | | (17,703) | | |
Deferred revenue adjustment(a)
|
| | | | 1,533 | | | | | | — | | | | | | — | | | | | | — | | |
Stock-based compensation
|
| | | | 547 | | | | | | 812 | | | | | | 1,004 | | | | | | 537 | | |
Change in fair value of warrant and derivative liabilities(b)
|
| | | | 9,406 | | | | | | (4,159) | | | | | | (8,346) | | | | | | 49 | | |
Other non-cash charges(c)
|
| | | | 2,407 | | | | | | 40 | | | | | | 2,483 | | | | | | 8,366 | | |
Acquisition related costs(d)
|
| | | | 1,051 | | | | | | — | | | | | | 148 | | | | | | — | | |
Other infrequent costs(e)
|
| | | | 2,735 | | | | | | 462 | | | | | | 834 | | | | | | 304 | | |
Costs incurred related to the transaction(f)
|
| | | | 889 | | | | | | — | | | | | | — | | | | | | — | | |
Adjusted EBITDA
|
| | | $ | (18,931) | | | | | $ | (9,819) | | | | | $ | (13,246) | | | | | $ | (8,447) | | |
Adjusted EBITDA Margin
|
| | | | (32)% | | | | | | (20)% | | | | | | (20)% | | | | | | (13)% | | |
| | |
Nine months ended
September 30, |
| |
Year ended December 31,
|
| ||||||||||||
(in thousands)
|
| |
2021
|
| |
2020
|
| |
2019
|
| |||||||||
Convertible Notes
|
| | | $ | 23,841 | | | | | $ | 59,680 | | | | | $ | 17,320 | | |
Series G Preferred Stock
|
| | | | 12,682 | | | | | | — | | | | | | — | | |
PPP Loan
|
| | | | — | | | | | | 8,000 | | | | | | — | | |
Senior Term Loan
|
| | | | 10,000 | | | | | | 8,237 | | | | | | — | | |
Total gross proceeds
|
| | | $ | 46,523 | | | | | $ | 75,917 | | | | | $ | 17,320 | | |
| | |
Nine months ended September 30,
|
| |
Year ended December 31,
|
| ||||||||||||||||||
(in thousands)
|
| |
2021
|
| |
2020
|
| |
2020
|
| |
2019
|
| ||||||||||||
Net loss
|
| | | $ | (88,462) | | | | | $ | (37,972) | | | | | $ | (51,272) | | | | | $ | (33,335) | | |
Net cash provided by (used in): | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating activities
|
| | | $ | (24,179) | | | | | $ | (12,063) | | | | | $ | (17,167) | | | | | $ | (16,903) | | |
Investing activities
|
| | | | (30,309) | | | | | | (2,103) | | | | | | (5,490) | | | | | | (3,145) | | |
Financing activities
|
| | | | 45,992 | | | | | | 42,497 | | | | | | 60,682 | | | | | | 23,587 | | |
| | |
Assuming No
Redemptions |
| |
Assuming 50%
Redemptions |
| |
Assuming Maximum
Redemptions |
| |||||||||||||||||||||||||||
| | |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| ||||||||||||||||||
DSAC Shareholders | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Public shares owned by public shareholders | | | | | 13,500,000 | | | | | | 10.6% | | | | | | 6,750,000 | | | | | | 5.3% | | | | | | — | | | | | | — | | |
Public shares owned by the Sponsor(1)(2)
|
| | | | 4,000,000 | | | | | | 3.1% | | | | | | 10,750,000 | | | | | | 8.4% | | | | | | 17,500,000 | | | | | | 13.7% | | |
Initial shares
|
| | | | 4,375,000 | | | | | | 3.4% | | | | | | 4,375,000 | | | | | | 3.4% | | | | | | 4,375,000 | | | | | | 3.4% | | |
PIPE shares
|
| | | | 10,000,000 | | | | | | 7.8% | | | | | | 10,000,000 | | | | | | 7.8% | | | | | | 10,000,000 | | | | | | 7.8% | | |
FiscalNote Stockholders | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Class A Shares(3)(4) | | | | | 87,561,867 | | | | | | 68.4% | | | | | | 87,561,867 | | | | | | 68.4% | | | | | | 87,561,867 | | | | | | 68.4% | | |
Class B Shares(5) | | | | | 8,491,491 | | | | | | 6.6% | | | | | | 8,491,491 | | | | | | 6.6% | | | | | | 8,491,491 | | | | | | 6.6% | | |
Total
|
| | | | 127,928,359 | | | | | | 100.0% | | | | | | 127,928,359 | | | | | | 100.0% | | | | | | 127,928,359 | | | | | | 100.0% | | |
|
DSAC
|
| |
New FiscalNote
|
|
| Authorized Share Capital | | | | |
|
Under the Cayman Constitutional Documents, DSAC is currently authorized to issue 201,000,000 shares, consisting of (a) 200,000,000 ordinary shares, including 180,000,000 DSAC Class A ordinary shares, par value $0.0001 per share, and 20,000,000 DSAC Class B ordinary shares, par value $0.0001 per share, and (b) 1,000,000 preference shares, par value $0.0001 per share.
Under the Cayman Constitutional Documents, an increase in share capital occurs by ordinary resolution.
|
| | New FiscalNote will be authorized to issue 1,809,000,000 shares, consisting of (a) 1,700,000,000 shares of New FiscalNote Class A common stock, par value $0.0001 per share , (b) 9,000,000 shares of New FiscalNote Class B common stock, par value $0.0001 per share, and (c) 100,000,000 shares of New FiscalNote preferred stock, par value $0.0001 per share. | |
| Rights of Preferred Stock | | | | |
| Subject to the Current Charter, and, where applicable, the rules of the designated stock exchange and/or any competent regulatory authority, all shares for the time being unissued shall be under the control of the directors who may: (a) issue, allot and dispose of the same to such persons, in such manner, on such terms and having such rights and being subject to such restrictions as they may from time to time determine; and (b) grant options with respect to such shares and issue warrants or similar instruments with respect thereto; and, for such purposes, the directors may | | | The New FiscalNote Board may fix for any class or series of preferred stock such powers, and such designations, preferences and relative, participating, optional or other special rights and such qualifications, limitations or restrictions thereof, as may be stated in the resolutions of the New FiscalNote Board providing for the issuance of such class or series. The resolutions providing for issuance of any series of preferred stock may provide that such series shall be superior or rank equally or be junior to any other series of preferred stock to the extent permitted by law. | |
|
DSAC
|
| |
New FiscalNote
|
|
| reserve an appropriate number of shares for the time being unissued; provided however that the directors shall not allot, issue, grant options over or otherwise dispose of shares (including fractions of a share) to the extent that it may affect the ability of DSAC to carry out a founder share conversion as set out in the Current Charter. | | | | |
| Number and Qualification of Directors | | | | |
| The Cayman Constitutional Documents provide that prior to the closing of a business combination the appointment of the DSAC Board is permitted by ordinary resolution of the holders of DSAC Class B ordinary shares. | | | Subject to the rights of holders of any series of preferred stock to elect directors, the number of the directors of New FiscalNote shall be fixed from time to time by the New FiscalNote Board. Unless otherwise approved by the Requisite Stockholder Consent, the number of the directors shall be no less than five (5) and shall not exceed twelve (12). | |
| Classification of the Board of Directors | | | | |
| For so long as DSAC’s shares are traded on a designated stock exchange, the directors shall be divided into three (3) classes designated as Class I, Class II and Class III, respectively. Directors shall be assigned to each class in accordance with a resolution or resolutions adopted by the board of directors. At the first annual general meeting of Members after the IPO, the term of office of the Class I directors shall expire and Class I directors shall be elected for a full term of three (3) years. At the second annual general meeting of members after the IPO, the term of office of the Class II directors shall expire and Class II directors shall be elected for a full term of three (3) years. At the third annual general meeting of members after the IPO, the term of office of the Class III directors shall expire and Class III directors shall be elected for a full term of three (3) years. At each succeeding annual general meeting of members, directors shall be elected for a full term of three (3) years to succeed the directors of the class whose terms expire at such annual general meeting. Notwithstanding the foregoing provisions of this article, each director shall hold office until the expiration of his term, until his successor shall have been duly elected and qualified or until his earlier death, resignation or removal. No decrease in the number of directors constituting the board of directors shall shorten the term of any incumbent director. | | | Subject to the special rights of the holders of any series of preferred stock to elect directors, the directors of New FiscalNote shall be divided, with respect to the time for which they severally hold office, into three classes designated as Class I, Class II and Class III. The Board is authorized to assign members of the Board already in office to such classes. The number of directors in each class shall be divided as nearly equal as is practicable. The initial term of office of the Class I directors shall expire at New FiscalNote’s first annual meeting of stockholders following the Effective Date, the initial term of office of the Class II directors shall expire at New FiscalNote’s second annual meeting of stockholders following the Effective Date, and the initial term of office of the Class III directors shall expire at New FiscalNote’s third annual meeting of stockholders following the Effective Date. At each annual meeting of stockholders following the Effective Date, directors elected to succeed those directors of the class whose terms then expire shall be elected for a term of office expiring at the third succeeding annual meeting of stockholders after their election. | |
| Election of Directors | | | | |
| Prior to the closing of a business combination, DSAC may by ordinary resolution of the holders of the DSAC Class B ordinary shares increase and decrease the number of directors and appoint any | | | The vote required for election of a director by the stockholders at a meeting of stockholders in which a quorum is present shall be the affirmative vote of a plurality of the votes cast by stockholders entitled | |
|
DSAC
|
| |
New FiscalNote
|
|
|
person to be a director or may by ordinary resolution of the holders of the DSAC Class B ordinary shares remove any director. For the avoidance of doubt, prior to the closing of a business combination, holders of DSAC Class A ordinary shares shall have no right to vote on the appointment or removal of any director, even if such director will be appointed in connection with the closing of a business combination. Therefore, only holders of the DSAC Class B ordinary shares will vote on the election of directors at the Special Meeting.
Each director shall hold office until the expiration of his term, until his successor shall have been duly elected and qualified or until his earlier death, resignation or removal. No decrease in the number of directors constituting the board of directors shall shorten the term of any incumbent director.
|
| |
to vote in such election.
Each director shall be elected or appointed for a term of office continuing until the annual meeting of stockholders of New FiscalNote at which such director’s term expires. Each director shall hold office until such director’s successor is elected and qualified, or until such director’s earlier death, resignation, retirement, disqualification or removal from office.
|
|
| Removal of Directors | | | | |
| Prior to the closing of a business combination, DSAC may by ordinary resolution of the holders of the DSAC Class B ordinary shares increase and decrease the number of DSAC directors and appoint any person to be a director or may by ordinary resolution of the holders of the DSAC Class B ordinary shares remove any director. Prior to the closing of a business combination, holders of DSAC Class A ordinary shares shall have no right to vote on the appointment or removal of any director, even if such director will be appointed in connection with the closing of a business combination. After the closing of a business combination, DSAC may by ordinary resolution appoint any person to be a director or may by ordinary resolution remove any director. | | | Subject to the rights of the holders of any series of preferred stock, no director may be removed from office except for cause and only with and immediately upon the Requisite Stockholder Consent. | |
| Voting | | | | |
| Under the Cayman Constitutional Documents, the holders of DSAC Class A ordinary shares and DSAC Class B ordinary shares are entitled to one vote for each such share on each matter properly submitted to DSAC’s shareholders entitled to vote. | | | Holders of New FiscalNote Class A common stock will be entitled to one (1) vote for each share of New FiscalNote Class A common stock held of record by such holder at all meetings of New FiscalNote stockholders and on all matters properly submitted to a vote of FiscalNote stockholders generally. Holders of New FiscalNote Class B common stock will be entitled to twenty-five (25) votes for each share of New FiscalNote Class B common stock held of record by such holder at all meetings of New FiscalNote stockholders and on all matters properly submitted to a vote of FiscalNote stockholders generally. | |
|
DSAC
|
| |
New FiscalNote
|
|
| | | | Holders of New FiscalNote common stock generally will vote together as a single class on all matters submitted to a vote of New FiscalNote stockholders (including the election and removal of directors), unless otherwise provided in the Proposed Charter or required by applicable law. Any action or matter submitted to a vote of the New FiscalNote stockholders will be approved if the number of votes cast in favor of the action or matter exceeds the number of votes cast in opposition to the action or matter, except that New FiscalNote’s directors will be elected by a plurality of the votes cast and that an affirmative vote of the holders of two-thirds (2/3) of the outstanding shares of New FiscalNote Class A common stock and New FiscalNote Class B common stock, voting together as a single class, is required to amend the Proposed Charter or approve any change of control transaction. Stockholders of New FiscalNote will not be entitled to cumulate their votes in the election of New FiscalNote’s directors. | |
| Cumulative Voting | | | | |
| Cayman Islands law does not prohibit cumulative voting, and DSAC’s Current Charter does not provide for cumulative voting. | | | There shall be no cumulative voting. | |
| Vacancies on the Board of Directors | | | | |
| Prior to the closing of a business combination, DSAC may by ordinary resolution of the holders of the DSAC Class B ordinary shares increase and decrease the number of Directors and appoint any person to be a director or may by ordinary resolution of the holders of the DSAC Class B ordinary shares remove any director. For the avoidance of doubt, prior to the closing of a business combination, holders of DSAC Class A ordinary shares shall have no right to vote on the appointment or removal of any director, even if such director will be appointed in connection with the closing of a business combination. | | | Subject to the rights of holders of any series of preferred stock and notwithstanding the requirement that the three classes shall be as nearly equal in number of directors as possible, newly created directorship that results from an increase in the number of directors or any vacancy on the Board that results from the death, disability, resignation, retirement, disqualification or removal of any director or from any other cause shall be filled: (i) prior to the Voting Threshold Date, solely by the stockholders of New FiscalNote with the Requisite Stockholder Consent, unless any such vacancy or newly created directorships remains unfilled for at least sixty (60) days, in which case such vacancy or newly created directorships may also be filled by the affirmative vote of a majority of the total number of directors then in office, even if less than a quorum, or by a sole remaining director; or (ii) on or after the Voting Threshold Date solely by the affirmative vote of a majority of the total number of directors then in office, even if less than a quorum, or by a sole remaining director. | |
|
DSAC
|
| |
New FiscalNote
|
|
| Stockholder Action by Written Consent | | | | |
| The Current Charter permits the shareholders to approve resolutions by way of unanimous written resolution. | | | Action required or permitted to be taken by the stockholders of New FiscalNote must be effected at an annual or special meeting of the stockholders and may not be effected by written consent in lieu of a meeting; provided, that prior to the Voting Threshold Date, such action may be taken by written consent by the holders of the outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting. | |
| Amendment to Certificate of Incorporation | | | | |
| DSAC may by special resolution alter or add to the Current Charter. | | | An amendment to the Proposed Charter requires the prior affirmative vote of the holders of two-thirds (2/3) of the outstanding shares of Class A common stock and Class B common stock, voting together as a single class. | |
| Amendment of the Bylaws | | | | |
| No similar provision. | | |
Subject to the terms of any series of preferred stock, the Board shall have the power to adopt, amend, alter or repeal the Bylaws by the affirmative vote of a majority of the directors present at any regular or special meeting of the Board at which a quorum is present.
The stockholders may not adopt, amend, alter or repeal the Bylaws, or adopt any provision inconsistent therewith, unless such action is approved, in addition to any other vote required by the Proposed Charter, by the Requisite Stockholder Consent.
|
|
| Quorum | | | | |
| No business shall be transacted at any general meeting unless a quorum of shareholders is present at the time when the meeting proceeds to business. Except as otherwise provided by the Current Charter, one or more shareholders holding at least a majority of the paid up voting share capital of DSAC present in person or by proxy and entitled to vote at that meeting shall form a quorum. | | | At each meeting of stockholders, the holders of a majority in voting power of the shares of the capital stock of New FiscalNote issued and outstanding and entitled to vote at the meeting, present in person or represented by proxy, shall constitute a quorum for the transaction of business; provided, however, that where a separate vote by a class or classes or series of capital stock is required by law or the Proposed Charter, the holders of a majority in voting power of the shares of such class or classes or series of the capital stock of New FiscalNote issued and outstanding and entitled to vote on such matter, present in person or represented by proxy, shall constitute a quorum entitled to take action with respect to the vote on such matter. A quorum, once established at a meeting, shall not be broken by the withdrawal of enough votes to leave less than a quorum. | |
|
DSAC
|
| |
New FiscalNote
|
|
| Interested Directors | | | | |
|
A director may hold any other office or place of profit under DSAC (other than the office of auditor) in conjunction with his office of director for such period and on such terms as to remuneration and otherwise as the directors may determine.
A director who is in any way, whether directly or indirectly, interested in a contract or proposed contract with DSAC shall declare the nature of his interest at a meeting of the directors. A general notice given to the directors by any director to the effect that he is to be regarded as interested in any contract or other arrangement which may thereafter be made with that company or firm shall be deemed a sufficient declaration of interest in regard to any contract so made. A director may vote in respect of any contract or proposed contract or arrangement notwithstanding that he may be interested therein and if he does so his vote shall be counted and he may be counted in the quorum at any meeting of the directors at which any such contract or proposed contract or arrangement shall come before the meeting for consideration.
|
| | No equivalent provision regarding Interested Directors in the Proposed Charter or Proposed Bylaws. | |
| Special Stockholder Meetings | | | | |
|
DSAC Board may call general meetings.
General meetings may also be convened on the requisition in writing of any shareholder or shareholders entitled to attend and vote at general meetings of DSAC holding at least 30% of the paid up voting share capital of DSAC. If at any time there are no directors, any two shareholders (or if there is only one shareholder, then that shareholder) entitled to vote at general meetings of DSAC may convene a general meeting
|
| |
Special meetings of stockholders for any purpose or purposes may be called at any time by the Board, the Chairperson of the Board or the Chief Executive Officer, and may not be called by another other Person or Persons; provided that, prior to the Final Conversion Date, special meetings of stockholders for any purpose or purposes may also be called by or at the request of stockholders collectively holding shares of capital stock with voting power sufficient to provide the Requisite Stockholder Consent.
Business transacted at any special meeting of stockholders shall be limited to matters relating to the purpose or purposes stated in the notice of meeting.
|
|
| Notice of Stockholder Meetings | | | | |
| At least five days’ notice in writing counting from the date service is deemed to take place as provided in the Current Charter specifying the place, the day and the hour of the meeting and the general nature of the business, shall be given in the manner hereinafter provided or in such other manner (if any) as may be prescribed by DSAC by ordinary resolution to such persons as are, under the Current Charter, entitled to receive such notices from DSAC, but with the consent of all the shareholders entitled | | |
Notice of each meeting of stockholders, whether annual or special, shall be given not less than ten (10) nor more than sixty (60) days before the date of the meeting to each stockholder entitled to vote at such meeting as of the record date for determining the stockholders entitled to notice of the meeting.
The notices of all meetings shall state the place, if any, date and time of the meeting, the means of remote communications, if any, by which
|
|
|
DSAC
|
| |
New FiscalNote
|
|
| to receive notice of some particular meeting and attend and vote thereat, that meeting may be convened by such shorter notice or without notice and in such manner as those shareholders may think fit. | | |
stockholders and proxyholders may be deemed to be present in person and vote at such meeting, and the record date for determining the stockholders entitled to vote at the meeting (if such date is different from the record date for stockholders entitled to notice of the meeting).
The notice of a special meeting shall state, in addition, the purpose or purposes for which the meeting is called.
|
|
| Stockholder Proposals (Other than Nomination of Persons for Election as Directors) | | | | |
| All business carried out at a general meeting shall be deemed special with the exception of sanctioning a dividend, the consideration of the accounts, balance sheets, any report of the directors or of DSAC’s auditors, and the fixing of the remuneration of DSAC’s auditors. No special business shall be transacted at any general meeting without the consent of all shareholders entitled to receive notice of that meeting unless notice of such special business has been given in the notice convening that meeting. | | | To be properly brought before an annual meeting, business (other than the nominations of persons for election to the Board) must constitute a proper matter for stockholder action and must be (i) specified in a notice of meeting given by or at the direction of the Board or any duly authorized committee thereof, (ii) if not specified in a notice of meeting, otherwise brought before the meeting by the Board or any duly authorized committee thereof or the Chairperson of the Board or (iii) otherwise properly brought before the meeting by a stockholder who (A) (1) was a stockholder of record both at the time of giving the notice and at the time of the meeting, (2) is entitled to vote at the meeting, and (3) has complied with the notice requirements of the Proposed Bylaws in all applicable respects or (B) properly made such proposal in compliance with Rule 14a-8 under the Exchange Act. | |
| Stockholder Nominations of Persons for Election as Directors | | | | |
| No similar provision. | | | Nominations of persons for election to the Board at an annual meeting of stockholders or a special meeting of stockholders at which directors are to be elected pursuant to New FiscalNote’s notice of meeting may be made (i) by or at the direction of the Board or any duly authorized committee thereof or (ii) by any stockholder of New FiscalNote who (x) timely complies with the notice procedures in the Proposed Bylaws, (y) is a stockholder of record on the date of the giving of such notice and on the record date for the determination of stockholders entitled to vote at such meeting and (z) is entitled to vote at such meeting and on such election. | |
| Limitation of Liability of Directors and Officers | | | | |
| DSAC’s officers and directors and their respective personal representatives (each an “Indemnified Person”) shall not be liable: (i) for the acts, receipts, neglects, defaults or omissions of any other director | | | A director of New FiscalNote shall not be personally liable to its stockholders for monetary damages for breach of fiduciary duty as a director provided, however, that nothing contained in the | |
|
DSAC
|
| |
New FiscalNote
|
|
| or officer or agent of DSAC; (ii) for any loss on account of defect of title to any property of DSAC; (iii) on account of the insufficiency of any security in or upon which any money of DSAC shall be invested; (iv) for any loss incurred through any bank, broker or other similar person; (v) for any loss occasioned by any negligence, default, breach of duty, breach of trust, error of judgement or oversight on such Indemnified Person’s part; or (vi) for any loss, damage or misfortune whatsoever which may happen in or arise from the execution or discharge of the duties, powers, authorities, or discretions of such Indemnified Person’s office or in relation thereto, unless the same shall happen through such Indemnified Person’s own actual fraud, willful default or willful neglect as determined by a court of competent jurisdiction. | | | Proposed Charter shall eliminate or limit the liability of a director (i) for any breach of the director’s duty of loyalty to New FiscalNote or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) pursuant to the provisions of Section 174 of the DGCL, or (iv) for any transaction from which the director derived an improper personal benefit | |
| Indemnification of Directors, Officers | | | | |
| Cayman Islands law does not limit the extent to which a company’s memorandum and articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against actual fraud, willful neglect or willful default. The Current Charter provide for indemnification of its officers and directors to the maximum extent permitted by law, including for any liability incurred in their capacities as such, except through their own actual fraud, willful neglect or willful default. | | | New FiscalNote may indemnify, and advance expenses, to the fullest extent permitted by law, to any person who is a party to or is threatened to be made a party to any threatened, pending or completed action, suit, investigation, arbitration or proceeding, whether civil, criminal, administrative or investigative by reason of the fact that the person is or was a director, officer, employee or agent of New FiscalNote or any of its subsidiaries or, while a director or officer of the New FiscalNote or any of its subsidiaries, or is or was serving at the request of New FiscalNote as a director, officer, employee or agent of another corporation, partnership, joint venture, or trust. | |
| Dividends | | | | |
|
Subject to any rights and restrictions for the time being attached to any shares, or as otherwise provided for in the Cayman Islands laws and the Current Charter, the directors may from time to time declare dividends (including interim dividends) and other distributions on shares in issue and authorize payment of the same out of the funds of DSAC lawfully available therefor. Subject to any rights and restrictions for the time being attached to any shares, DSAC by ordinary resolution may declare dividends, but no dividend shall exceed the amount recommended by the directors.
Subject to any rights and restrictions for the time being attached to any shares, all dividends shall be declared and paid according to the amounts paid up on the shares, but if and for so long as nothing is paid up on any of the shares dividends may be
|
| |
Shares of Class A common stock and Class B common stock shall be treated equally, identically and ratably, on a per share basis, with respect to any dividends or distributions as may be declared and paid from time to time by the Board; provided, however, that in the event a dividend is paid in the form of shares of Class A common stock or Class B common stock, then holders of Class A common stock shall be entitled to receive shares of Class A common stock, and holders of Class B common stock shall be entitled to receive shares of Class B common stock, with holders of shares of Class A common stock and Class B common stock receiving, on a per share basis, an identical number of shares of Class A common stock or Class B common stock, as applicable.
The Board may pay or make a disparate dividend or
|
|
|
DSAC
|
| |
New FiscalNote
|
|
| declared and paid according to the par value of the shares. | | | distribution per share of Class A common stock or Class B common stock if such disparate dividend or distribution is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class A common stock and Class B common stock, each voting separately as a class | |
| Liquidation | | | | |
|
If DSAC shall be wound up, the liquidator shall apply the assets of DSAC in such manner and order as he thinks fit in satisfaction of creditors’ claims.
If DSAC shall be wound up, the liquidator may, with the sanction of an ordinary resolution divide amongst the shareholders in specie or kind the whole or any part of the assets of DSAC (whether they shall consist of property of the same kind or not) and may, for such purpose set such value as he deems fair upon any property to be divided as aforesaid and may determine how such division shall be carried out as between the shareholders or different classes. The liquidator may, with the like sanction, vest the whole or any part of such assets in trustees upon such trusts for the benefit of the shareholders as the liquidator, with the like sanction shall think fit, but so that no shareholder shall be compelled to accept any assets whereon there is any liability
|
| | Subject to the preferential or other rights of any holders of preferred stock then outstanding, after payment or provision for payment of the debts and other liabilities, holders of Class A common stock and Class B common stock will be entitled to receive ratably all assets of New FiscalNote available for distribution to its stockholders unless disparate or different treatment of the shares of each such class with respect to distributions is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class A common stock and Class B common stock, each voting separately as a class | |
| Supermajority Voting Provisions | | | | |
| Whenever the capital of DSAC is divided into different classes (and as otherwise determined by the directors) the rights attached to any such class may, subject to any rights or restrictions for the time being attached to any class only be materially adversely varied or abrogated with the consent in writing of the holders of not less than two-thirds of the issued shares of the relevant class, or with the sanction of a resolution passed at a separate meeting of the holders of the shares of such class by a majority of two-thirds of the votes cast at such a meeting. To every such separate meeting all the provisions of the Current Charter relating to general meetings of DSAC or to the proceedings thereat shall, mutatis mutandis, apply, except that the necessary quorum shall be one or more persons at least holding or representing by proxy one-third in nominal or par value amount of the issued shares of the relevant class (but so that if at any adjourned meeting of such holders a quorum as above defined is not present, those shareholders who are present shall form a quorum) and that, subject to any rights or restrictions for the time being attached to the shares of that class, every shareholder of the class | | |
So long as any shares of New FiscalNote Class A common stock and New FiscalNote Class B common stock remain outstanding, the affirmative vote of the holders of two-thirds (2/3) of the outstanding shares of New FiscalNote Class A common stock and New FiscalNote Class B common stock, voting together as a single class, is required to amend the Proposed Charter or approve any change of control transaction.
Additionally, on and after the Voting Threshold Date, the affirmative vote of the holders of two-thirds (2/3) of the outstanding shares of New FiscalNote Class A common stock and New FiscalNote Class B common stock, voting together as a single class, is required to (i) amend the Proposed Bylaws, (ii) change the number of directors from less than five (5) to more than twelve (12), and (iii) remove a director for cause.
|
|
|
DSAC
|
| |
New FiscalNote
|
|
| shall on a poll have one vote for each share of the class held by him. For the purposes of this provision, the directors may treat all the classes or any two or more classes as forming one class if they consider that all such classes would be affected in the same way by the proposals under consideration, but in any other case shall treat them as separate classes. The directors may vary the rights attaching to any class without the consent or approval of shareholders provided that the rights will not, in the determination of the directors, be materially adversely varied or abrogated by such action. | | | | |
| Anti-Takeover Provisions and Other Stockholder Protections | | | | |
| The Current Charter provides for a staggered board of directors and the ability of the board of directors to designate the terms of and issue new series of preferred shares, which may make the removal of management more difficult and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices for DSAC’s securities. | | | Same. | |
| Preemptive Rights | | | | |
| There are no preemptive rights relating to the DSAC ordinary shares. | | | Same. | |
| Fiduciary Duties of Directors | | | | |
|
A director owes fiduciary duties to a company, including to exercise loyalty, honesty and good faith to DSAC as a whole.
In addition to the above, directors also owe a duty of care which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent person having both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same functions as are carried out by that director in relation to the company and the general knowledge skill and experience of that director.
|
| | Under Delaware law, the standards of conduct for directors have developed through Delaware court case law. Generally, directors of Delaware corporations are subject to a duty of loyalty and a duty of care. The duty of loyalty requires directors to refrain from self-dealing, and the duty of care requires directors in managing New FiscalNote’s affairs to use that level of care which ordinarily careful and prudent persons would use in similar circumstances. When directors act consistently with their duties of loyalty and care, their decisions generally are presumed to be valid under the business judgment rule | |
| Inspection of Books and Records | | | | |
| The directors shall determine whether and to what extent and at what times and places and under what conditions or regulations the accounts and books of DSAC or any of them shall be open to the inspection of shareholders not being directors and no shareholder (not being a director) shall have any right of inspecting any account or book or document of DSAC except as conferred by law or authorized by the directors or by ordinary resolution. | | | No similar provision. | |
|
DSAC
|
| |
New FiscalNote
|
|
| Choice of Forum | | | | |
| No similar provision. | | | Unless New FiscalNote consents in writing to the selection of an alternative forum, (i) the Court of Chancery of the State of Delaware (or, in the event that the Chancery Court does not have jurisdiction, the federal district court for the District of Delaware or other state courts of the State of Delaware) shall, to the fullest extent permitted by law, be the sole and exclusive forum for (1) any derivative action or proceeding brought on behalf of New FiscalNote, (2) any action asserting a claim of breach of a fiduciary duty owed by, or any other wrongdoing by, any current or former director, officer, other employee or stockholder of New FiscalNote, (3) any action asserting a claim against New FiscalNote arising pursuant to any provision of the DGCL, the Proposed Charter or Bylaws or as to which the DGCL confers jurisdiction on the Court of Chancery, (4) any action to interpret, apply, enforce or determine the validity of any provisions of the Proposed Charter or Bylaws, or (5) any other action asserting a claim governed by the internal affairs doctrine and (ii) the federal district courts of the United States shall be the exclusive forum for the resolution of any action, suit or proceeding asserting a cause of action arising under the Securities Act. | |
| | | | This provision will not apply to claims arising under the Exchange Act or other federal securities laws for which there is exclusive federal jurisdiction. | |
Name and Address of Beneficial
Owner |
| |
Before the Business Combination
|
| |
After the Business Combination
|
| |||||||||||||||||||||||||||||||||||||||
|
Assuming No Redemption
|
| |
Assuming Maximum Redemption
|
| |||||||||||||||||||||||||||||||||||||||||
|
DSAC
Class A ordinary shares |
| |
DSAC
Class B ordinary shares |
| |
% of
Total Voting Power** |
| |
New
FiscalNote Class A common stock |
| |
New
FiscalNote Class B common stock |
| |
% of
Total Voting Power** |
| |
New
FiscalNote Class A common stock |
| |
New
FiscalNote Class B common stock |
| |
% of
Total Voting Power** |
| ||||||||||||||||||||
|
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| |||||||||||
Directors and Executive Officers of DSAC
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Duddell Street Holdings Limited(1)(2)
|
| |
|
| |
|
| |
|
| |
|
| |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Manoj Jain(1)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Sohit Khurana(1)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Allan Finnerty(1)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Marc Holtzman(1)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Bradford Allen(1)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Mark Derrick Collier(1)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
All Directors and Executive Officers of DSAC as a Group (6 Individuals)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Directors and Executive Officers of New FiscalNote After Consummation of the Business Combination
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Tim Hwang
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Gerald Yao
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Michael J. Callahan
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Key Compton
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Stanley McChrystal
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Keith Nilsson
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Anna Sedgley
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Brandon Sweeney
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Conrad Yiu
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Chris Gerhart
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Jennifer Yi Boyer
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Jon Slabaugh
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Josh Resnik
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Krystal Putman-Garcia
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Reed Fawell
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Manoj Jain***
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[*]*** | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
All Directors and Executive Officers of New FiscalNote as a Group (15 Individuals)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
5% Beneficial Owners of New FiscalNote
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Duddell Street Holdings Limited(1)(2)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Name
|
| |
Age
|
| |
Position
|
|
Tim Hwang | | |
29
|
| | Chairman, Chief Executive Officer, Director and Co-Founder | |
Gerald Yao | | |
29
|
| | Chief Strategy Officer, Director | |
Jon Slabaugh | | |
57
|
| | Chief Financial Officer | |
Jennifer Yi Boyer | | |
47
|
| | Chief People Officer | |
Josh Resnik | | |
51
|
| | SVP, General Counsel and Chief Content Officer | |
Krystal Putman-Garcia | | |
42
|
| | Chief Marketing Officer | |
Reed Fawell | | |
47
|
| | Chief Revenue Officer | |
Chris Gerhart | | |
56
|
| | Chief Information Officer | |
Michael J. Callahan | | |
53
|
| | Director | |
Key Compton | | |
52
|
| | Director | |
Manoj Jain* | | |
43
|
| | Director | |
Stanley McChrystal | | |
67
|
| | Director | |
Keith Nilsson | | |
52
|
| | Director | |
Anna Sedgley | | |
50
|
| | Director | |
Brandon Sweeney | | |
54
|
| | Director | |
Conrad Yiu | | |
47
|
| | Director | |
[•]* | | |
[*]
|
| | Director | |
Name and principal position
|
| |
Year
|
| |
Salary
($) |
| |
Bonus
($) |
| |
Equity
awards ($)(1) |
| |
Non-equity
incentive plan compensation ($)(2) |
| |
All other
compensation ($)(3) |
| |
Total
($) |
| |||||||||||||||||||||
Timothy Hwang,
|
| | | | 2020 | | | | | $ | 250,000 | | | | | $ | 66,667 | | | | | $ | 278,950 | | | | | $ | — | | | | | $ | 13,248 | | | | | $ | 608,865 | | |
Chief Executive Officer
& Co-Founder |
| | | | 2019 | | | | | $ | 200,000 | | | | | $ | 150,000 | | | | | $ | — | | | | | $ | — | | | | | $ | 15,875 | | | | | $ | 365,875 | | |
Josh Resnik,
|
| | | | 2020 | | | | | $ | 279,583 | | | | | $ | 53,891 | | | | | $ | 140,038 | | | | | $ | — | | | | | $ | 37,613 | | | | | $ | 511,125 | | |
Senior Vice President,
General Counsel & Chief Content Officer |
| | | | 2019 | | | | | $ | 265,000 | | | | | $ | 52,196 | | | | | $ | 48,654 | | | | | $ | — | | | | | $ | 30,316 | | | | | $ | 396,166 | | |
Reed Fawell,
|
| | | | 2020 | | | | | $ | 235,417 | | | | | $ | 37,500 | | | | | $ | 84,023 | | | | | $ | 127,795 | | | | | $ | 34,134 | | | | | $ | 518,869 | | |
Senior Vice President &
Chief Revenue Officer |
| | | | 2019 | | | | | $ | 225,000 | | | | | $ | 25,000 | | | | | $ | 21,886 | | | | | $ | 133,981 | | | | | $ | 30,365 | | | | | $ | 436,232 | | |
| | |
Option Awards
|
| |||||||||||||||||||||||||||
Name
|
| |
Grant
Date |
| |
Number of
Securities Underlying Unexercised Options (#) Exercisable |
| |
Number of
Securities Underlying Unexercised Options (#) Unexercisable |
| |
Option
Exercise Price ($) |
| |
Option
Expiration Date |
| |||||||||||||||
Timothy Hwang
|
| | | | 6/18/2018(1) | | | | | | 935,500 | | | | | | — | | | | | $ | 1.77 | | | | | | 6/17/2028 | | |
| | | | | 7/29/2020(2) | | | | | | — | | | | | | 250,000 | | | | | $ | 2.89 | | | | | | 7/28/2030 | | |
Josh Resnik
|
| | | | 5/2/2019(2) | | | | | | 17,437 | | | | | | 27,563 | | | | | $ | 2.65 | | | | | | 5/1/2029 | | |
| | | | | 7/29/2020(2) | | | | | | — | | | | | | 125,000 | | | | | $ | 2.89 | | | | | | 7/28/2030 | | |
Reed Fawell
|
| | | | 6/18/2018(5) | | | | | | 29,062 | | | | | | 15,938 | | | | | $ | 1.77 | | | | | | 6/17/2028 | | |
| | | | | 5/2/2019(6) | | | | | | 5,000 | | | | | | 15,000 | | | | | $ | 2.65 | | | | | | 5/1/2029 | | |
| | | | | 7/29/2020(7) | | | | | | — | | | | | | 75,000 | | | | | $ | 2.89 | | | | | | 7/28/2030 | | |
Name
|
| |
Fees Earned or
Paid in Cash ($) |
| |
Stock Awards
($)(1) |
| |
All Other
Compensation ($) |
| |
Total
($) |
| ||||||||||||
Timothy Hwang, Chairman
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Gerald Yao
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Michael J. Callahan
|
| | | | — | | | | | $ | 72,000 | | | | | | — | | | | | | — | | |
Keith Nilsson
|
| | | | — | | | | | $ | 144,000 | | | | | | — | | | | | | — | | |
Stanley McChrystal
|
| | | | — | | | | | $ | 144,000 | | | | | | — | | | | | | — | | |
Brandon Sweeney
|
| | | | — | | | | | $ | 72,000 | | | | | | — | | | | | | — | | |
Conrad Yiu
|
| | | | — | | | | | | —(2) | | | | | | — | | | | | | — | | |
| | | | | | Page | | |
| Financial Statements: | | | | | | | |
| | | | | F-2 | | | |
| | | | | F-3 | | | |
| | | | | F-4 | | | |
| | | | | F-5 | | | |
| | | | | F-6 | | | |
| | | | | F-7 | | |
| Unaudited Condensed Financial Statements: | | | | | | | |
| | | | | F-25 | | | |
| | | | | F-26 | | | |
| | | | | F-27 | | | |
| | | | | F-28 | | | |
| | | | | F-29 | | |
| | |
Page(s)
|
| | |||||
Audited consolidated financial statements | | | | | | | | | ||
As of December 31, 2020 and 2019 and for the years then ended | | | | | | | | | ||
| | | | F-58 | | | | | | |
| | | | F-59 | | | | |||
| | | | F-60 | | | | |||
| | | | F-61 | | | | |||
| | | | F-62 | | | | |||
| | | | F-63 | | | | |||
Unaudited condensed consolidated financial statements | | | | | | | | | ||
As of September 30, 2020 and December 31, 2020 and for the nine months ended September 30, 2021 and 2020
|
| | | | | | | | ||
| | | | F-102 | | | | |||
| | | | F-103 | | | | |||
| | | | F-104 | | | | |||
| | | | F-105 | | | | |||
| | | | F-107 | | | |
| Assets | | | | | | | |
| Current assets: | | | | | | | |
|
Due from related party
|
| | | $ | 411,692 | | |
|
Prepaid expenses
|
| | | | 789,798 | | |
|
Total current assets
|
| | | | 1,201,490 | | |
|
Investments held in Trust Account
|
| | | | 175,030,689 | | |
|
Total Assets
|
| | | $ | 176,232,179 | | |
| Liabilities, Class A ordinary shares subject to Possible Redemption and Shareholders’ Equity | | | | | | | |
| Current liabilities: | | | | | | | |
|
Accounts payable
|
| | | $ | 4,291 | | |
|
Accrued expenses
|
| | | | 179,780 | | |
|
Note payable – related party
|
| | | | 175,626 | | |
|
Total current liabilities
|
| | | | 359,697 | | |
|
Derivative warrant liabilities
|
| | | | 20,805,000 | | |
|
Deferred underwriting commissions
|
| | | | 6,125,000 | | |
|
Total liabilities
|
| | | $ | 27,289,697 | | |
| Commitments and Contingencies (Note 6) | | | | | | | |
|
Class A ordinary shares; 17,500,000 shares subject to possible redemption at $10.00 per share
|
| | | | 175,000,000 | | |
| Shareholders’ Equity: | | | | | | | |
|
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
|
| | | | — | | |
|
Class A ordinary shares, $0.0001 par value; 180,000,000 shares authorized; 0 shares issued and outstanding (excluding 17,500,000 shares subject to possible redemption)
|
| | | | — | | |
|
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 4,375,000 shares issued and outstanding
|
| | | | 437 | | |
|
Additional paid-in capital
|
| | | | — | | |
|
Accumulated deficit
|
| | | | (26,057,955) | | |
|
Total shareholders’ equity
|
| | | | (26,057,518) | | |
|
Total Liabilities, Class A ordinary shares subject to Possible Redemption and Shareholders’ Equity
|
| | | $ | 176,232,179 | | |
|
General and administrative expenses
|
| | | $ | 672,065 | | |
|
Loss from operations
|
| | | | (672,065) | | |
|
Change in fair value of derivative warrant liabilities
|
| | | | (7,980,000) | | |
|
Financing cost – derivative warrant liabilities
|
| | | | (469,465) | | |
|
Interest earned on investments held in Trust Account
|
| | | | 30,688 | | |
|
Net loss
|
| | | $ | (9,090,842) | | |
|
Weighted average shares outstanding of ordinary shares subject to redemption, basic and
diluted |
| | | | 8,536,585 | | |
|
Basic and diluted net income per share, ordinary shares subject to redemption
|
| | | $ | (0.70) | | |
|
Weighted average shares outstanding of ordinary shares, basic and diluted
|
| | | | 4,375,000 | | |
|
Basic and diluted net loss per share, ordinary shares
|
| | | $ | (0.70) | | |
| | |
Ordinary Shares
|
| |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Total
Shareholders’ Equity |
| ||||||||||||||||||||||||||||||
|
Class A
|
| |
Class B
|
| ||||||||||||||||||||||||||||||||||||||
|
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||
Balance – August 28, 2020 (inception)
|
| | | | — | | | | | $ | — | | | | | | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
Issuance of Class B ordinary shares to Sponsor
|
| | | | — | | | | | | — | | | | | | 5,031,250 | | | | | | 503 | | | | | | 24,497 | | | | | | — | | | | | | 25,000 | | |
Excess of cash received over fair value of private placement warrants
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 550,000 | | | | | | — | | | | | | 550,000 | | |
Forfeiture of Class B ordinary shares
|
| | | | — | | | | | | — | | | | | | (656,250) | | | | | | (66) | | | | | | 66 | | | | | | — | | | | | | — | | |
Accretion of Class A Shares subject to possible redemption
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (574,563) | | | | | | (16,967,113) | | | | | | (17,541,676) | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (9,090,842) | | | | | | (9,090,842) | | |
Balance – December 31, 2020
|
| | | | — | | | | | $ | — | | | | | | 4,375,000 | | | | | $ | 437 | | | | | $ | — | | | | | $ | (26,057,955) | | | | | $ | (26,057,518) | | |
| Cash Flows from Operating Activities: | | | | | | | |
|
Net loss
|
| | | $ | (9,090,842) | | |
| Adjustments to reconcile net loss to net cash used in operating activities: | | | | | | | |
|
General and administrative expenses paid by Sponsor under note payable
|
| | | | 62,017 | | |
|
General and administrative expenses paid by Sponsor under due to related party
|
| | | | 407,051 | | |
|
Financing cost – derivative warrant liabilities
|
| | | | 469,465 | | |
|
Change in fair value of derivative warrant liabilities
|
| | | | 7,980,000 | | |
|
Interest income on investments held in Trust Account
|
| | | | (30,689) | | |
| Changes in operating assets and liabilities: | | | | | | | |
|
Prepaid expenses
|
| | | | 88,927 | | |
|
Accounts payable
|
| | | | 4,291 | | |
|
Accrued expenses
|
| | | | 109,780 | | |
|
Net cash used in operating activities
|
| | | | — | | |
| Cash Flows from Investing Activities: | | | | | | | |
|
Cash deposited in Trust Account
|
| | | | (175,000,000) | | |
|
Net cash used in investing activities
|
| | | | (175,000,000) | | |
| Cash Flows from Financing Activities: | | | | | | | |
|
Proceeds received from initial public offering
|
| | | | 175,000,000 | | |
|
Net cash provided by financing activities
|
| | | | 175,000,000 | | |
|
Net increase in cash
|
| | | | — | | |
|
Cash – beginning of the period
|
| | |
|
—
|
| |
|
Cash – end of the period
|
| | | $ | — | | |
| Supplemental disclosure of noncash investing and financing activities: | | | | | | | |
|
Prepaid expenses paid by Sponsor in exchange for issuance of Class B ordinary shares
|
| | | $ | 25,000 | | |
|
Prepaid expenses paid by Sponsor included in due to related party
|
| | | $ | 853,725 | | |
|
Offering costs included in accrued expenses
|
| | | $ | 70,000 | | |
|
Offering costs included in note payable – related party
|
| | | $ | 113,610 | | |
|
Offering costs included in due to related party
|
| | | $ | 327,532 | | |
|
Deferred underwriting commissions in connection with the initial public offering
|
| | | $ | 6,125,000 | | |
|
Gross proceeds received from private placement held in Sponsor’s bank account
|
| | | $ | 550,000 | | |
|
Offering costs paid by Sponsor out of proceeds received from private placement
|
| | | $ | 3,500,000 | | |
|
Accretion of Class A Ordinary Shares to Accretion Amount
|
| | | $ | 17,541,677 | | |
| | |
As of December 31, 2020
|
| | | | | | | |||||||||||||||
| | |
As Previously
Reported |
| |
Restatement
Adjustment |
| |
As Restated
in Amendment No. 1 |
| | | |||||||||||||
Balance Sheet | | | | | | | | | | | | | | | | | | | | | | ||||
Total assets
|
| | | $ | 177,820,487 | | | | | $ | — | | | | | $ | 177,820,487 | | | | | ||||
Liabilities, redeemable non-controlling interest and stockholders’ equity
|
| | | | | | | | | | | | | | | | | | | | | ||||
Total current liabilities
|
| | | $ | 1,948,005 | | | | | $ | — | | | | | $ | 1,948,005 | | | | | ||||
Deferred underwriting commissions
|
| | | | 6,125,000 | | | | | | — | | | | | | 6,125,000 | | | | | ||||
Derivative warrant liabilities
|
| | | | — | | | | | | 20,805,000 | | | | | | 20,805,000 | | | | | ||||
Total liabilities
|
| | | | 8,073,005 | | | | | | 20,805,000 | | | | | | 28,878,005 | | | | | ||||
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption
|
| | | | 164,747,480 | | | | | | (20,805,000) | | | | | | 143,942,480 | | | | | ||||
Stockholders’ equity | | | | | | | | | | | | | | | | | | | | | | ||||
Preference shares – $0.0001 par value
|
| | | | — | | | | | | — | | | | | | — | | | | | ||||
Class A ordinary shares – $0.0001 par value
|
| | | | 103 | | | | | | 208 | | | | | | 311 | | | | | ||||
Class B ordinary shares – $0.0001 par value
|
| | | | 437 | | | | | | — | | | | | | 437 | | | | | ||||
Additional paid-in-capital
|
| | | | 5,640,839 | | | | | | 8,449,257 | | | | | | 14,090,096 | | | | | ||||
Accumulated deficit
|
| | | | (641,377) | | | | | | (8,449,465) | | | | | | (9,090,842) | | | | | ||||
Total stockholders’ equity
|
| | | | 5,000,002 | | | | | | — | | | | | | 5,000,002 | | | | | ||||
Total liabilities and stockholders’ equity
|
| | | $ | 177,820,487 | | | | | $ | — | | | | | $ | 177,820,487 | | | | |
| | |
Period From August 28, 2020 (inception) Through December 31, 2020
|
| | | | | | | |||||||||||||||
| | |
As Previously
Reported |
| |
Restatement
Adjustment |
| |
As Restated
in Amendment No. 1 |
| | | |||||||||||||
Statement of Operations and Comprehensive Loss
|
| | | | | | | | | | | | | | | | | | | | | ||||
Loss from operations
|
| | | $ | (672,065) | | | | | $ | — | | | | | $ | (672,065) | | | | | ||||
Other (expense) income:
|
| | | | | | | | | | | | | | | | | | | | | ||||
Change in fair value of warrant liabilities
|
| | | | — | | | | | | (7,980,000) | | | | | | (7,980,000) | | | | | ||||
Financing costs – derivative warrant liabilities
|
| | | | — | | | | | | (469,465) | | | | | | (469,465) | | | | | ||||
Interest income rom investments held in Trust Account
|
| | | | 30,688 | | | | | | — | | | | | | 30,688 | | | | | ||||
Total other (expense) income
|
| | | | 30,688 | | | | | | (8,449,465) | | | | | | (8,418,777) | | | | | ||||
Net loss
|
| | | $ | (641,377) | | | | | $ | (8,449,465) | | | | | $ | (9,090,842) | | | | | ||||
Basic and Diluted weighted-average Class A ordinary shares outstanding
|
| | | | 16,499,937 | | | | | | (1,295,800) | | | | | | 15,204,137 | | | | | ||||
Basic and Diluted net loss per Class A share
|
| | | $ | 0.00 | | | | | | — | | | | | $ | 0.00 | | | | | ||||
Basic and Diluted weighted-average Class B ordinary shares outstanding
|
| | | | 4,862,836 | | | | | | 632,097 | | | | | | 5,494,933 | | | | | ||||
Basic and Diluted net loss per Class B share
|
| | | $ | (0.13) | | | | | | — | | | | | $ | (1.65) | | | | |
| | |
Period From August 28, 2020 (inception) Through December 31, 2020
|
| | | | | | | |||||||||||||||
| | |
As Previously
Reported |
| |
Restatement
Adjustment |
| |
As Restated
in Amendment No. 1 |
| | | |||||||||||||
Statement of Cash Flows | | | | | | | | | | | | | | | | | | | | | | ||||
Net loss
|
| | | $ | (641,377) | | | | | $ | (8,449,465) | | | | | $ | (9,090,842) | | | | | ||||
Adjustment to reconcile net loss to net cash used in operating activities
|
| | | | 641,377 | | | | | | 8,449,465 | | | | | | 9,090,842 | | | | | ||||
Net cash used in operating activities
|
| | | | — | | | | | | — | | | | | | — | | | | | ||||
Net cash used in investing activities
|
| | | | (175,000,000) | | | | | | — | | | | | | (175,000,000) | | | | | ||||
Net cash provided by financing activities
|
| | | | 175,000,000 | | | | | | — | | | | | | 175,000,000 | | | | | ||||
Net change in cash
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | | | |
December 31, 2020
|
| |
As Restated
in Amendment No. 1 |
| |
Adjustment
|
| |
As Adjusted
|
| |||||||||
Total assets
|
| | | $ | 176,232,179 | | | | | $ | — | | | | | $ | 176,232,179 | | |
Total liabilities
|
| | | $ | 27,289,697 | | | | | $ | — | | | | | $ | 27,289,697 | | |
Class A ordinary shares subject to redemption
|
| | | | 143,942,480 | | | | | | 31,057,520 | | | | | | 175,000,000 | | |
Preference shares
|
| | | | — | | | | | | — | | | | | | — | | |
Class A ordinary shares
|
| | | | 311 | | | | | | (311) | | | | | | — | | |
Class B ordinary shares
|
| | | | 437 | | | | | | — | | | | | | 437 | | |
Additional paid-in capital
|
| | | | 14,090,096 | | | | | | (14,090,096) | | | | | | — | | |
Accumulated deficit
|
| | | | (9,090,842) | | | | | | (16,967,113) | | | | | | (26,057,955) | | |
Total shareholders’ equity (deficit)
|
| | | $ | 5,000,002 | | | | |
$
|
(31,057,520)
|
| | | | $ | (26,057,518) | | |
Total liabilities, Class A ordinary shares subject to redemption and shareholders’ equity (deficit)
|
| | | $ | 176,232,179 | | | | | $ | — | | | | | $ | 176,232,179 | | |
| | |
Form 10-K/A: For the Period from August 28, 2020
(inception) through December 31, 2020 |
| |||||||||||||||
|
As Reported
in Amendment No. 1 |
| |
Adjustment
|
| |
As Restated
|
| |||||||||||
Cash Flow from Operating Activities
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | |
Cash Flows from Investing Activities
|
| | | $ | (175,000,000) | | | | | $ | — | | | | | $ | 175,000,000 | | |
Cash Flows from Financing Activities
|
| | | $ | 175,000,000 | | | | | $ | — | | | | | $ | (175,000,000) | | |
Supplemental Disclosure of Noncash Financing Activities:
|
| | | | | | | | | | | | | | | | | | |
Prepaid expenses paid by Sponsor in exchange for issuance of Class B ordinary shares
|
| | | $ | 25,000 | | | | | $ | — | | | | | $ | (25,000) | | |
Offering costs included in accrued expenses
|
| | | $ | 70,000 | | | | | $ | — | | | | | $ | (70,000) | | |
Offering costs included in note payable – related party
|
| | | $ | 113,610 | | | | | $ | — | | | | | $ | (113,610) | | |
Offering costs included in due to related party
|
| | | $ | 327,532 | | | | | $ | — | | | | | $ | (327,532) | | |
Deferred underwriting commissions in connection with the IPO
|
| | | $ | 6,125,000 | | | | | $ | — | | | | | $ | (6,125,000) | | |
Gross proceeds received from private placement held
in Sponsor’s bank account |
| | | $ | 550,000 | | | | | $ | — | | | | | $ | (550,000) | | |
Offering costs paid by Sponsor out of proceeds received from Private Placement
|
| | | $ | 3,500,000 | | | | | $ | — | | | | | $ | (3,500,000) | | |
Initial value of Class A ordinary shares subject to possible redemption
|
| | | $ | 152,178,640 | | | | | $ | (152,178,640) | | | | | $ | — | | |
| | |
Form 10-K/A: For the Period from August 28, 2020
(inception) through December 31, 2020 |
| |||||||||||||||
|
As Reported
in Amendment No. 1 |
| |
Adjustment
|
| |
As Restated
|
| |||||||||||
Change in value of Class A ordinary shares subject to possible redemption
|
| | | $ | (8,236,161) | | | | | $ | 8,236,161 | | | | | $ | — | | |
Accretion of Class A Ordinary Shares to Accretion Amount
|
| | | $ | — | | | | | $ | — | | | | | $ | 17,541,677 | | |
November 2, 2020 – IPO Balance Sheet
|
| |
As Restated
in Amendment No. 1 |
| |
Adjustment
|
| |
As Adjusted
|
| |||||||||
Total assets
|
| | | $ | 177,051,800 | | | | | $ | — | | | | | $ | 177,051,800 | | |
Total liabilities
|
| | | $ | 19,873,158 | | | | | $ | — | | | | | $ | 19,873,158 | | |
Class A ordinary shares subject to redemption
|
| | | | 152,178,640 | | | | | | 22,821,360 | | | | | | 175,000,000 | | |
Preference shares
|
| | | | — | | | | | | | | | | | | | | |
Class A ordinary shares
|
| | | | 228 | | | | | | (228) | | | | | | — | | |
Class B ordinary shares
|
| | | | 503 | | | | | | — | | | | | | 503 | | |
Additional paid-in capital
|
| | | | 5,853,952 | | | | | | (5,853,952) | | | | | | — | | |
Accumulated deficit
|
| | | | (854,681) | | | | | | (16,967,180) | | | | | | (17,821,861) | | |
Total shareholders’ equity (deficit)
|
| | | $ | 5,000,002 | | | | |
$
|
(22,821,360)
|
| | | | $ | (17,821,358) | | |
Total liabilities, Class A ordinary shares subject to redemption and shareholders’ equity (deficit)
|
| | | $ | 177,051,800 | | | | | $ | — | | | | | $ | 177,051,800 | | |
| | |
EPS for Class A ordinary shares (redeemable)
|
| |||||||||||||||
|
As Restated
in Amendment No. 1 |
| |
Adjustment
|
| |
As Adjusted
|
| |||||||||||
Form 10-K/A (December 31, 2020) | | | | | | | | | | | | | | | | | | | |
Net loss
|
| | | | (9,090,842) | | | | | | — | | | | | | (9,090,842) | | |
Weighted average shares outstanding
|
| | | | 15,204,137 | | | | | | (6,667,552) | | | | | | 8,536,585 | | |
Basic and diluted earnings per share
|
| | | | 0.00 | | | | | | 0.70 | | | | | | (0.70) | | |
| | |
EPS for Class B ordinary shares (non-redeemable)
|
| |||||||||||||||
|
As Restated
in Amendment No. 1 |
| |
Adjustment
|
| |
As Adjusted
|
| |||||||||||
Form 10-K/A December 31, 2020 | | | | | | | | | | | | | | | | | | | |
Net loss
|
| | | | (9,090,842) | | | | | | — | | | | | | (9,090,842) | | |
Weighted average shares outstanding
|
| | | | 5,494,933 | | | | | | (1,119,933) | | | | | | 4,375,000 | | |
Basic and diluted earnings per share
|
| | | | (1.66) | | | | | | (0.96) | | | | | | (0.70) | | |
| | |
For The Period From August 28, 2020
(inception) through December 31, 2020
|
| |||||||||
| | |
Class A
|
| |
Class B
|
| ||||||
Basic and diluted net loss per ordinary share: | | | | | | | | | | | | | |
Numerator: | | | | | | | | | | | | | |
Allocation of net loss
|
| | | $ | (6,010,474) | | | | | $ | (3,080,368) | | |
Denominator: | | | | | | | | | | | | | |
Basic and diluted weighted average ordinary shares outstanding
|
| | | | 8,536,585 | | | | | | 4,375,000 | | |
Basic and diluted net loss per ordinary share
|
| | | $ | (0.70) | | | | | $ | (0.70) | | |
|
Gross Proceeds
|
| | | $ | 175,000,000 | | |
| Less: | | | | | | | |
|
Proceeds allocated to Public Warrants
|
| | | | (7,875,000) | | |
|
Class A ordinary shares issuance costs
|
| | | | (9,666,677) | | |
| Plus: | | | | | | | |
|
Accretion of carrying value to redemption value
|
| | | | 17,541,677 | | |
|
Class A ordinary shares subject to possible redemption
|
| | | $ | 175,000,000 | | |
| | |
Fair Value Measured as of December 31, 2020
|
| |||||||||||||||||||||
| | |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| ||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Investments held in Trust Account
|
| | | $ | 175,030,689 | | | | | | — | | | | |
|
—
|
| | | | $ | 175,030,689 | | |
Liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | |
Derivative public warrant liabilities (restated)
|
| | | $ | 12,775,000 | | | | | $ | — | | | | | $ | — | | | | | $ | 12,775,000 | | |
Derivative private warrant liabilities (restated)
|
| | | $ | — | | | | | $ | — | | | | | $ | 8,030,000 | | | | | $ | 8,030,000 | | |
Total fair value
|
| | | $ | 187,805,689 | | | | | $ | — | | | | | $ | 8,030,000 | | | | | $ | 195,835,689 | | |
| | |
As of
November 2, 2020 |
| |
As of
December 31, 2020 |
| ||||||
Option term (in years)
|
| | | | 6.50 | | | | | | 6.34 | | |
Volatility
|
| | | | 16.30% | | | | | | 21.50% | | |
Risk-free interest rate
|
| | | | 0.57% | | | | | | 0.55% | | |
Expected dividends
|
| | | | — | | | | | | — | | |
Exercise Price
|
| | | $ | 11.50 | | | | | $ | 11.50 | | |
|
Derivative warrant liabilities at August 28, 2020 (inception)
|
| | | $ | — | | |
|
Issuance of Public and Private Warrants
|
| | | | 12,825,000 | | |
|
Change in fair value of derivative warrant liabilities
|
| | | | 7,980,000 | | |
|
Derivative warrant liabilities at December 31, 2020
|
| | | $ | 20,805,000 | | |
| | |
September 30,
2021 |
| |
December 31,
2020 |
| ||||||
| | |
(unaudited)
|
| |
(Restated)
|
| ||||||
Assets | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | |
Cash
|
| | | $ | 98,665 | | | | | $ | — | | |
Due from related party
|
| | | | — | | | | | | 411,692 | | |
Prepaid expenses
|
| | | | 381,322 | | | | | | 789,798 | | |
Total current assets
|
| | | | 479,987 | | | | | | 1,201,490 | | |
Investments held in Trust Account
|
| | | | 175,084,390 | | | | | | 175,030,689 | | |
Total Assets
|
| | | $ | 175,564,377 | | | | | $ | 176,232,179 | | |
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit
|
| | | | | | | | | | | | |
Current liabilities: | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 1,607,415 | | | | | $ | 4,291 | | |
Accrued expenses
|
| | | | 1,386,753 | | | | | | 179,780 | | |
Note payable – related party
|
| | | | — | | | | | | 175,626 | | |
Total current liabilities
|
| | | | 2,994,168 | | | | | | 359,697 | | |
Deferred underwriting commissions
|
| | | | 6,125,000 | | | | | | 6,125,000 | | |
Derivative warrant liabilities
|
| | | | 9,547,500 | | | | | | 20,805,000 | | |
Total Liabilities
|
| | | $ | 18,666,668 | | | | | $ | 27,289,697 | | |
Commitments and Contingencies (Note 6) | | | | | | | | | | | | | |
Class A ordinary shares; 17,500,000 shares subject to possible redemption at $10.00 per share at September 30, 2021 and December 31, 2020, respectively
|
| | | | 175,000,000 | | | | | | 175,000,000 | | |
Shareholders’ Deficit | | | | | | | | | | | | | |
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at September 30, 2021 and December 31, 2020
|
| | | | — | | | | | | — | | |
Class A ordinary shares, $0.0001 par value; 180,000,000 shares authorized at September 30, 2021 and December 31, 2020, respectively
|
| | | | — | | | | | | — | | |
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 4,375,000 shares issued and outstanding at September 30, 2021 and December 31, 2020
|
| | | | 437 | | | | | | 437 | | |
Additional paid-in capital
|
| | | | — | | | | | | — | | |
Accumulated deficit
|
| | | | (18,102,728) | | | | | | (26,057,955) | | |
Total shareholders’ deficit
|
| | | | (18,102,291) | | | | | | (26,057,518) | | |
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit
|
| | | $ | 175,564,377 | | | | | $ | 176,232,179 | | |
| | |
For the Three
Months Ended September 30, 2021 |
| |
For The Nine
Months Ended September 30, 2021 |
| |
For The Period
From August 28, 2020 (inception) through September 30, 2020 |
| |||||||||
General and administrative expenses
|
| | | $ | 1,071,145 | | | | | $ | 3,355,975 | | | | | $ | 35,148 | | |
Loss from operations
|
| | | | (1,071,145) | | | | | | (3,355,975) | | | | | | (35,148) | | |
Other income: | | | | | | | | | | | | | | | | | | | |
Interest earned on investments held in Trust Account
|
| | | | 2,253 | | | | | | 53,702 | | | | | | — | | |
Change in fair value of derivative warrant
liabilities |
| | | | 3,562,500 | | | | | | 11,257,500 | | | | | | — | | |
Net income (loss)
|
| | | $ | 2,493,608 | | | | | $ | 7,955,227 | | | | | $ | (35,148) | | |
Weighted average shares outstanding of Class A ordinary shares, basic and diluted
|
| | | | 17,500,000 | | | | | | 17,500,000 | | | | | | — | | |
Basic and diluted net income per share, Class A ordinary shares subject to redemption
|
| | | $ | 0.11 | | | | | $ | 0.36 | | | | | $ | — | | |
Weighted average shares outstanding of Class B ordinary shares, basic and diluted
|
| | | | 4,375,000 | | | | | | 4,375,000 | | | | | | 4,375,000 | | |
Basic and diluted net income (loss) per share, Class B ordinary shares
|
| | | $ | 0.11 | | | | | $ | 0.36 | | | | | $ | (0.01) | | |
| | |
Ordinary Shares
|
| |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Total
Shareholders’ Deficit |
| ||||||||||||||||||||||||||||||
|
Class A
|
| |
Class B
|
| ||||||||||||||||||||||||||||||||||||||
|
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||
Balance – December 31, 2020(1)
|
| | | | — | | | | | $ | — | | | | | | 4,375,000 | | | | | $ | 437 | | | | | $ | — | | | | | $ | (26,057,955) | | | | | $ | (26,057,518) | | |
Net income
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,500,152 | | | | | | 3,500,152 | | |
Balance – March 31, 2021 (unaudited)(1)
|
| | | | — | | | | | | — | | | | | | 4,375,000 | | | | | | 437 | | | | | | — | | | | | | (22,557,803) | | | | | | (22,557,366) | | |
Net income
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,961,467 | | | | | | 1,961,467 | | |
Balance – June 30, 2021 (unaudited)(1)
|
| | | | — | | | | | | — | | | | | | 4,375,000 | | | | | | 437 | | | | | | — | | | | | | (20,596,336) | | | | | | (20,595,899) | | |
Net income
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,493,608 | | | | | | 2,493,608 | | |
Balance – September 30, 2021 (unaudited)
|
| | | | — | | | | | $ | — | | | | | | 4,375,000 | | | | | $ | 437 | | | | | $ | — | | | | | $ | (18,102,728) | | | | | $ | (18,102,291) | | |
| | |
Ordinary Shares
|
| |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Total
Shareholders’ Deficit |
| ||||||||||||||||||||||||||||||
|
Class A
|
| |
Class B
|
| ||||||||||||||||||||||||||||||||||||||
|
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||
Balance – August 28, 2020 (inception)
|
| | | | — | | | | | $ | — | | | | | | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
Issuance of Class B ordinary shares to Sponsor
|
| | | | — | | | | | | — | | | | | | 5,031,250 | | | | | | 503 | | | | | | 24,497 | | | | | | — | | | | | | 25,000 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (35,148) | | | | | | (35,148) | | |
Balance – September 30, 2020 (unaudited)
|
| | | | — | | | | | $ | — | | | | | | 5,031,250 | | | | | $ | 503 | | | | | $ | 24,497 | | | | | $ | (35,148) | | | | | $ | (10,148) | | |
| | |
For The Nine
Months Ended September 30, 2021 |
| |
For The Period From
August 28, 2020 (inception) through September 30, 2020 |
| ||||||
Cash Flows from Operating Activities: | | | | | | | | | | | | | |
Net income (loss)
|
| | | $ | 7,955,227 | | | | | $ | (35,148) | | |
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
|
| | | | | | | | | | | | |
General and administrative expenses paid by related party
|
| | | | 88,206 | | | | | | 272 | | |
Interest income on investments held in Trust Account
|
| | | | (53,702) | | | | | | — | | |
Change in fair value of derivative warrant liabilities
|
| | | | (11,257,500) | | | | | | — | | |
Changes in operating assets and liabilities:
|
| | | | | | | | | | | | |
Prepaid expenses
|
| | | | 408,477 | | | | | | — | | |
Accounts payable
|
| | | | 1,603,124 | | | | | | 34,876 | | |
Accrued expenses
|
| | | | 1,206,973 | | | | | | — | | |
Net cash used in operating activities
|
| | | | (49,195) | | | | | | — | | |
Cash Flows from Financing Activities: | | | | | | | | | | | | | |
Proceeds from settlement of receivable from related party
|
| | | | 323,486 | | | | | | — | | |
Repayment of note payable to related party
|
| | | | (175,626) | | | | | | — | | |
Net cash provided by financing activities
|
| | | | 147,860 | | | | | | — | | |
Net increase in cash
|
| | | | 98,665 | | | | | | — | | |
Cash – beginning of the period
|
| | | | — | | | | | | — | | |
Cash – end of the period
|
| | | $ | 98,665 | | | | | $ | — | | |
Supplemental disclosure of noncash investing and financing activities: | | | | | | | | | | | | | |
Prepaid expenses paid by Sponsor in exchange for issuance of Class B ordinary shares
|
| | | $ | — | | | | | $ | 25,000 | | |
Offering costs included in accrued expenses
|
| | | $ | — | | | | | $ | 218,352 | | |
Offering costs included in note payable – related party
|
| | | $ | — | | | | | $ | 86,410 | | |
March 31, 2021
|
| |
As Reported
|
| |
Adjustment
|
| |
As Adjusted
|
| |||||||||
Total assets
|
| | | $ | 175,915,799 | | | | | $ | — | | | | | $ | 175,915,799 | | |
Total liabilities
|
| | | $ | 23,473,165 | | | | | $ | — | | | | | $ | 23,473,165 | | |
Class A ordinary shares subject to redemption
|
| | | | 147,442,630 | | | | | | 27,557,370 | | | | | | 175,000,000 | | |
Preference shares
|
| | | | — | | | | | | — | | | | | | — | | |
Class A ordinary shares
|
| | | | 276 | | | | | | (276) | | | | | | — | | |
Class B ordinary shares
|
| | | | 437 | | | | | | — | | | | | | 437 | | |
Additional paid-in capital
|
| | | | 10,589,981 | | | | | | (10,589,981) | | | | | | — | | |
Accumulated deficit
|
| | | | (5,590,690) | | | | | | (16,967,113) | | | | | | (22,557,803) | | |
Total shareholders’ equity (deficit)
|
| | | $ | 5,000,004 | | | | | $ | (27,557,370) | | | | | $ | (22,557,366) | | |
Total liabilities, Class A ordinary shares subject to redemption and shareholders’ equity (deficit)
|
| | | $ | 175,915,799 | | | | | $ | — | | | | | $ | 175,915,799 | | |
| | |
As Reported
|
| |
Adjustment
|
| |
As Restated
|
| |||||||||
Cash Flow from Operating Activities
|
| | | $ | (88,206) | | | | | $ | — | | | | | $ | (88,206) | | |
Cash Flows from Investing Activities
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | |
Cash Flows from Financing Activities
|
| | | $ | 236,066 | | | | | $ | — | | | | | $ | (236,066) | | |
Supplemental Disclosure of Noncash Financing Activities:
|
| | | | | | | | | | | | | | | | | | |
Change in value of Class A ordinary shares subject to possible redemption
|
| | | $ | 3,500,150 | | | | | $ | (3,500,150) | | | | | $ | — | | |
June 30, 2021
|
| |
As Reported
|
| |
Adjustment
|
| |
As Adjusted
|
| |||||||||
Total assets
|
| | | $ | 175,641,121 | | | | | $ | — | | | | | $ | 175,641,121 | | |
Total liabilities
|
| | | $ | 21,237,021 | | | | | $ | — | | | | | $ | 21,237,021 | | |
Class A ordinary shares subject to redemption
|
| | | | 149,404,090 | | | | | | 25,595,910 | | | | | | 175,000,000 | | |
Preference shares
|
| | | | — | | | | | | — | | | | | | — | | |
Class A ordinary shares
|
| | | | 256 | | | | | | (256) | | | | | | — | | |
Class B ordinary shares
|
| | | | 437 | | | | | | — | | | | | | 437 | | |
Additional paid-in capital
|
| | | | 8,628,540 | | | | | | (8,628,540) | | | | | | — | | |
Accumulated deficit
|
| | | | (3,629,223) | | | | | | (16,967,114) | | | | | | (20,596,337) | | |
Total shareholders’ equity (deficit)
|
| | | $ | 5,000,010 | | | | | $ | (25,595,910) | | | | | $ | (20,595,900) | | |
Total liabilities, Class A ordinary shares subject to redemption and shareholders’ equity (deficit)
|
| | | $ | 175,641,121 | | | | | $ | — | | | | | $ | 175,641,121 | | |
| | |
As Reported
|
| |
Adjustment
|
| |
As Restated
|
| |||||||||
Cash Flow from Operating Activities
|
| | | $ | (124,326) | | | | | $ | — | | | | | $ | 124,326 | | |
Cash Flows from Investing Activities
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | |
Cash Flows from Financing Activities
|
| | | $ | 147,860 | | | | | $ | — | | | | | $ | (147,860) | | |
Supplemental Disclosure of Noncash Financing Activities:
|
| | | $ | — | | | | | | | | | | | | | | |
Change in value of Class A ordinary shares subject to possible redemption
|
| | | $ | 1,961,461 | | | | | $ | (1,961,461) | | | | | $ | — | | |
| | |
EPS for Class A ordinary shares (redeemable)
|
| |||||||||||||||
| | |
As Reported
|
| |
Adjustment
|
| |
As Adjusted
|
| |||||||||
Form 10-Q (March 31, 2021) – three months ended March 31, 2021
|
| | | | | | | | | | | | | | | | | | |
Net income
|
| | | | 3,500,152 | | | | | | — | | | | | | 3,500,152 | | |
Weighted average shares outstanding
|
| | | | 14,398,137 | | | | | | 3,101,863 | | | | | | 17,500,000 | | |
Basic and diluted earnings per share
|
| | | | 0.00 | | | | | | (0.16) | | | | | | 0.16 | | |
Form 10-Q (June 30, 2021) – three months ended June 30, 2021
|
| | | | | | | | | | | | | | | | | | |
Net income
|
| | | | 1,961,467 | | | | | | — | | | | | | 1,961,467 | | |
Weighted average shares outstanding
|
| | | | 14,746,418 | | | | | | 2,753,582 | | | | | | 17,500,000 | | |
Basic and diluted earnings per share
|
| | | | 0.00 | | | | | | (0.09) | | | | | | 0.09 | | |
Form 10-Q (June 30, 2021) – six months ended June 30, 2021
|
| | | | | | | | | | | | | | | | | | |
Net income
|
| | | | 5,461,619 | | | | | | — | | | | | | 5,461,619 | | |
Weighted average shares outstanding
|
| | | | 14,573,240 | | | | | | 2,926,760 | | | | | | 17,500,000 | | |
Basic and diluted earnings per share
|
| | | | 0.00 | | | | | | (0.25) | | | | | | 0.25 | | |
| | |
EPS for Class B ordinary shares (non-redeemable)
|
| |||||||||||||||
| | |
As Reported
|
| |
Adjustment
|
| |
As Adjusted
|
| |||||||||
Form 10-Q (March 31, 2021): | | | | | | | | | | | | | | | | | | | |
Net income
|
| | | | 3,500,152 | | | | | | — | | | | | | 3,500,152 | | |
Weighted average shares outstanding
|
| | | | 7,476,863 | | | | | | (3,101,863) | | | | | | 4,375,000 | | |
Basic and diluted earnings per share
|
| | | | 0.46 | | | | | | 0.30 | | | | | | 0.16 | | |
Form 10-Q (June 30, 2021) – three months ended June 30, 2021
|
| | | | | | | | | | | | | | | | | | |
Net income
|
| | | | 1,961,467 | | | | | | — | | | | | | 1,961,467 | | |
Weighted average shares outstanding
|
| | | | 7,128,582 | | | | | | (2,753,582) | | | | | | 4,375,000 | | |
Basic and diluted earnings per share
|
| | | | 0.27 | | | | | | 0.18 | | | | | | 0.09 | | |
Form 10-Q (June 30, 2021) – six months ended June 30, 2021
|
| | | | | | | | | | | | | | | | | | |
Net income
|
| | | | 5,461,619 | | | | | | — | | | | | | 5,461,619 | | |
Weighted average shares outstanding
|
| | | | 7,301,760 | | | | | | (2,926,760) | | | | | | 4,375,000 | | |
Basic and diluted earnings per share
|
| | | | 0.74 | | | | | | 0.49 | | | | | | 0.25 | | |
| | |
Three Months Ended
September 30, 2021 |
| |
Nine Months Ended
September 30, 2021 |
| |
The Period From
August 28, 2020 (inception) through September 30, 2020 |
| |||||||||||||||||||||||||||
| | |
Class A
|
| |
Class B
|
| |
Class A
|
| |
Class B
|
| |
Class A
|
| |
Class B
|
| ||||||||||||||||||
Basic and diluted net income (loss) per ordinary share:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Numerator: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Allocation of net income (loss)
|
| | | $ | 1,994,886 | | | | | $ | 498,722 | | | | | $ | 6,364,182 | | | | | $ | 1,591,045 | | | | | $ | — | | | | | $ | (35,148) | | |
| | | | | | | | | | | | | |||||||||||||||||||||||||
Denominator: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Basic and diluted weighted average ordinary shares outstanding
|
| | | | 17,500,000 | | | | | | 4,375,000 | | | | | | 17,500,000 | | | | | | 4,375,000 | | | | | | — | | | | | | 4,375,000 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||
Basic and diluted net income (loss) per ordinary share
|
| | | $ | 0.11 | | | | | $ | 0.11 | | | | | $ | 0.36 | | | | | $ | 0.36 | | | | | $ | — | | | | | $ | (0.01) | | |
|
Gross Proceeds
|
| | | $ | 175,000,000 | | |
| Less: | | | | | | | |
|
Proceeds allocated to Public Warrants
|
| | | | (7,875,000) | | |
|
Class A ordinary shares issuance costs
|
| | | | (9,666,677) | | |
| Plus: | | | | | | | |
|
Remeasurement adjustment on redeemable common stock
|
| | | | 17,541,677 | | |
|
Class A ordinary shares subject to possible redemption
|
| | | $ | 175,000,000 | | |
|
| | |
Fair Value Measured as of September 30, 2021
|
| |||||||||||||||||||||
| | |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| ||||||||||||
Assets: | | | | | | | | | | | | | | | | | | | | | | | | | |
Investments held in Trust Account
|
| | | $ | 175,084,390 | | | | | $ | — | | | | | $ | — | | | | | $ | 175,084,390 | | |
Liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | |
Derivative public warrant liabilities
|
| | | | 5,862,500 | | | | | | — | | | | | | — | | | | | | 5,862,500 | | |
Derivative private warrant liabilities
|
| | | | — | | | | | | 3,685,000 | | | | | | — | | | | | | 3,685,000 | | |
| | |
Fair Value Measured as of December 31, 2020
|
| |||||||||||||||||||||
| | |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| ||||||||||||
Assets: | | | | | | | | | | | | | | | | | | | | | | | | | |
Investments held in Trust Account
|
| | | $ | 175,030,689 | | | | | $ | — | | | | | $ | — | | | | | $ | 175,030,689 | | |
Liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | |
Derivative public warrant liabilities
|
| | | | 12,775,000 | | | | | | — | | | | | | — | | | | | | 12,775,000 | | |
Derivative private warrant liabilities
|
| | | | — | | | | | | — | | | | | | 8,030,000 | | | | | | 8,030,000 | | |
| | |
As of June 30,
2021 |
| |
As of December 31,
2020 |
| ||||||
Option term (in years)
|
| | | | 5.75 | | | | | | 6.34 | | |
Volatility
|
| | | | 14.80% | | | | | | 21.50% | | |
Risk-free interest rate
|
| | | | 0.99% | | | | | | 0.55% | | |
Expected dividends
|
| | | | — | | | | | | — | | |
Exercise Price
|
| | | $ | 11.50 | | | | | | 11.50 | | |
| | |
As of September 30,
2021 |
| |||
Derivative warrant liabilities at January 1, 2021 – Level 3
|
| | | $ | 8,030,000 | | |
Change in fair value of derivative warrant liabilities – Level 3
|
| | | | (1,430,000) | | |
Derivative warrant liabilities at March 31, 2021 – Level 3
|
| | | $ | 6,600,000 | | |
Change in fair value of derivative warrant liabilities – Level 3
|
| | | | (1,540,000) | | |
Derivative warrant liabilities at June 30, 2021 – Level 3
|
| | | $ | 5,060,000 | | |
Transfer of private placement warrants to Level 2
|
| | | | (3,685,000) | | |
Change in fair value of derivative warrant liabilities – Level 3
|
| | | | (1,375,000) | | |
Derivative warrant liabilities at September 30, 2021 – Level 3
|
| | |
$
|
—
|
| |
| | |
As of December 31,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Assets | | | | | | | | | | | | | |
Current assets | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 44,227 | | | | | $ | 6,280 | | |
Restricted cash
|
| | | | 793 | | | | | | 792 | | |
Accounts receivable, net
|
| | | | 6,389 | | | | | | 9,931 | | |
Costs capitalized to obtain revenue contracts, net
|
| | | | 2,122 | | | | | | — | | |
Prepaid expenses and other current assets
|
| | | | 2,738 | | | | | | 2,814 | | |
Total current assets
|
| | | | 56,269 | | | | | | 19,817 | | |
Property and equipment, net
|
| | | | 8,145 | | | | | | 8,724 | | |
Capitalized software costs, net
|
| | | | 3,931 | | | | | | 483 | | |
Noncurrent costs capitalized to obtain revenue contracts
|
| | | | 1,799 | | | | | | — | | |
Goodwill
|
| | | | 120,671 | | | | | | 120,569 | | |
Intangible assets
|
| | | | 89,291 | | | | | | 93,440 | | |
Equity method investment
|
| | | | — | | | | | | 87 | | |
Total assets
|
| | | $ | 280,106 | | | | | $ | 243,120 | | |
Liabilities, Temporary Equity and Stockholders’ Deficit | | | | | | | | | | | | | |
Current liabilities | | | | | | | | | | | | | |
Short-term debt and current maturities of long-term debt
|
| | | $ | 3,251 | | | | | $ | 15,367 | | |
Accounts payable
|
| | | | 2,911 | | | | | | 4,074 | | |
Accrued payroll
|
| | | | 2,805 | | | | | | 2,167 | | |
Accrued expenses
|
| | | | 2,995 | | | | | | 2,537 | | |
Deferred revenue, current portion
|
| | | | 16,854 | | | | | | 18,548 | | |
Customer deposits
|
| | | | 2,035 | | | | | | 657 | | |
Other current liabilities
|
| | | | 4,297 | | | | | | 3,148 | | |
Total current liabilities
|
| | | | 35,148 | | | | | | 46,498 | | |
Long-term debt, net of current maturities
|
| | | | 211,968 | | | | | | 155,427 | | |
Deferred tax liabilities
|
| | | | 6,956 | | | | | | 6,756 | | |
Deferred revenue, noncurrent portion
|
| | | | 667 | | | | | | 799 | | |
Deferred rent
|
| | | | 7,970 | | | | | | 6,634 | | |
Sublease loss liability, noncurrent portion
|
| | | | 2,753 | | | | | | 2,920 | | |
Lease incentive liability, noncurrent portion
|
| | | | 4,968 | | | | | | 5,495 | | |
Other noncurrent liabilities
|
| | | | 1,943 | | | | | | 951 | | |
Total liabilities
|
| | | | 272,373 | | | | | | 225,480 | | |
Commitment and contingencies (Note 13) | | | | | | | | | | | | | |
Temporary equity | | | | | | | | | | | | ||
Redeemable, convertible preferred stock (Note 9)
|
| | | | 238,963 | | | | | | 206,972 | | |
Stockholders’ deficit: | | | | | | | | | | | | | |
Common stock ($0.00001 par value, 99,066,892 and 51,566,892 authorized shares at December 31, 2020 and 2019; 10,425,584 and 9,263,575 issued and outstanding at December 31, 2020 and 2019, respectively)
|
| | | | — | | | | | | — | | |
Additional paid-in capital
|
| | | | 5,808 | | | | | | — | | |
Accumulated other comprehensive loss
|
| | | | (63) | | | | | | (154) | | |
Accumulated deficit
|
| | | | (236,975) | | | | | | (189,178) | | |
Total stockholders’ deficit
|
| | | | (231,230) | | | | | | (189,332) | | |
Total liabilities, temporary equity and stockholders’ deficit
|
| | | $ | 280,106 | | | | | $ | 243,120 | | |
| | |
Year Ended December 31,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Revenues: | | | | | | | | | | | | | |
Subscription
|
| | | $ | 60,002 | | | | | $ | 56,969 | | |
Advertising and other
|
| | | | 5,155 | | | | | | 8,901 | | |
Total revenues
|
| | | | 65,157 | | | | | | 65,870 | | |
Operating expenses: | | | | | | | | | | | | | |
Cost of revenues
|
| | | | 12,621 | | | | | | 13,193 | | |
Research and development
|
| | | | 15,122 | | | | | | 14,810 | | |
Sales and marketing
|
| | | | 21,559 | | | | | | 21,817 | | |
Editorial
|
| | | | 14,303 | | | | | | 15,367 | | |
General and administrative
|
| | | | 20,740 | | | | | | 16,675 | | |
Amortization of intangible assets
|
| | | | 7,345 | | | | | | 7,304 | | |
Loss on sublease
|
| | | | — | | | | | | 5,829 | | |
Loss on debt extinguishment
|
| | | | 2,433 | | | | | | — | | |
Total operating expenses
|
| | | | 94,123 | | | | | | 94,995 | | |
Operating loss
|
| | | | (28,966) | | | | | | (29,125) | | |
Interest expense, net
|
| | | | 31,829 | | | | | | 22,940 | | |
Change in fair value of warrant and derivative liabilities
|
| | | | (8,346) | | | | | | 49 | | |
Other expense (income)
|
| | | | 177 | | | | | | (22) | | |
Net loss before income taxes and loss on equity method investment
|
| | | | (52,626) | | | | | | (52,092) | | |
Benefit for income taxes
|
| | | | (1,435) | | | | | | (18,824) | | |
Net loss before loss on equity method investment
|
| | | | (51,191) | | | | | | (33,268) | | |
Loss on equity method investment
|
| | | | (81) | | | | | | (67) | | |
Net loss
|
| | | | (51,272) | | | | | | (33,335) | | |
Other comprehensive gain (loss)
|
| | | | 91 | | | | | | (35) | | |
Total comprehensive loss
|
| | | $ | (51,181) | | | | | $ | (33,370) | | |
Net loss
|
| | | $ | (51,272) | | | | | $ | (33,335) | | |
Deemed dividend
|
| | | $ | (31,991) | | | | | $ | (10,717) | | |
Net loss used to compute earnings per share
|
| | | $ | (83,263) | | | | | $ | (44,052) | | |
Net loss per share, basic and diluted
|
| | | $ | (8.74) | | | | | $ | (4.82) | | |
Weighted average shares used to compute earnings per share
|
| | | | 9,521,927 | | | | | | 9,135,122 | | |
| | |
Temporary Equity
|
| | |
Equity
|
| ||||||||||||||||||||||||||||||||||||||||||
| | |
Preferred Stock
|
| | |
Common Stock
|
| |
Additional
paid-in capital |
| |
Accumulated
other comprehensive loss |
| |
Accumulated
deficit |
| |
Total
stockholders’ deficit |
| ||||||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| | |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||||||
Balance at December 31, 2018
|
| | | | 38,258,865 | | | | | $ | 196,255 | | | | | | | 9,084,103 | | | | | $ | — | | | | | $ | — | | | | | $ | (119) | | | | | $ | (149,699) | | | | | $ | (149,818) | | |
Stock option forfeiture cumulative-effect
adjustment |
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 27 | | | | | | — | | | | | | (27) | | | | | | — | | |
Balance, net of cumulative-effect adjustment
|
| | | | 38,258,865 | | | | | | 196,255 | | | | | | | 9,084,103 | | | | | | — | | | | | | 27 | | | | | | (119) | | | | | | (149,726) | | | | | | (149,818) | | |
Accretion of preferred stock to redemption value
|
| | | | — | | | | | | 10,717 | | | | | | | — | | | | | | — | | | | | | (4,600) | | | | | | — | | | | | | (6,117) | | | | | | (10,717) | | |
Exercise of stock options
|
| | | | — | | | | | | — | | | | | | | 179,472 | | | | | | — | | | | | | 36 | | | | | | — | | | | | | — | | | | | | 36 | | |
Stock-based compensation expense
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 537 | | | | | | — | | | | | | — | | | | | | 537 | | |
Capital contribution
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 4,000 | | | | | | — | | | | | | — | | | | | | 4,000 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (33,335) | | | | | | (33,335) | | |
Foreign currency translation loss
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | (35) | | | | | | — | | | | | | (35) | | |
Balance at December 31, 2019
|
| | | | 38,258,865 | | | | | $ | 206,972 | | | | | | | 9,263,575 | | | | | $ | — | | | | | $ | — | | | | | $ | (154) | | | | | $ | (189,178) | | | | | $ | (189,332) | | |
Cumulative impact of ASC606 adoption,
net of taxes |
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,475 | | | | | | 3,475 | | |
Balance, net of cumulative-effect adjustment
|
| | | | 38,258,865 | | | | | | 206,972 | | | | | | | 9,263,575 | | | | | | — | | | | | | — | | | | | | (154) | | | | | | (185,703) | | | | | | (185,857) | | |
Accretion of preferred stock to redemption value
|
| | | | — | | | | | | 31,991 | | | | | | | — | | | | | | — | | | | | | (31,991) | | | | | | — | | | | | | — | | | | | | (31,991) | | |
Shares issued
|
| | | | — | | | | | | — | | | | | | | 856,444 | | | | | | — | | | | | | 2,758 | | | | | | — | | | | | | — | | | | | | 2,758 | | |
Warrants issued
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 562 | | | | | | — | | | | | | — | | | | | | 562 | | |
Beneficial conversion feature, net of taxes
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 33,228 | | | | | | — | | | | | | — | | | | | | 33,228 | | |
Exercise of stock options
|
| | | | — | | | | | | — | | | | | | | 305,565 | | | | | | — | | | | | | 247 | | | | | | — | | | | | | — | | | | | | 247 | | |
Stock-based compensation expense
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 1,004 | | | | | | — | | | | | | — | | | | | | 1,004 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (51,272) | | | | | | (51,272) | | |
Foreign currency translation gain
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | 91 | | | | | | — | | | | | | 91 | | |
Balance at December 31, 2020
|
| | | | 38,258,865 | | | | | $ | 238,963 | | | | | | | 10,425,584 | | | | | $ | — | | | | | $ | 5,808 | | | | | $ | (63) | | | | | $ | (236,975) | | | | | $ | (231,230) | | |
| | |
Year Ended December 31,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Operating Activities: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (51,272) | | | | | $ | (33,335) | | |
Adjustments to reconcile net loss to net cash used in operating activities: | | | | | | | | | | | | | |
Depreciation
|
| | | | 1,104 | | | | | | 970 | | |
Amortization of intangible assets and capitalized software development costs
|
| | | | 10,405 | | | | | | 10,546 | | |
Amortization of deferred costs to obtain
|
| | | | 1,949 | | | | | | — | | |
Stock-based compensation expense
|
| | | | 1,004 | | | | | | 537 | | |
Bad debt expense (recovery)
|
| | | | 25 | | | | | | (88) | | |
Change in fair value of acquisition contingent consideration
|
| | | | 75 | | | | | | (146) | | |
Change in fair value of warrant and derivative liabilities
|
| | | | (8,344) | | | | | | 49 | | |
Loss on disposal of fixed assets
|
| | | | — | | | | | | 2,683 | | |
Deferred income tax benefit
|
| | | | (2,286) | | | | | | (19,620) | | |
Paid-in-kind interest
|
| | | | 21,462 | | | | | | 9,140 | | |
Non-cash interest expense
|
| | | | 3,063 | | | | | | 5,230 | | |
Loss on equity method investment
|
| | | | 81 | | | | | | 67 | | |
Loss on debt extinguishment
|
| | | | 2,433 | | | | | | — | | |
Gain on bargain purchase consideration
|
| | | | (25) | | | | | | — | | |
Changes in operating assets and liabilities:
|
| | | | | | | | | | | | |
Accounts receivable
|
| | | | 3,619 | | | | | | (1,073) | | |
Costs capitalized to obtain revenue contracts
|
| | | | (2,121) | | | | | | — | | |
Prepaid expenses and other current assets
|
| | | | 84 | | | | | | 393 | | |
Accounts payable
|
| | | | (1,667) | | | | | | 1,093 | | |
Accrued payroll
|
| | | | 627 | | | | | | 973 | | |
Accrued expenses
|
| | | | 423 | | | | | | (1,898) | | |
Deferred revenue
|
| | | | (1,879) | | | | | | 483 | | |
Customer deposits
|
| | | | 1,365 | | | | | | 511 | | |
Other current liabilities
|
| | | | 1,381 | | | | | | 769 | | |
Deferred rent
|
| | | | 1,336 | | | | | | 3,218 | | |
Sublease liability
|
| | | | (145) | | | | | | 3,066 | | |
Lease incentive liability
|
| | | | (527) | | | | | | (471) | | |
Other noncurrent liabilities
|
| | | | 663 | | | | | | — | | |
Net cash used in operating activities
|
| | | | (17,167) | | | | | | (16,903) | | |
Investing Activities: | | | | | | | | | | | | | |
Capital expenditures
|
| | | | (4,163) | | | | | | (2,840) | | |
Purchases of intangible assets
|
| | | | (1,327) | | | | | | (151) | | |
Cash paid for equity method investment
|
| | | | — | | | | | | (154) | | |
Net cash used in investing activities
|
| | | | (5,490) | | | | | | (3,145) | | |
Financing Activities: | | | | | | | | | | | | | |
Proceeds from long-term debt, net of issuance costs
|
| | | | 227,134 | | | | | | 17,173 | | |
Payments of long-term debt
|
| | | | (156,228) | | | | | | — | | |
Net (payments) proceeds on revolving debt
|
| | | | (10,471) | | | | | | 6,700 | | |
Proceeds from exercise of stock options
|
| | | | 247 | | | | | | 36 | | |
Debt issuance costs related to debt amendments
|
| | | | — | | | | | | (322) | | |
Net cash provided by financing activities
|
| | | | 60,682 | | | | | | 23,587 | | |
Effects of exchange rates on cash
|
| | | | (77) | | | | | | (17) | | |
Net increase in cash, cash equivalents, and restricted cash
|
| | | | 37,948 | | | | | | 3,522 | | |
Cash, cash equivalents, and restricted cash, beginning of period
|
| | | | 7,072 | | | | | | 3,550 | | |
Cash, cash equivalents, and restricted cash, end of period
|
| | | $ | 45,020 | | | | | $ | 7,072 | | |
Supplemental Noncash Investing and Financing Activities | | | | | | | | | | | | | |
Beneficial conversion feature in conjunction with long-term debt issuance, net of taxes
|
| | | $ | 33,228 | | | | | $ | — | | |
Warrants issued in conjunction with long-term debt issuance
|
| | | $ | 562 | | | | | $ | — | | |
Issuance of stock as part of asset acquisition
|
| | | $ | 2,758 | | | | | $ | — | | |
Property and equipment included in accounts payable
|
| | | $ | 12 | | | | | $ | 339 | | |
Accretion of preferred stock to redemption value
|
| | | $ | 31,991 | | | | | $ | 10,717 | | |
Supplemental Cash Flow Activities | | | | | | | | | | | | | |
Cash paid for interest
|
| | | $ | 9,039 | | | | | $ | 8,570 | | |
Cash paid for taxes
|
| | | $ | 54 | | | | | $ | 350 | | |
| | |
Year Ended December 31,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Subscription
|
| | | $ | 60,002 | | | | | $ | 56,969 | | |
Advertising
|
| | | $ | 2,455 | | | | | $ | 4,661 | | |
Books
|
| | | $ | 975 | | | | | $ | 1,784 | | |
Other non-recurring revenue
|
| | | | 1,725 | | | | | | 2,456 | | |
Total
|
| | | $ | 65,157 | | | | | $ | 65,870 | | |
| | |
Year Ended December 31,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
North America
|
| | | $ | 63,360 | | | | | $ | 64,714 | | |
Europe
|
| | | | 1,574 | | | | | | 1,156 | | |
Asia
|
| | | | 223 | | | | | | — | | |
Total
|
| | | $ | 65,157 | | | | | $ | 65,870 | | |
|
Balance at December 31, 2019
|
| | | $ | 19,347 | | |
|
Cumulative effect of adoption of ASC 606
|
| | | | — | | |
|
Balance at January 1, 2020
|
| | | $ | 19,347 | | |
|
Deferred revenue acquired in Factsquared acquisition
|
| | | | 26 | | |
|
Revenue recognized in the current period from amounts in the prior balance
|
| | | | (18,548) | | |
|
New deferrals, net of amounts recognized in the current period
|
| | | | 16,635 | | |
|
Effects of foreign currency
|
| | | | 61 | | |
|
Balance at December 31, 2020
|
| | | $ | 17,521 | | |
|
Cash
|
| | | $ | 1,545 | | |
|
Fair value of common shares
|
| | | | 2,758 | | |
|
Total purchase price
|
| | | $ | 4,303 | | |
| Tangible assets and liabilities: | | | | | | | |
|
Other current assets
|
| | | $ | 3 | | |
|
Accounts payable and accrued liabilities
|
| | | | (165) | | |
|
Deferred revenue
|
| | | | (26) | | |
|
Deferred tax liability
|
| | | | (1,354) | | |
|
Net tangible liability
|
| | | $ | (1,542) | | |
| Identifiable intangible assets: | | | | | | | |
|
Developed technology
|
| | | | 5,845 | | |
|
Total
|
| | | $ | 4,303 | | |
| | |
As of December 31,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Leasehold improvements
|
| | | $ | 9,490 | | | | | $ | 9,219 | | |
Furniture and fixtures
|
| | | | 1,009 | | | | | | 1,009 | | |
Equipment
|
| | | | 215 | | | | | | 198 | | |
Computer equipment
|
| | | | 2,694 | | | | | | 2,457 | | |
Total property and equipment
|
| | | $ | 13,408 | | | | | $ | 12,883 | | |
Less: accumulated depreciation
|
| | | | (5,263) | | | | | | (4,159) | | |
Total property and equipment, net
|
| | | $ | 8,145 | | | | | $ | 8,724 | | |
| | |
December 31, 2020
|
| |
December 31, 2019
|
| |
Weighted
Average Remaining Useful Life (Years) |
| |||||||||||||||||||||||||||||||||
| | |
Gross
Carrying Amount |
| |
Accumulated
Amortization |
| |
Net Carrying
Amount |
| |
Gross
Carrying Amount |
| |
Accumulated
Amortization |
| |
Net Carrying
Amount |
| |
December 31,
2020 |
| |||||||||||||||||||||
Developed technology
|
| | | $ | 21,986 | | | | | $ | (8,409) | | | | | $ | 13,577 | | | | | $ | 16,100 | | | | | $ | (5,571) | | | | | $ | 10,529 | | | | | | 3.7 | | |
Customer relationships
|
| | | | 56,653 | | | | | | (11,920) | | | | | | 44,733 | | | | | | 56,606 | | | | | | (7,214) | | | | | | 49,392 | | | | | | 10.8 | | |
Databases
|
| | | | 27,880 | | | | | | (4,756) | | | | | | 23,124 | | | | | | 27,872 | | | | | | (2,745) | | | | | | 25,127 | | | | | | 11.6 | | |
Tradenames
|
| | | | 8,933 | | | | | | (1,508) | | | | | | 7,425 | | | | | | 8,933 | | | | | | (870) | | | | | | 8,063 | | | | | | 11.6 | | |
Patents
|
| | | | 444 | | | | | | (12) | | | | | | 432 | | | | | | 331 | | | | | | (2) | | | | | | 329 | | | | | | 19.0 | | |
Total
|
| | | $ | 115,896 | | | | | $ | (26,605) | | | | | $ | 89,291 | | | | | $ | 109,842 | | | | | $ | (16,402) | | | | | $ | 93,440 | | | | | | 9.9 | | |
|
2021
|
| | | $ | 10,634 | | |
|
2022
|
| | | | 10,198 | | |
|
2023
|
| | | | 10,126 | | |
|
2024
|
| | | | 9,362 | | |
|
2025
|
| | | | 6,570 | | |
|
Thereafter
|
| | | | 42,401 | | |
|
Total
|
| | | $ | 89,291 | | |
| | |
December 31, 2020
|
| |
December 31, 2019
|
| ||||||||||||||||||||||||||||||
| | |
Gross
Carrying Amount |
| |
Accumulated
Amortization |
| |
Net Carrying
Amount |
| |
Gross
Carrying Amount |
| |
Accumulated
Amortization |
| |
Net
Carrying Amount |
| ||||||||||||||||||
Capitalized software development costs
|
| | | $ | 4,133 | | | | | $ | (202) | | | | | $ | 3,931 | | | | | $ | 483 | | | | | $ | — | | | | | $ | 483 | | |
|
Balance at December 31, 2018
|
| | | $ | 120,591 | | |
|
Adjustments(a)
|
| | | | (22) | | |
|
Balance at December 31, 2019
|
| | | $ | 120,569 | | |
| Adjustments(a) | | | | | 102 | | |
|
Balance at December 31, 2020
|
| | | $ | 120,671 | | |
| | |
December 31, 2020
|
| |||||||||||||||||||||||||||
| | |
Face
Value |
| |
Unamortized
Premium/ Discount(a) |
| |
Carrying
Value of Debt |
| |
Bifurcated
Embedded Derivative |
| |
Adjusted
Carrying Value |
| |||||||||||||||
First out term loan
|
| | | $ | 45,000 | | | | | $ | (1,197) | | | | | $ | 43,803 | | | | | $ | — | | | | | $ | 43,803 | | |
Last out term loan
|
| | | | 40,484(b) | | | | | | (391) | | | | | | 40,093 | | | | | | — | | | | | | 40,093 | | |
Senior Secured Subordinated Promissory Note
|
| | | | 78,427 | | | | | | (53,685) | | | | | | 24,742 | | | | | | 19,607 | | | | | | 44,349 | | |
Convertible notes
|
| | | | 86,146 (c) | | | | | | (17,977) | | | | | | 68,169 | | | | | | 10,805 | | | | | | 78,974 | | |
PPP loan
|
| | | | 8,000 | | | | | | — | | | | | | 8,000 | | | | | | — | | | | | | 8,000 | | |
Total carrying value
|
| | | $ | 258,057 | | | | | $ | (73,250) | | | | | $ | 184,807 | | | | | $ | 30,412 | | | | | $ | 215,219 | | |
Less: current portion
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | (3,251) | | |
Total noncurrent debt
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 211,968 | | |
| | |
December 31, 2019
|
| |||||||||||||||||||||||||||
| | |
Face
Value |
| |
Unamortized
Premium/ Discount(a) |
| |
Carrying
Value of Debt |
| |
Bifurcated
Embedded Derivative |
| |
Adjusted
Carrying Value |
| |||||||||||||||
Senior Secured Subordinated Promissory Note
|
| | | $ | 69,482 | | | | | $ | (234) | | | | | $ | 69,248 | | | | | $ | — | | | | | $ | 69,248 | | |
Convertible notes
|
| | | | 18,063 | | | | | | (4,874) | | | | | | 13,189 | | | | | | 5,039 | | | | | | 18,228 | | |
Revolving credit facility
|
| | | | 10,227 | | | | | | — | | | | | | 10,227 | | | | | | — | | | | | | 10,227 | | |
Apollo capital term loan
|
| | | | 75,198 | | | | | | (2,107) | | | | | | 73,091 | | | | | | — | | | | | | 73,091 | | |
Total carrying value
|
| | | $ | 172,970 | | | | | $ | (7,215) | | | | | $ | 165,755 | | | | | $ | 5,039 | | | | | $ | 170,794 | | |
Less: current portion
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | (15,367) | | |
Total noncurrent debt
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 155,427 | | |
| | |
December 31, 2020
|
| |||||||||||||||||||||||||||||||||||||||||||||
| | |
Principal
|
| |
Deferred
Financing Fees |
| |
PIK
Interest Accrual |
| |
Debt
Discount |
| |
Amortization
of Deferred Financing Fees |
| |
Amortization of
Deferred Debt Discount |
| |
Derivative
Liabilities |
| |
Total
|
| ||||||||||||||||||||||||
2019 Notes
|
| | | $ | 17,320 | | | | | $ | (147) | | | | | $ | 3,330 | | | | | $ | (4,986) | | | | | $ | 41 | | | | | $ | 990 | | | | | $ | 2,857 | | | | | $ | 19,405 | | |
2020 Notes
|
| | | | 59,680 | | | | | | (1,027) | | | | | | 5,816 | | | | | | (14,112) | | | | | | 96 | | | | | | 1,168 | | | | | | 7,948 | | | | | | 59,569 | | |
Total
|
| | | $ | 77,000 | | | | | $ | (1,174) | | | | | $ | 9,146 | | | | | $ | (19,098) | | | | | $ | 137 | | | | | $ | 2,158 | | | | | $ | 10,805 | | | | | $ | 78,974 | | |
| | |
December 31, 2019
|
| |||||||||||||||||||||||||||||||||||||||||||||
| | |
Principal
|
| |
Deferred
Financing Fees |
| |
PIK
Interest Accrual |
| |
Debt
Discount |
| |
Amortization
of Deferred Financing Fees |
| |
Amortization of
Deferred Debt Discount |
| |
Derivative
Liabilities |
| |
Total
|
| ||||||||||||||||||||||||
2019 Notes
|
| | | $ | 17,320 | | | | | $ | (147) | | | | | $ | 743 | | | | | $ | (4,986) | | | | | $ | 10 | | | | | $ | 249 | | | | | $ | 5,039 | | | | | $ | 18,228 | | |
| | |
Group A
|
| |
Group B
|
| |
Group C
|
| |
Group D
|
| |
Total
|
| |||||||||||||||
Principal amount
|
| | | $ | 71,570 | | | | | $ | 430 | | | | | $ | 1,000 | | | | | $ | 4,000 | | | | | $ | 77,000 | | |
Maturity year
|
| | | | 2025 | | | | | | 2020 | | | | | | 2021 | | | | | | 2024 | | | | | | | | |
Annual interest rate
|
| |
15%
|
| |
6%
|
| |
7%
|
| |
15%
|
| | | | | | | ||||||||||||
Conversion options: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
At the holders’ option
|
| | | | X | | | | | | X | | | | | | | | | | | | | | | | | | | | |
Automatic upon contingent event
|
| | | | X | | | | | | X | | | | | | X | | | | | | X | | | | | | | | |
Variable conversion prices with discounts
|
| | | | X | | | | | | X | | | | | | X | | | | | | | | | | | | | | |
Embedded features: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Borrower prepayment right
|
| | | | X | | | | | | | | | | | | | | | | | | | | | | | | | | |
Lender automatic redemption right
|
| | | | X | | | | | | | | | | | | | | | | | | | | | | | | | | |
Lender contingent redemption right
|
| | | | X | | | | | | | | | | | | | | | | | | | | | | | | | | |
Registration rights
|
| | | | X | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | |
Principal
|
| |
Paid-in-kind
Interest |
| |
Total
|
| |||||||||
2021
|
| | | $ | 1,430 | | | | | $ | 184 | | | | | $ | 1,614 | | |
2022
|
| | | | 16,500 | | | | | | — | | | | | | 16,500 | | |
2023
|
| | | | 67,000 | | | | | | 34,347 | | | | | | 101,347 | | |
2024
|
| | | | 82,427 | | | | | | 38,331 | | | | | | 120,758 | | |
2025
|
| | | | 71,570 | | | | | | 86,038 | | | | | | 157,608 | | |
Total
|
| | | $ | 238,927 | | | | | $ | 158,900 | | | | | $ | 397,827 | | |
| | |
Redemption Value
As of December 31, |
| |||||||||
Series of Preferred Stock
|
| |
2020
|
| |
2019
|
| ||||||
Series A redeemable, convertible preferred stock ($0.00001 par value, 12,851,709 authorized, issued and outstanding at December 31, 2020 and 2019)
|
| | | $ | 63,973 | | | | | $ | 52,495 | | |
Series B redeemable, convertible preferred stock ($0.00001 par value, 4,349,416 authorized, 4,336,912 issued and outstanding at December 31, 2020 and 2019)
|
| | | | 21,743 | | | | | | 16,693 | | |
Series C redeemable, convertible preferred stock ($0.00001 par value, 3,630,822 authorized, issued and outstanding at December 31, 2020 and 2019)
|
| | | | 18,876 | | | | | | 16,869 | | |
Series C-1 redeemable, convertible preferred stock ($0.00001 par value, 1,750,000 authorized, 1,452,330 issued and outstanding at December 31, 2020 and 2019)
|
| | | | 7,957 | | | | | | 6,000 | | |
Series D redeemable, convertible preferred stock ($0.00001 par value, 1,912,410 authorized, issued and outstanding at December 31, 2020 and 2019)
|
| | | | 25,000 | | | | | | 25,000 | | |
Series D-1 redeemable, convertible preferred stock ($0.00001 par value, 709,495 authorized, issued and outstanding at December 31, 2020 and 2019)
|
| | | | 7,400 | | | | | | 7,446 | | |
Series E redeemable, convertible preferred stock ($0.00001 par value, 9,385,200 authorized, issued and outstanding at December 31, 2020 and 2019)
|
| | | | 61,104 | | | | | | 54,661 | | |
Series F redeemable, convertible preferred stock ($0.00001 par value, 48,979,987 and
3,979,987 authorized at December 31, 2021 and 2020, respectively; 3,979,987 issued and outstanding at December 31, 2020 and 2019, respectively) |
| | | | 32,910 | | | | | | 27,808 | | |
Total Temporary Equity
|
| | | $ | 238,963 | | | | | $ | 206,972 | | |
Warrant Holder
|
| |
Underlying Shares
|
| |
Exercise
Price |
| |
Issuance Date
|
| |
Expiration Date
|
| |
Balance
Sheet Classification |
| |||
Comerica | | | 12,504 Shares of Series B | | | | $ | 2.40 | | | |
June 2015
|
| |
June 2025
|
| | Liability | |
Eastward | | |
100,000 Shares of common stock
|
| | | $ | 1.75 | | | |
January 2017
|
| |
January 2027
|
| | Liability | |
Runway | | |
194,673 Shares of common stock
|
| | | $ | 0.01 | | | |
October 2020
|
| |
October 2030
|
| | Equity | |
| | |
Year Ended December 31,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Expected volatility
|
| | | | 40.10% | | | | | | 38.59% | | |
Expected life (years)
|
| | | | 6.06 | | | | | | 5.99 | | |
Expected dividend yield
|
| | | | 0.00% | | | | | | 0.00% | | |
Risk-free interest rate
|
| | | | 0.61% | | | | | | 2.38% | | |
Fair value of options
|
| | | $ | 1.13 | | | | | $ | 1.10 | | |
| | |
Number of
shares |
| |
Weighted-
average exercise price |
| |
Weighted-
average remaining contractual life (years) |
| |
Aggregate
intrinsic value (in thousands) |
| ||||||||||||
Outstanding at December 31, 2018
|
| | | | 3,239,200 | | | | | $ | 1.41 | | | | | | 8.20 | | | | | $ | 4,087 | | |
Granted
|
| | | | 794,304 | | | | | | 2.65 | | | | | | | | | | | | | | |
Exercised
|
| | | | (179,472) | | | | | | 0.57 | | | | | | | | | | | | | | |
Cancelled and forfeited
|
| | | | (446,799) | | | | | | 2.02 | | | | | | | | | | | | | | |
Outstanding at December 31, 2019
|
| | | | 3,407,233 | | | | | $ | 1.66 | | | | | | 7.71 | | | | | $ | 7,453 | | |
Granted
|
| | | | 1,516,426 | | | | | | 2.89 | | | | | | | | | | | | | | |
Exercised
|
| | | | (305,565) | | | | | | 0.74 | | | | | | | | | | | | | | |
Cancelled and forfeited
|
| | | | (366,546) | | | | | | 2.43 | | | | | | | | | | | | | | |
Outstanding at December 31, 2020
|
| | | | 4,251,548 | | | | | $ | 2.10 | | | | | | 7.55 | | | | | $ | 7,048 | | |
Vested and exercisable as of December 31, 2020
|
| | | | 2,498,844 | | | | | $ | 1.63 | | | | | | 6.55 | | | | | $ | 7,048 | | |
| | |
Year Ended December 31,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Cost of revenues
|
| | | $ | 5 | | | | | $ | 2 | | |
Research and development
|
| | | | 89 | | | | | | 70 | | |
Sales and marketing
|
| | | | 77 | | | | | | 89 | | |
Editorial
|
| | | | 56 | | | | | | 94 | | |
General and administrative
|
| | | | 777 | | | | | | 282 | | |
Total
|
| | | $ | 1,004 | | | | | $ | 537 | | |
| | |
Year Ended December 31,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Net loss
|
| | | $ | (51,272) | | | | | $ | (33,335) | | |
Deemed dividend – preferred stock accretion
|
| | | | (31,991) | | | | | | (10,717) | | |
Net loss used to compute earnings per share
|
| | | $ | (83,263) | | | | | $ | (44,052) | | |
| | |
Year Ended December 31,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Current taxes | | | | | | | | | | | | | |
Federal provision
|
| | | $ | 120 | | | | | $ | 246 | | |
State provision
|
| | | | 723 | | | | | | 540 | | |
Foreign provision
|
| | | | 8 | | | | | | 20 | | |
Total current provision
|
| | | | 851 | | | | | | 806 | | |
Deferred taxes | | | | | | | | | | | | | |
Federal benefit
|
| | | | (9,359) | | | | | | (9,183) | | |
State benefit
|
| | | | (3,132) | | | | | | (1,717) | | |
Foreign benefit
|
| | | | (85) | | | | | | (201) | | |
Valuation allowance
|
| | | | 10,290 | | | | | | (8,529) | | |
Total deferred benefit
|
| | | | (2,286) | | | | | | (19,630) | | |
Total benefit for income taxes
|
| | | $ | (1,435) | | | | | $ | (18,824) | | |
| | |
Year Ended December 31,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
U.S. Federal provision at statutory rate
|
| | | | 21.0% | | | | | | 21.0% | | |
State income taxes, net of federal benefit
|
| | | | (0.4)% | | | | | | 0.5% | | |
AHYDO interest disallowance
|
| | | | (2.7)% | | | | | | (1.1)% | | |
Foreign tax rate differential
|
| | | | 0.0% | | | | | | 0.1% | | |
Others
|
| | | | (0.7)% | | | | | | (2.4)% | | |
Fair value adjustments
|
| | | | 0.0% | | | | | | 0.0% | | |
Change in valuation allowance
|
| | | | (14.5)% | | | | | | 18.2% | | |
Effective tax rate
|
| | | | 2.7% | | | | | | 36.3% | | |
| | |
As of December 31,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Deferred tax assets | | | | | | | | | | | | | |
Deferred financing costs
|
| | | $ | 780 | | | | | $ | — | | |
Stock compensation
|
| | | | 300 | | | | | | 168 | | |
Section 163(j) interest limitation
|
| | | | 5,233 | | | | | | 3,405 | | |
Disallowed Original Issue Discount Interest
|
| | | | 5,769 | | | | | | 2,082 | | |
Deferred rent
|
| | | | 3,457 | | | | | | 3,192 | | |
Deferred state income tax
|
| | | | 1,166 | | | | | | 1,292 | | |
Deferred revenue
|
| | | | 1,414 | | | | | | 1,282 | | |
Reserves and accruals
|
| | | | 667 | | | | | | 520 | | |
Sublease loss liability
|
| | | | 840 | | | | | | 884 | | |
Federal net operating loss carryforward
|
| | | | 15,574 | | | | | | 12,218 | | |
State net operating loss carryforward
|
| | | | 3,639 | | | | | | 2,196 | | |
Foreign net operating loss carryforward
|
| | | | 161 | | | | | | 148 | | |
Other deferred tax assets
|
| | | | — | | | | | | 31 | | |
Total deferred tax assets
|
| | | | 39,000 | | | | | | 27,418 | | |
Deferred tax liabilities
|
| | | | | | | | | | | | |
Basis difference in fixed assets
|
| | | | (1,332) | | | | | | (1,137) | | |
Basis difference in intangibles assets and goodwill
|
| | | | (24,901) | | | | | | (26,031) | | |
Debt discount and derivative liabilities
|
| | | | (8,738) | | | | | | — | | |
Other deferred tax liabilities
|
| | | | (2,387) | | | | | | — | | |
Total deferred tax liabilities
|
| | | | (37,358) | | | | | | (27,168) | | |
Valuation allowance
|
| | | | (8,598) | | | | | | (7,006) | | |
Net deferred tax liabilities
|
| | | $ | (6,956) | | | | | $ | (6,756) | | |
| | |
As of December 31,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Series B preferred stock fair value
|
| | | $ | 5.01 | | | | | $ | 3.85 | | |
Time to maturity (years)
|
| | | | 4.5 | | | | | | 5.5 | | |
Risk-free interest rate
|
| | | | 0.31% | | | | | | 1.73% | | |
Volatility
|
| | | | 111% | | | | | | 65% | | |
Exercise price
|
| | | $ | 2.40 | | | | | $ | 2.40 | | |
| | |
As of December 31,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Common stock fair value
|
| | | $ | 3.22 | | | | | $ | 3.56 | | |
Times to maturity (years)
|
| | | | 6.0 | | | | | | 8.0 | | |
Risk-free interest rate
|
| | | | 0.51% | | | | | | 2.62% | | |
Volatility
|
| | | | 105% | | | | | | 75% | | |
Exercise price
|
| | | $ | 1.75 | | | | | $ | 1.75 | | |
| | |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| ||||||||||||
Liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | |
Contingent consideration
|
| | | $ | — | | | | | $ | — | | | | | $ | 276 | | | | | $ | 276 | | |
Warrant liabilities
|
| | | $ | — | | | | | $ | — | | | | | $ | 330 | | | | | $ | 330 | | |
Embedded redemption features on convertible notes
|
| | | $ | — | | | | | $ | — | | | | | $ | 10,805 | | | | | $ | 10,805 | | |
Embedded redemption features on promissory note
|
| | | $ | — | | | | | $ | — | | | | | $ | 19,607 | | | | | $ | 19,607 | | |
| | |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| ||||||||||||
Liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | |
Contingent consideration
|
| | | $ | — | | | | | $ | — | | | | | $ | 201 | | | | | $ | 201 | | |
Warrant liabilities
|
| | | $ | — | | | | | $ | — | | | | | $ | 329 | | | | | $ | 329 | | |
Embedded redemption features on convertible notes
|
| | | $ | — | | | | | $ | — | | | | | $ | 5,039 | | | | | $ | 5,039 | | |
| | |
Contingent
Consideration |
| |
Warrant
Liabilities |
| |
Embedded
Redemption Features in Convertible Notes |
| |
Embedded
Redemption Features in Promissory Note |
| ||||||||||||
Balance at December 31, 2018
|
| | | $ | 347 | | | | | $ | 333 | | | | | $ | — | | | | | $ | — | | |
Derivative liabilities at issuance date
|
| | | | — | | | | | | — | | | | | | 4,986 | | | | | | — | | |
Change in fair value included in the determination of net loss
|
| | | | (146) | | | | | | (4) | | | | | | 53 | | | | | | — | | |
Balance at December 31, 2019
|
| | | | 201 | | | | | | 329 | | | | | | 5,039 | | | | | | — | | |
Derivative liabilities at issuance date
|
| | | | — | | | | | | — | | | | | | 14,111 | | | | | | 19,607 | | |
Change in fair value included in the determination of net loss
|
| | | | 75 | | | | | | 1 | | | | | | (8,345) | | | | | | — | | |
Balance at December 31, 2020
|
| | | $ | 276 | | | | | $ | 330 | | | | | $ | 10,805 | | | | | $ | 19,607 | | |
|
2021
|
| | | $ | 9,585 | | |
|
2022
|
| | | | 10,393 | | |
|
2023
|
| | | | 7,144 | | |
|
2024
|
| | | | 6,080 | | |
|
Thereafter
|
| | | | 37,035 | | |
|
Total
|
| | | | 70,237 | | |
|
Sublease Income
|
| | | | 11,739 | | |
|
Net minimum lease payments
|
| | | $ | 58,498 | | |
| | |
September 30, 2021
|
| |
December 31, 2020
|
| ||||||
Assets | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 35,722 | | | | | $ | 44,227 | | |
Restricted cash
|
| | | | 842 | | | | | | 793 | | |
Accounts receivable, net
|
| | | | 9,024 | | | | | | 6,389 | | |
Costs capitalized to obtain revenue contracts, net
|
| | | | 2,359 | | | | | | 2,122 | | |
Prepaid expenses and other current assets
|
| | | | 4,899 | | | | | | 2,738 | | |
Total current assets
|
| | | | 52,846 | | | | | | 56,269 | | |
Property and equipment, net
|
| | | | 7,653 | | | | | | 8,145 | | |
Capitalized software costs, net
|
| | | | 6,562 | | | | | | 3,931 | | |
Noncurrent costs capitalized to obtain revenue contracts, net
|
| | | | 1,872 | | | | | | 1,799 | | |
Goodwill
|
| | | | 175,684 | | | | | | 120,671 | | |
Intangible assets, net
|
| | | | 116,065 | | | | | | 89,291 | | |
Total assets
|
| | | $ | 360,682 | | | | | $ | 280,106 | | |
Liabilities, Temporary Equity and Stockholders’ Deficit | | | | | | | | | | | | | |
Current liabilities: | | | | | | | | | | | | | |
Short-term debt and current maturities of long-term debt
|
| | | $ | 9,350 | | | | | $ | 3,251 | | |
Accounts payable
|
| | | | 2,675 | | | | | | 2,911 | | |
Accrued payroll
|
| | | | 3,747 | | | | | | 2,805 | | |
Accrued expenses
|
| | | | 4,861 | | | | | | 2,995 | | |
Deferred revenue, current portion
|
| | | | 27,650 | | | | | | 16,854 | | |
Customer deposits
|
| | | | 1,647 | | | | | | 2,035 | | |
Other current liabilities
|
| | | | 6,298 | | | | | | 4,297 | | |
Total current liabilities
|
| | | | 56,228 | | | | | | 35,148 | | |
Long-term debt, net of current maturities
|
| | | | 289,464 | | | | | | 211,968 | | |
Deferred tax liabilities
|
| | | | 4,670 | | | | | | 6,956 | | |
Deferred revenue, net of current portion
|
| | | | 799 | | | | | | 667 | | |
Deferred rent
|
| | | | 8,505 | | | | | | 7,970 | | |
Sublease loss liability, net of current portion
|
| | | | 3,657 | | | | | | 2,753 | | |
Lease incentive liability, net of current portion
|
| | | | 4,572 | | | | | | 4,968 | | |
Other noncurrent liabilities
|
| | | | 5,288 | | | | | | 1,943 | | |
Total liabilities
|
| | | | 373,183 | | | | | | 272,373 | | |
Commitment and contingencies (Note 12) | | | | | | | | | | | | | |
Temporary equity | | | | | | | | | | | | | |
Redeemable, convertible preferred stock (Note 8)
|
| | | | 469,805 | | | | | | 238,963 | | |
Stockholders’ deficit: | | | | | | | | | | | | | |
Common stock ($0.00001 par value, 99,066,892 authorized shares at
September 30, 2021 and December 31, 2020; 14,866,061 and 10,425,584 issued and outstanding at September 30, 2021 and December 31, 2020, respectively) |
| | | | — | | | | | | — | | |
Additional paid-in capital
|
| | | | — | | | | | | 5,808 | | |
Accumulated other comprehensive loss
|
| | | | (609) | | | | | | (63) | | |
Accumulated deficit
|
| | | | (481,697) | | | | | | (236,975) | | |
Total stockholders’ deficit
|
| | | | (482,306) | | | | | | (231,230) | | |
Total liabilities, temporary equity and stockholders’ deficit
|
| | | $ | 360,682 | | | | | $ | 280,106 | | |
| | |
Nine Months Ended September 30,
|
| |||||||||
|
2021
|
| |
2020
|
| ||||||||
Revenues: | | | | | | | | | | | | | |
Subscription
|
| | | $ | 53,098 | | | | | $ | 44,717 | | |
Advisory, advertising, and other
|
| | | | 5,352 | | | | | | 3,793 | | |
Total revenues
|
| | | | 58,450 | | | | | | 48,510 | | |
Operating expenses: | | | | | | | | | | | | | |
Cost of revenues
|
| | | | 14,664 | | | | | | 9,811 | | |
Research and development
|
| | | | 17,671 | | | | | | 11,304 | | |
Sales and marketing
|
| | | | 21,258 | | | | | | 15,612 | | |
Editorial
|
| | | | 10,967 | | | | | | 10,929 | | |
General and administrative
|
| | | | 25,184 | | | | | | 14,944 | | |
Amortization of intangible assets
|
| | | | 6,651 | | | | | | 5,507 | | |
Loss on sublease
|
| | | | 1,362 | | | | | | — | | |
Total operating expenses
|
| | | | 97,757 | | | | | | 68,107 | | |
Operating loss
|
| | | | (39,307) | | | | | | (19,597) | | |
Interest expense, net
|
| | | | 46,102 | | | | | | 22,483 | | |
Change in fair value of warrant and derivative liabilities
|
| | | | 9,406 | | | | | | (4,159) | | |
Other expense
|
| | | | 384 | | | | | | 152 | | |
Net loss before income taxes and loss on equity method investment
|
| | | | (95,199) | | | | | | (38,073) | | |
Benefit for income taxes
|
| | | | (6,737) | | | | | | (182) | | |
Net loss before loss on equity method investment
|
| | | | (88,462) | | | | | | (37,891) | | |
Loss on equity method investment
|
| | | | — | | | | | | (81) | | |
Net loss
|
| | | | (88,462) | | | | | | (37,972) | | |
Other comprehensive (loss) gain
|
| | | | (546) | | | | | | 48 | | |
Total comprehensive loss
|
| | | $ | (89,008) | | | | | $ | (37,924) | | |
Net loss
|
| | | $ | (88,462) | | | | | $ | (37,972) | | |
Deemed (dividend) contribution
|
| | | | (218,250) | | | | | | 3,359 | | |
Net loss used to compute earnings per share
|
| | | $ | (306,712) | | | | | $ | (34,613) | | |
Net loss per share, basic and diluted
|
| | | $ | (24.83) | | | | | $ | (3.67) | | |
Weighted average shares used to compute earnings per share
|
| | | | 12,351,464 | | | | | | 9,430,338 | | |
| | |
Temporary Equity
|
| | |
Equity
|
| ||||||||||||||||||||||||||||||||||||||||||
| | |
Preferred Stock
|
| | |
Common Stock
|
| |
Additional
paid-in capital |
| |
Accumulated
other comprehensive loss |
| |
Accumulated
deficit |
| |
Total
stockholders’ deficit |
| ||||||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| | |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||||||
Balance at December 31, 2019
|
| | | | 38,258,865 | | | | | $ | 206,972 | | | | | | | 9,263,575 | | | | | $ | — | | | | | $ | — | | | | | $ | (154) | | | | | $ | (189,178) | | | | | $ | (189,332) | | |
Cumulative impact of ASC 606 adoption, net of taxes
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,475 | | | | | | 3,475 | | |
Balance, net of cumulative-effect adjustment
|
| | | | 38,258,865 | | | | | | 206,972 | | | | | | | 9,263,575 | | | | | | — | | | | | | — | | | | | | (154) | | | | | | (185,703) | | | | | | (185,857) | | |
Change in redemption value of preferred stock
|
| | | | — | | | | | | (3,359) | | | | | | | — | | | | | | — | | | | | | 3,359 | | | | | | — | | | | | | — | | | | | | 3,359 | | |
Exercise of stock options
|
| | | | — | | | | | | — | | | | | | | 225,987 | | | | | | — | | | | | | 102 | | | | | | — | | | | | | — | | | | | | 102 | | |
Stock-based compensation expense
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 812 | | | | | | — | | | | | | — | | | | | | 812 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (37,972) | | | | | | (37,972) | | |
Foreign currency translation gain
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | 48 | | | | | | — | | | | | | 48 | | |
Balance at September 30, 2020
|
| | | | 38,258,865 | | | | | $ | 203,613 | | | | | | | 9,489,562 | | | | | $ | — | | | | | $ | 4,273 | | | | | $ | (106) | | | | | $ | (223,675) | | | | | $ | (219,508) | | |
Balance at December 31, 2020
|
| | | | 38,258,865 | | | | | | 238,963 | | | | | | | 10,425,584 | | | | | | — | | | | | | 5,808 | | | | | | (63) | | | | | | (236,975) | | | | | | (231,230) | | |
Change in redemption value of preferred stock
|
| | | | — | | | | | | 213,797 | | | | | | | — | | | | | | — | | | | | | (57,990) | | | | | | — | | | | | | (155,807) | | | | | | (213,797) | | |
Exercise of stock options
|
| | | | — | | | | | | — | | | | | | | 266,522 | | | | | | — | | | | | | 364 | | | | | | — | | | | | | — | | | | | | 364 | | |
Stock-based compensation expense
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 547 | | | | | | — | | | | | | — | | | | | | 547 | | |
Issuance of preferred stock and warrants
|
| | | | 1,248,467 | | | | | | 17,045 | | | | | | | — | | | | | | — | | | | | | 252 | | | | | | — | | | | | | (453) | | | | | | (201) | | |
Shares issued in business combinations
|
| | | | — | | | | | | — | | | | | | | 4,173,955 | | | | | | — | | | | | | 32,966 | | | | | | — | | | | | | — | | | | | | 32,966 | | |
Capital distribution
|
| | | | — | | | | | | — | | | | | | | | | | | | | | | | | | | (3,686) | | | | | | | | | | | | | | | | | | (3,686) | | |
Seller convertible notes issued at premium
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 7,178 | | | | | | — | | | | | | — | | | | | | 7,178 | | |
Beneficial conversion feature, net of taxes
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 14,561 | | | | | | — | | | | | | — | | | | | | 14,561 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (88,462) | | | | | | (88,462) | | |
Foreign currency translation loss
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | (546) | | | | | | — | | | | | | (546) | | |
Balance at September 30, 2021
|
| | | | 39,507,332 | | | | | $ | 469,805 | | | | | | | 14,866,061 | | | | | $ | — | | | | | $ | — | | | | | $ | (609) | | | | | $ | (481,697) | | | | | $ | (482,306) | | |
| | |
Nine Months Ended September 30,
|
| |||||||||
|
2021
|
| |
2020
|
| ||||||||
Operating Activities: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (88,462) | | | | | $ | (37,972) | | |
Adjustments to reconcile net loss to net cash used in operating activities: | | | | | | | | | | | | | |
Depreciation
|
| | | | 870 | | | | | | 826 | | |
Amortization of intangible assets and capitalized software development costs
|
| | | | 10,728 | | | | | | 7,871 | | |
Amortization of deferred costs to obtain revenue contracts
|
| | | | 1,820 | | | | | | 1,428 | | |
Stock-based compensation expense
|
| | | | 547 | | | | | | 812 | | |
Bad debt expense
|
| | | | 106 | | | | | | 10 | | |
Change in fair value of acquisition contingent consideration
|
| | | | 1,045 | | | | | | 65 | | |
Change in fair value of warrant and derivative liabilities
|
| | | | 9,406 | | | | | | (4,159) | | |
Deferred income tax benefit
|
| | | | (5,299) | | | | | | (828) | | |
Paid-in-kind interest
|
| | | | 26,972 | | | | | | 14,497 | | |
Non-cash interest expense
|
| | | | 15,126 | | | | | | 2,010 | | |
Loss on sublease
|
| | | | 1,362 | | | | | | — | | |
Loss on equity method investment
|
| | | | — | | | | | | 81 | | |
Gain on bargain purchase acquisition
|
| | | | — | | | | | | (25) | | |
Changes in operating assets and liabilities:
|
| | | | | | | | | | | | |
Accounts receivable, net
|
| | | | 1,793 | | | | | | 4,109 | | |
Prepaid expenses and other current assets
|
| | | | (1,432) | | | | | | (109) | | |
Costs capitalized to obtain revenue contracts, net
|
| | | | (2,140) | | | | | | (1,364) | | |
Accounts payable
|
| | | | (1,073) | | | | | | (937) | | |
Accrued payroll
|
| | | | 224 | | | | | | (571) | | |
Accrued expenses
|
| | | | 1,085 | | | | | | (273) | | |
Deferred revenue
|
| | | | 3,264 | | | | | | 400 | | |
Customer deposits
|
| | | | (386) | | | | | | 356 | | |
Other current liabilities
|
| | | | 604 | | | | | | 590 | | |
Deferred rent
|
| | | | 535 | | | | | | 1,419 | | |
Sublease loss liability, net of current portion
|
| | | | (458) | | | | | | (472) | | |
Lease incentive liability, net of current portion
|
| | | | (396) | | | | | | (396) | | |
Other noncurrent liabilities
|
| | | | (20) | | | | | | (569) | | |
Net cash used in operating activities
|
| | | | (24,179) | | | | | | (12,063) | | |
Investing Activities: | | | | | | | | | | | | | |
Capital expenditures
|
| | | | (3,931) | | | | | | (2,066) | | |
Purchases of intangible assets
|
| | | | — | | | | | | (72) | | |
Return of equity method investment
|
| | | | — | | | | | | 6 | | |
Cash paid for acquisitions, net of cash acquired
|
| | | | (26,378) | | | | | | 29 | | |
Net cash used in investing activities
|
| | | | (30,309) | | | | | | (2,103) | | |
Financing Activities: | | | | | | | | | | | | | |
Proceeds from long-term debt, net of issuance costs
|
| | | | 33,147 | | | | | | 45,804 | | |
Net payments of long-term debt
|
| | | | — | | | | | | (938) | | |
Net payments on revolving debt
|
| | | | — | | | | | | (10,471) | | |
Proceeds from Small Business Administration PPP Loan
|
| | | | — | | | | | | 8,000 | | |
Proceeds from exercise of stock options
|
| | | | 364 | | | | | | 102 | | |
Net proceeds from issuance of preferred stock
|
| | | | 12,481 | | | | | | — | | |
Net cash provided by financing activities
|
| | | | 45,992 | | | | | | 42,497 | | |
Effects of exchange rates on cash
|
| | | | 40 | | | | | | 26 | | |
Net change in cash, cash equivalents, and restricted cash
|
| | | | (8,456) | | | | | | 28,357 | | |
Cash, cash equivalents, and restricted cash, beginning of period
|
| | | | 45,020 | | | | | | 7,072 | | |
Cash, cash equivalents, and restricted cash, end of period
|
| | | $ | 36,564 | | | | | $ | 35,429 | | |
| | |
Nine Months Ended September 30,
|
| |||||||||
|
2021
|
| |
2020
|
| ||||||||
Supplemental Noncash Investing and Financing Activities: | | | | | | | | | | | | | |
Accretion of preferred stock to redemption value
|
| | | $ | 213,797 | | | | | $ | (3,359) | | |
Issuance of common stock as part of business combinations
|
| | | $ | 32,966 | | | | | $ | — | | |
Fair value of seller notes issued in connection with business combinations
|
| | | $ | 21,438 | | | | | $ | — | | |
Beneficial conversion feature in conjunction with long-term debt issuance, net of taxes
|
| | | $ | 14,561 | | | | | $ | — | | |
PIK interest settled through the issuance of additional convertible notes to noteholders
|
| | | $ | 7,551 | | | | | $ | 1,614 | | |
Issuance of preferred stock in conjunction with debt modification
|
| | | $ | 4,363 | | | | | $ | — | | |
Warrants issued in conjunction with long-term debt issuance
|
| | | $ | 252 | | | | | $ | — | | |
Property and equipment purchases included in accounts payable
|
| | | $ | 29 | | | | | $ | 62 | | |
Supplemental Cash Flow Activities: | | | | | | | | | | | | | |
Cash paid for interest
|
| | | $ | 3,339 | | | | | $ | 5,839 | | |
Cash paid for taxes
|
| | | $ | 162 | | | | | $ | 45 | | |
| | |
Nine Months Ended September 30,
|
| |||||||||
|
2021
|
| |
2020
|
| ||||||||
Subscription
|
| | | $ | 53,098 | | | | | $ | 44,717 | | |
Advertising
|
| | | | 1,898 | | | | | | 1,604 | | |
Books
|
| | | | 1,094 | | | | | | 865 | | |
Advisory
|
| | | | 1,052 | | | | | | — | | |
Other non-recurring revenue
|
| | | | 1,308 | | | | | | 1,324 | | |
Total
|
| | | $ | 58,450 | | | | | $ | 48,510 | | |
| | |
Nine Months
Ended September 30, |
| |||||||||
|
2021
|
| |
2020
|
| ||||||||
North America
|
| | | $ | 52,433 | | | | | $ | 47,308 | | |
Europe
|
| | | | 5,307 | | | | | | 1,120 | | |
Asia
|
| | | | 307 | | | | | | 82 | | |
Australia
|
| | | | 403 | | | | | | — | | |
Total
|
| | | $ | 58,450 | | | | | $ | 48,510 | | |
|
Balance at December 31, 2019
|
| | | $ | 19,347 | | |
|
Revenue recognized in the current period from amounts in the prior balance
|
| | | | (17,139) | | |
|
New deferrals, net of amounts recognized in the current period
|
| | | | 17,556 | | |
|
Effects of foreign currency
|
| | | | 7 | | |
|
Balance at September 30, 2020
|
| | | $ | 19,771 | | |
|
Balance at December 31, 2020
|
| | | $ | 17,521 | | |
|
Deferred revenue acquired in 2021 acquisitions
|
| | | | 7,788 | | |
|
Revenue recognized in the current period from amounts in the prior balance
|
| | | | (15,411) | | |
|
New deferrals, net of amounts recognized in the current period
|
| | | | 18,681 | | |
|
Effects of foreign currency
|
| | | | (130) | | |
|
Balance at September 30, 2021
|
| | | $ | 28,449 | | |
|
Cash
|
| | | $ | 3,850 | | |
|
Fair value of common shares
|
| | | | 2,626 | | |
| | | | | $ | 6,476 | | |
|
Cash
|
| | | $ | 207 | | |
|
Accounts receivable
|
| | | | 668 | | |
|
Other assets
|
| | | | 274 | | |
|
Goodwill
|
| | | | 4,797 | | |
|
Intangible assets
|
| | | | 4,600 | | |
|
Accounts payable and accrued expenses
|
| | | | (1,052) | | |
|
Deferred revenue
|
| | | | (2,340) | | |
|
Deferred tax liability
|
| | | | (441) | | |
|
Other liabilities
|
| | | | (237) | | |
|
Total
|
| | | $ | 6,476 | | |
| | |
Estimated
Fair Value |
| |
Estimated
Useful Life (Years) |
| |||
Customer relationships
|
| | | $ | 750 | | | |
3 – 4
|
|
Expert network
|
| | | $ | 2,924 | | | |
6
|
|
Tradename
|
| | | $ | 926 | | | |
15
|
|
|
Cash
|
| | | $ | 7,290 | | |
|
Fair value of seller notes
|
| | | | 10,232 | | |
| | | | | $ | 17,522 | | |
|
Cash
|
| | | $ | 51 | | |
|
Accounts receivable
|
| | | | 389 | | |
|
Goodwill
|
| | | | 13,402 | | |
|
Intangible assets
|
| | | | 3,816 | | |
|
Accounts payable and accrued expenses
|
| | | | (136) | | |
|
Total
|
| | | $ | 17,522 | | |
| | |
Estimated
Fair Value |
| |
Estimated
Useful Life (Years) |
| ||||||
Customer relationships
|
| | | $ | 2,314 | | | | | | 7 | | |
Developed technology
|
| | | $ | 1,349 | | | | | | 10 | | |
Tradename
|
| | | $ | 153 | | | | | | 4 | | |
|
Cash
|
| | | $ | 2,241 | | |
|
Fair value of seller notes
|
| | | | 2,078 | | |
| | | | | $ | 4,319 | | |
|
Cash
|
| | | $ | 315 | | |
|
Accounts receivable
|
| | | | 185 | | |
|
Other assets
|
| | | | 85 | | |
|
Goodwill
|
| | | | 3,315 | | |
|
Intangible assets
|
| | | | 1,474 | | |
|
Accounts payable and accrued expenses
|
| | | | (220) | | |
|
Deferred revenue
|
| | | | (360) | | |
|
Deferred tax liability
|
| | | | (475) | | |
|
Total
|
| | | $ | 4,319 | | |
| | |
Estimated
Fair Value |
| |
Estimated
Useful Life (Years) |
| |||
Customer relationships
|
| | | $ | 937 | | | |
7
|
|
Developed technology
|
| | | $ | 537 | | | |
10 – 20
|
|
|
Cash
|
| | | $ | 10,113 | | |
|
Fair value of seller notes
|
| | | | 9,128 | | |
| | | | | $ | 19,241 | | |
|
Cash
|
| | | $ | 201 | | |
|
Accounts receivable
|
| | | | 2,862 | | |
|
Other assets
|
| | | | 229 | | |
|
Goodwill
|
| | | | 12,059 | | |
|
Intangible assets
|
| | | | 9,122 | | |
|
Accounts payable and accrued expenses
|
| | | | (208) | | |
|
Deferred revenue
|
| | | | (4,411) | | |
|
Unfavorable lease liability
|
| | | | (613) | | |
|
Total
|
| | | $ | 19,241 | | |
| | |
Estimated
Fair Value |
| |
Estimated
Useful Life (Years) |
| ||||||
Customer relationships
|
| | | $ | 8,855 | | | | | | 7 | | |
Tradename
|
| | | $ | 267 | | | | | | 4 | | |
Unfavorable lease
|
| | | $ | (613) | | | | | | 2 | | |
|
Cash
|
| | | $ | 833 | | |
|
Fair value of contributed interests
|
| | | | 315 | | |
|
Fair value of common stock
|
| | | | 8,271 | | |
| | | | | $ | 9,419 | | |
|
Cash
|
| | | $ | 149 | | |
|
Other current assets
|
| | | | 13 | | |
|
Goodwill
|
| | | | 5,241 | | |
|
Intangible assets
|
| | | | 4,909 | | |
|
Accounts payable and accrued expenses
|
| | | | (58) | | |
|
Deferred tax liability
|
| | | | (835) | | |
|
Total
|
| | | $ | 9,419 | | |
| | |
Estimated
Fair Value |
| |
Estimated
Useful Life (Years) |
| ||||||
Developed technology
|
| | | $ | 4,909 | | | | | | 10 | | |
|
Cash
|
| | | $ | 1,925 | | |
|
Fair value of common stock and replacement options
|
| | | | 6,510 | | |
|
Fair value of contingent stock and options
|
| | | | 196 | | |
| | | | | $ | 8,631 | | |
|
Cash
|
| | | $ | 126 | | |
|
Accounts receivable
|
| | | | 165 | | |
|
Other assets
|
| | | | 258 | | |
|
Goodwill
|
| | | | 3,118 | | |
|
Intangible assets
|
| | | | 5,336 | | |
|
Accounts payable and accrued expenses
|
| | | | (245) | | |
|
Deferred revenue
|
| | | | (95) | | |
|
Other liabilities
|
| | | | (32) | | |
|
Total
|
| | | $ | 8,631 | | |
| | |
Estimated
Fair Value |
| |
Estimated
Useful Life (Years) |
| ||||||
Customer relationships
|
| | | $ | 3,477 | | | | | | 7 | | |
Developed technology
|
| | | $ | 1,195 | | | | | | 4 | | |
Tradename
|
| | | $ | 664 | | | | | | 20 | | |
| Cash | | | | $ | 1,120 | | |
|
Fair value of common stock
|
| | | | 6,079 | | |
|
Fair value of contingent consideration
|
| | | | 1,206 | | |
| | | | | $ | 8,405 | | |
| Cash | | | | $ | 595 | | |
|
Accounts receivable
|
| | | | 179 | | |
|
Prepaid expenses
|
| | | | 21 | | |
| Goodwill | | | | | 4,973 | | |
|
Intangible assets
|
| | | | 3,720 | | |
|
Accounts payable and accrued expenses
|
| | | | (173) | | |
|
Deferred tax liability
|
| | | | (609) | | |
|
Deferred revenue
|
| | | | (301) | | |
|
Total
|
| | | $ | 8,405 | | |
| | |
Estimated
Fair Value |
| |
Estimated
Useful Life (Years) |
| ||||||
Customer relationships
|
| | | $ | 1,828 | | | | | | 11 | | |
Developed technology
|
| | | $ | 623 | | | | | | 10 | | |
Database | | | | $ | 1,269 | | | | | | 15 | | |
| Cash | | | | $ | 678 | | |
|
Fair value of common stock
|
| | | | 9,481 | | |
|
Fair value of contingent consideration
|
| | | | 1,700 | | |
| | | | | $ | 11,859 | | |
| Cash | | | | $ | 40 | | |
|
Other assets
|
| | | | 90 | | |
| Goodwill | | | | | 8,621 | | |
|
Intangible assets
|
| | | | 3,705 | | |
|
Accounts payable and accrued expenses
|
| | | | (316) | | |
|
Deferred revenue
|
| | | | (281) | | |
|
Total
|
| | | $ | 11,859 | | |
| | |
Estimated
Fair Value |
| |
Estimated
Useful Life (Years) |
| ||||||
Customer relationships
|
| | | $ | 2,033 | | | | | | 14 | | |
Developed technology
|
| | | $ | 1,672 | | | | | | 10 | | |
| | |
Nine Months Ended September 30,
|
| |||||||||
|
2021
|
| |
2020
|
| ||||||||
Revenues
|
| | | $ | 66,582 | | | | | $ | 66,171 | | |
Net loss
|
| | | $ | (94,408) | | | | | $ | (47,670) | | |
|
Cash
|
| | | $ | 1,545 | | |
|
Fair value of common shares
|
| | | | 2,758 | | |
| | | | | $ | 4,303 | | |
| Tangible assets and liabilities: | | | | | | | |
|
Other current assets
|
| | | $ | 3 | | |
|
Accounts payable and accrued liabilities
|
| | | | (165) | | |
|
Deferred revenue
|
| | | | (26) | | |
|
Deferred tax liability
|
| | | | (1,354) | | |
|
Net tangible liability
|
| | | $ | (1,542) | | |
| Identifiable intangible assets: | | | | | | | |
|
Developed technology
|
| | | | 5,845 | | |
|
Total
|
| | | $ | 4,303 | | |
| | |
September 30, 2021
|
| |
December 31, 2020
|
| |
Weighted
Average Remaining Useful Life (Years) September 30, 2021 |
| |||||||||||||||||||||||||||||||||
|
Gross
Carrying Amount |
| |
Accumulated
Amortization |
| |
Net
Carrying Amount |
| |
Gross
Carrying Amount |
| |
Accumulated
Amortization |
| |
Net
Carrying Amount |
| ||||||||||||||||||||||||||
Developed technology
|
| | | $ | 32,135 | | | | | $ | (11,414) | | | | | $ | 20,721 | | | | | $ | 21,986 | | | | | $ | (8,409) | | | | | $ | 13,577 | | | | | | 6.0 | | |
Customer relationships
|
| | | | 76,727 | | | | | | (16,154) | | | | | | 60,573 | | | | | | 56,653 | | | | | | (11,920) | | | | | | 44,733 | | | | | | 9.7 | | |
Databases
|
| | | | 29,144 | | | | | | (6,264) | | | | | | 22,880 | | | | | | 27,880 | | | | | | (4,756) | | | | | | 23,124 | | | | | | 11.1 | | |
Tradenames
|
| | | | 10,920 | | | | | | (2,070) | | | | | | 8,850 | | | | | | 8,933 | | | | | | (1,508) | | | | | | 7,425 | | | | | | 11.5 | | |
Patents
|
| | | | 512 | | | | | | (24) | | | | | | 488 | | | | | | 444 | | | | | | (12) | | | | | | 432 | | | | | | 17.8 | | |
Expert network
|
| | | | 2,851 | | | | | | (298) | | | | | | 2,553 | | | | | | — | | | | | | — | | | | | | — | | | | | | 5.4 | | |
Total
|
| | | $ | 152,289 | | | | | $ | (36,224) | | | | | $ | 116,065 | | | | | $ | 115,896 | | | | | $ | (26,605) | | | | | $ | 89,291 | | | | | | 9.4 | | |
|
2021 (remainder)
|
| | | $ | 3,735 | | |
|
2022
|
| | | | 14,808 | | |
|
2023
|
| | | | 14,796 | | |
|
2024
|
| | | | 13,994 | | |
|
2025
|
| | | | 10,856 | | |
|
Thereafter
|
| | | | 57,876 | | |
|
Total
|
| | | $ | 116,065 | | |
| | |
September 30, 2021
|
| |
December 31, 2020
|
| ||||||||||||||||||||||||||||||
|
Gross Carrying
Amount |
| |
Accumulated
Amortization |
| |
Net
Carrying Amount |
| |
Gross Carrying
Amount |
| |
Accumulated
Amortization |
| |
Net
Carrying Amount |
| ||||||||||||||||||||
Capitalized software development costs
|
| | | $ | 7,817 | | | | | $ | (1,255) | | | | | $ | 6,562 | | | | | $ | 4,133 | | | | | $ | (202) | | | | | $ | 3,931 | | |
|
Balance at December 31, 2020
|
| | | $ | 120,671 | | |
|
Oxford Analytica
|
| | | | 4,797 | | |
|
Fireside
|
| | | | 13,402 | | |
|
Timebase
|
| | | | 3,315 | | |
|
Board.org
|
| | | | 12,059 | | |
|
Equilibrium
|
| | | | 5,241 | | |
|
Predata
|
| | | | 3,118 | | |
|
Curate
|
| | | | 4,973 | | |
|
Forge
|
| | | | 8,621 | | |
|
Impact of foreign currency fluctuations
|
| | | | (513) | | |
|
Balance at September 30, 2021
|
| | | $ | 175,684 | | |
| | |
September 30, 2021
|
| |||||||||||||||||||||||||||
| | |
Face
Value |
| |
Unamortized
Premium/Discount(a) |
| |
Carrying
Value of Debt |
| |
Bifurcated
Embedded Derivative |
| |
Adjusted
Carrying Value |
| |||||||||||||||
First out term loan
|
| | | $ | 55,000 | | | | | $ | (55) | | | | | $ | 54,945 | | | | | $ | — | | | | | $ | 54,945 | | |
Last out term loan
|
| | | | 48,913(b) | | | | | | 20 | | | | | | 48,933 | | | | | | — | | | | | | 48,933 | | |
Senior Secured Subordinated Promissory Note
|
| | | | 86,291(c) | | | | | | (42,487) | | | | | | 43,444 | | | | | | 25,954 | | | | | | 69,398 | | |
Convertible notes
|
| | | | 119,525(d) | | | | | | (35,021) | | | | | | 84,504 | | | | | | 19,142 | | | | | | 103,646 | | |
2021 seller convertible notes
|
| | | | 9,455(e) | | | | | | (879) | | | | | | 8,576 | | | | | | — | | | | | | 8,576 | | |
2021 seller term notes
|
| | | | 7,377(f) | | | | | | (2,061) | | | | | | 5,316 | | | | | | — | | | | | | 5,316 | | |
PPPP loan
|
| | | | 8,000 | | | | | | — | | | | | | 8,000 | | | | | | — | | | | | | 8,000 | | |
Total carrying value
|
| | | $ | 334,561 | | | | | $ | (80,843) | | | | | $ | 253,718 | | | | | $ | 45,096 | | | | | | 298,814 | | |
Less: current portion
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | (9,350) | | |
Total noncurrent debt
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 289,464 | | |
| | |
December 31, 2020
|
| |||||||||||||||||||||||||||
|
Face
Value |
| |
Unamortized
Premium/Discount(a) |
| |
Carrying
Value of Debt |
| |
Bifurcated
Embedded Derivative |
| |
Adjusted
Carrying Value |
| |||||||||||||||||
First out term loan
|
| | | $ | 45,000 | | | | | $ | (1,197) | | | | | $ | 43,803 | | | | | $ | — | | | | | $ | 43,803 | | |
Last out term loan
|
| | | | 40,484 (g) | | | | | | (391) | | | | | | 40,093 | | | | | | — | | | | | | 40,093 | | |
Senior Secured Subordinated Promissory Note
|
| | | | 78,427 | | | | | | (53,685) | | | | | | 24,742 | | | | | | 19,607 | | | | | | 44,349 | | |
Convertible notes
|
| | | | 86,146(h) | | | | | | (17,977) | | | | | | 68,169 | | | | | | 10,805 | | | | | | 78,974 | | |
PPP loan
|
| | | | 8,000 | | | | | | — | | | | | | 8,000 | | | | | | — | | | | | | 8,000 | | |
Total carrying value
|
| | | $ | 258,057 | | | | | $ | (73,250) | | | | | $ | 184,807 | | | | | $ | 30,412 | | | | | | 215,219 | | |
Less: current portion
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | (3,251) | | |
Total noncurrent debt
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 211,968 | | |
| | |
September 30, 2021
|
| |||||||||||||||||||||||||||||||||||||||||||||
|
Principal
|
| |
Deferred
Financing Fees |
| |
PIK Interest
Accrual |
| |
Debt
Discount |
| |
Amortization
of Deferred Financing Fees |
| |
Amortization
of Deferred Debt Discount |
| |
Derivative
Liabilities |
| |
Total
|
| ||||||||||||||||||||||||||
2019 Notes
|
| | | $ | 17,320 | | | | | $ | (3,454) | | | | | $ | 3,988 | | | | | $ | (986) | | | | | $ | 639 | | | | | $ | 908 | | | | | $ | 2,595 | | | | | $ | 21,010 | | |
2020 Notes
|
| | | | 59,680 | | | | | | (1,027) | | | | | | 13,095 | | | | | | (14,111) | | | | | | 202 | | | | | | 2,612 | | | | | | 10,510 | | | | | | 70,961 | | |
2021 Notes
|
| | | | 23,841 | | | | | | (249) | | | | | | 1,601 | | | | | | (21,224) | | | | | | 22 | | | | | | 1,647 | | | | | | 6,037 | | | | | | 11,675 | | |
Total
|
| | | $ | 100,841 | | | | | $ | (4,730) | | | | | $ | 18,684 | | | | | $ | (36,321) | | | | | $ | 863 | | | | | $ | 5,167 | | | | | $ | 19,142 | | | | | $ | 103,646 | | |
| | |
December 31, 2020
|
| |||||||||||||||||||||||||||||||||||||||||||||
|
Principal
|
| |
Deferred
Financing Fees |
| |
PIK Interest
Accrual |
| |
Debt
Discount |
| |
Amortization
of Deferred Financing Fees |
| |
Amortization
of Deferred Debt Discount |
| |
Derivative
Liabilities |
| |
Total
|
| ||||||||||||||||||||||||||
2019 Notes
|
| | | $ | 17,320 | | | | | $ | (147) | | | | | $ | 3,330 | | | | | $ | (4,986) | | | | | $ | 41 | | | | | $ | 990 | | | | | $ | 2,857 | | | | | $ | 19,405 | | |
2020 Notes
|
| | | | 59,680 | | | | | | (1,027) | | | | | | 5,816 | | | | | | (14,112) | | | | | | 96 | | | | | | 1,168 | | | | | | 7,948 | | | | | | 59,569 | | |
Total
|
| | | $ | 77,000 | | | | | $ | (1,174) | | | | | $ | 9,146 | | | | | $ | (19,098) | | | | | $ | 137 | | | | | $ | 2,158 | | | | | $ | 10,805 | | | | | $ | 78,974 | | |
| | |
Group A
|
| |
Group B
|
| |
Group C
|
| |
Group D
|
| |
Total
|
| |||||||||||||||
Principal amount
|
| | | $ | 95,411 | | | | | $ | 430 | | | | | $ | 1,000 | | | | | $ | 4,000 | | | | | $ | 100,841 | | |
Maturity year
|
| | | | 2025 | | | | | | 2024 | | | | | | 2024 | | | | | | 2024 | | | | | | | | |
Annual interest rate
|
| |
15%
|
| |
6%
|
| |
7%
|
| |
15%
|
| | | | | | | ||||||||||||
Conversion options: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
At the holders’ option
|
| |
X
|
| | | | | | | | | | | | | |
X
|
| | | | | | | ||||||
Automatic upon contingent event
|
| |
X
|
| |
X
|
| |
X
|
| |
X
|
| | | | | | | ||||||||||||
Variable conversion prices with discounts
|
| |
X
|
| | | | | | | |
X
|
| |
X
|
| | | | | | | |||||||||
Embedded features: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Borrower prepayment right
|
| | | | | | | | | | | | | | | | | | | |
X
|
| | | | | | | |||
Lender automatic redemption right
|
| |
X
|
| | | | | | | | | | | | | | | | | | | | | | | | | |||
Lender contingent redemption right
|
| |
X
|
| | | | | | | | | | | | | | | | | | | | | | | | | |||
Registration rights
|
| |
X
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Series of preferred stock
|
| |
Redemption Value As of
|
| |||||||||
|
September 30, 2021
|
| |
December 31,
2020 |
| ||||||||
Series A redeemable, convertible preferred stock ($0.00001 par value, 12,851,709 authorized, issued and outstanding at September 30, 2021 and December 31, 2020)
|
| | | $ | 148,405 | | | | | $ | 63,973 | | |
Series B redeemable, convertible preferred stock ($0.00001 par value, 4,349,416 authorized, 4,336,912 issued and outstanding at September 30, 2021 and December 31, 2020)
|
| | | | 50,136 | | | | | | 21,743 | | |
Series C redeemable, convertible preferred stock ($0.00001 par value, 3,630,822 authorized, issued and outstanding at September 30, 2021 and December 31, 2020)
|
| | | | 42,110 | | | | | | 18,876 | | |
Series C-1 Redeemable, Convertible Preferred Stock ($0.00001 Par Value, 1,750,000 authorized, 1,452,330 issued and outstanding at September 30, 2021 and December 31, 2020)
|
| | | | 16,974 | | | | | | 7,957 | | |
Series D redeemable, convertible preferred stock ($0.00001 par value, 1,912,410 authorized, issued and outstanding at September 30, 2021 and December 31, 2020)
|
| | | | 26,005 | | | | | | 25,000 | | |
Series D-1 redeemable, convertible preferred stock ($0.00001 par value, 709,495 authorized, issued and outstanding at September 30, 2021 and December 31, 2020)
|
| | | | 9,128 | | | | | | 7,400 | | |
Series E redeemable, convertible preferred stock ($0.00001 par value, 9,385,200 authorized, issued and outstanding at September 30, 2021 and December 31, 2020)
|
| | | | 110,342 | | | | | | 61,104 | | |
Series F redeemable, convertible preferred stock ($0.00001 par value,
48,979,987 authorized at September 30, 2021 and December 31, 2020, 4,529,471 and 3,979,987 issued and outstanding at September 30, 2021 and December 31, 2020, respectively) |
| | | | 54,023 | | | | | | 32,910 | | |
Series G redeemable, convertible preferred stock ($0.00001 par value, 1,929,130 authorized at September 30, 2021 and 698,983 issued and outstanding at September 30, 2021)
|
| | | | 12,682 | | | | | | — | | |
Total temporary equity
|
| | | $ | 469,805 | | | | | $ | 238,963 | | |
Warrant Holder
|
| |
Underlying Shares
|
| |
Exercise
Price |
| |
Issuance Date
|
| |
Expiration
Date |
| |
Balance
Sheet Classification |
| ||||||
Comerica | | | 12,504 Shares of Series B | | | | $ | 2.40 | | | |
June 2015
|
| |
June 2025
|
| | | | Liability | | |
Eastward | | |
100,000 Shares of common stock
|
| | | $ | 1.75 | | | |
January 2017
|
| |
January 2027
|
| | | | Liability | | |
Runway | | |
194,673 Shares of common stock
|
| | | $ | 0.01 | | | |
October 2020
|
| |
October 2030
|
| | | | Equity | | |
Series G Investor | | |
75,327 Shares of common stock
|
| | | $ | 0.01 | | | |
February 2021
|
| |
February 2024
|
| | | | Equity | | |
| | |
Number of
shares |
| |
Weighted-average
exercise price |
| |
Weighted-average
remaining contractual life (years) |
| |
Aggregate
intrinsic value (in thousands) |
| ||||||||||||
Outstanding at December 31, 2020
|
| | | | 4,251,548 | | | | | $ | 2.10 | | | | | | 7.6 | | | | | $ | 7,048 | | |
Granted
|
| | | | 3,808,088 | | | | | | 4.11 | | | | | | | | | | | | | | |
Exercised
|
| | | | (266,522) | | | | | | 1.65 | | | | | | | | | | | | | | |
Cancelled and forfeited
|
| | | | (670,375) | | | | | | 2.86 | | | | | | | | | | | | | | |
Outstanding at September 30, 2021
|
| | | | 7,122,739 | | | | | $ | 3.28 | | | | | | 7.6 | | | | | $ | 52,015 | | |
Vested and exercisable as of September 30, 2021
|
| | | | 2,752,955 | | | | | $ | 1.93 | | | | | | 5.9 | | | | | $ | 23,560 | | |
Vested and expected to vest as of September 30, 2021
|
| | | | 7,122,739 | | | | | | | | | | | | | | | | | | | | |
| | |
Nine Months Ended
September 30, 2021 |
|
Expected volatility
|
| |
29.5% – 30.8%
|
|
Expected life (years)
|
| |
5.3 – 6.3
|
|
Expected dividend yield
|
| |
0.00%
|
|
Risk-free interest rate
|
| |
0.5% – 1.1%
|
|
Fair value of options
|
| |
$0.90 – $3.29
|
|
| | |
Nine Months Ended September 30,
|
| |||||||||
|
2021
|
| |
2020
|
| ||||||||
Cost of revenues
|
| | | $ | 9 | | | | | $ | 4 | | |
Research and development
|
| | | | 216 | | | | | | 68 | | |
Sales and marketing
|
| | | | 97 | | | | | | 58 | | |
Editorial
|
| | | | 67 | | | | | | 37 | | |
General and administrative
|
| | | | 158 | | | | | | 645 | | |
Total
|
| | | $ | 547 | | | | | $ | 812 | | |
| | |
Nine Months Ended September 30,
|
| |||||||||
|
2021
|
| |
2020
|
| ||||||||
Net loss
|
| | | $ | (88,462) | | | | | $ | (37,972) | | |
Deemed dividend – change in redemption value of preferred stock
|
| | | | (213,797) | | | | | | 3,359 | | |
Deemed dividend – in conjunction with convertible debt modification
|
| | | | (4,000) | | | | | | — | | |
Deemed dividend – preferred stock issuance
|
| | | | (453) | | | | | | — | | |
Net loss used to compute earnings per share
|
| | | $ | (306,712) | | | | | $ | (34,613) | | |
| | |
Equilibrium
|
| |
Predata
|
| |
Curate
|
| |
Forge
|
| |||||||||
Risk premium
|
| |
8.00%
|
| | | | 5.00% | | | | | | 8.00% | | | | | | 11.00% | | |
Risk free rate
|
| |
0.22% – 0.32%
|
| | | | 0.04% | | | | | | 0.22% | | | | | | 0.29% | | |
| | |
Equilibrium
|
| |
Predata
|
| |
Curate
|
| |
Forge
|
| |||||||||
Revenue volatility
|
| |
30.00 %
|
| | |
|
20.00
% |
| | | |
|
30.00
% |
| | | |
|
40.00
% |
| |
Expected life (years)
|
| |
1.7 – 2.2
|
| | | | 0.4 | | | | | | 2.0 | | | | | | 2.3 | | |
| | |
As of September 30, 2021
|
| |
As of December 31, 2020
|
| ||||||
Series B preferred stock fair value
|
| | | $ | 11.89 | | | | | $ | 5.01 | | |
Time to maturity (years)
|
| | | | 3.8 | | | | | | 4.5 | | |
Risk-free interest rate
|
| | | | 0.72% | | | | | | 0.31% | | |
Volatility
|
| | | | 67% | | | | | | 111% | | |
Exercise price
|
| | | $ | 2.40 | | | | | $ | 2.40 | | |
| | |
As of September 30, 2021
|
| |
As of December 31, 2020
|
| ||||||
Common stock fair value
|
| | | $ | 10.78 | | | | | $ | 3.22 | | |
Times to maturity (years)
|
| | | | 5.3 | | | | | | 6.0 | | |
Risk-free interest rate
|
| | | | 1.05% | | | | | | 0.51% | | |
Volatility
|
| | | | 60% | | | | | | 105% | | |
Exercise price
|
| | | $ | 1.75 | | | | | $ | 1.75 | | |
| | |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| ||||||||||||
Liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | |
Contingent consideration
|
| | | $ | — | | | | | $ | — | | | | | $ | 4,147 | | | | | $ | 4,147 | | |
Warrant liabilities
|
| | | $ | — | | | | | $ | — | | | | | $ | 1,024 | | | | | $ | 1,024 | | |
Embedded redemption features on convertible notes
|
| | | $ | — | | | | | $ | — | | | | | $ | 19,142 | | | | | $ | 19,142 | | |
Embedded redemption features on promissory note
|
| | | $ | — | | | | | $ | — | | | | | $ | 25,954 | | | | | $ | 25,954 | | |
| | |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| ||||||||||||
Liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | |
Contingent consideration
|
| | | $ | — | | | | | $ | — | | | | | $ | 276 | | | | | $ | 276 | | |
Warrant liabilities
|
| | | $ | — | | | | | $ | — | | | | | $ | 330 | | | | | $ | 330 | | |
Embedded redemption features on convertible notes
|
| | | | | | | | | | | | | | | $ | 10,805 | | | | | $ | 10,805 | | |
Embedded redemption features on promissory note
|
| | | $ | — | | | | | $ | — | | | | | $ | 19,607 | | | | | $ | 19,607 | | |
| | |
Contingent
Consideration |
| |
Warrant
Liabilities |
| |
Embedded Redemption
Features in Convertible Notes |
| |
Embedded Redemption
Features in Promissory Note |
| ||||||||||||
Balance at December 31, 2019
|
| | | $ | 201 | | | | | $ | 329 | | | | | $ | 5,039 | | | | | $ | — | | |
Derivative liabilities at issuance date
|
| | | | — | | | | | | — | | | | | | 12,154 | | | | | | — | | |
Settlement
|
| | | | (250) | | | | | | — | | | | | | — | | | | | | — | | |
Change in fair value included in the determination of net loss(a)
|
| | | | 315 | | | | | | (33) | | | | | | (4,126) | | | | | | — | | |
Balance at September 30, 2020
|
| | | $ | 266 | | | | | $ | 296 | | | | | $ | 13,067 | | | | | $ | — | | |
Balance at December 31, 2020
|
| | | $ | 276 | | | | | $ | 330 | | | | | $ | 10,805 | | | | | $ | 19,607 | | |
Derivative liabilities at issuance date
|
| | | | — | | | | | | — | | | | | | 5,972 | | | | | | — | | |
Contingent consideration and compensation at issuance date
|
| | | | 3,102 | | | | | | — | | | | | | — | | | | | | — | | |
Settlement
|
| | | | (276) | | | | | | — | | | | | | — | | | | | | — | | |
Change in fair value included in the determination of net loss(a)
|
| | | | 1,045 | | | | | | 694 | | | | | | 2,365 | | | | | | 6,347 | | |
Balance at September 30, 2021
|
| | | $ | 4,147 | | | | | $ | 1,024 | | | | | $ | 19,142 | | | | | $ | 25,954 | | |
| | |
PAGE
|
| |||
| | | | A-2 | | | |
| | | | A-2 | | | |
| | | | A-16 | | | |
| | | | A-17 | | | |
| | | | A-17 | | | |
| | | | A-17 | | | |
| | | | A-17 | | | |
| | | | A-17 | | | |
| | | | A-18 | | | |
| | | | A-18 | | | |
| | | | A-18 | | | |
| | | | A-18 | | | |
| | | | A-19 | | | |
| | | | A-19 | | | |
| | | | A-19 | | | |
| | | | A-19 | | | |
| | | | A-20 | | | |
| | | | A-20 | | | |
| | | | A-21 | | | |
| | | | A-22 | | | |
| | | | A-22 | | | |
| | | | A-23 | | | |
| | | | A-23 | | | |
| | | | A-24 | | | |
| | | | A-24 | | | |
| | | | A-25 | | | |
| | | | A-26 | | | |
| | | | A-26 | | | |
| | | | A-27 | | | |
| | | | A-27 | | | |
| | | | A-27 | | | |
| | | | A-28 | | | |
| | | | A-28 | | | |
| | | | A-29 | | | |
| | | | A-30 | | | |
| | | | A-30 | | | |
| | | | A-30 | | | |
| | | | A-30 | | | |
| | | | A-31 | | | |
| | | | A-32 | | |
| | |
PAGE
|
| |||
| | | | A-34 | | | |
| | | | A-35 | | | |
| | | | A-36 | | | |
| | | | A-37 | | | |
| | | | A-39 | | | |
| | | | A-39 | | | |
| | | | A-40 | | | |
| | | | A-40 | | | |
| | | | A-40 | | | |
| | | | A-40 | | | |
| | | | A-41 | | | |
| | | | A-41 | | | |
| | | | A-41 | | | |
| | | | A-42 | | | |
| | | | A-42 | | | |
| | | | A-42 | | | |
| | | | A-43 | | | |
| | | | A-43 | | | |
| | | | A-44 | | | |
| | | | A-44 | | | |
| | | | A-44 | | | |
| | | | A-45 | | | |
| | | | A-45 | | | |
| | | | A-45 | | | |
| | | | A-46 | | | |
| | | | A-46 | | | |
| | | | A-46 | | | |
| | | | A-46 | | | |
| | | | A-47 | | | |
| | | | A-47 | | | |
| | | | A-47 | | | |
| | | | A-47 | | | |
| | | | A-49 | | | |
| | | | A-50 | | | |
| | | | A-50 | | | |
| | | | A-50 | | | |
| | | | A-51 | | | |
| | | | A-51 | | | |
| | | | A-51 | | | |
| | | | A-53 | | | |
| | | | A-53 | | | |
| | | | A-53 | | | |
| | | | A-54 | | |
| | |
PAGE
|
| |||
| | | | A-54 | | | |
| | | | A-54 | | | |
| | | | A-54 | | | |
| | | | A-54 | | | |
| | | | A-56 | | | |
| | | | A-56 | | | |
| | | | A-56 | | | |
| | | | A-56 | | | |
| | | | A-57 | | | |
| | | | A-57 | | | |
| | | | A-57 | | | |
| | | | A-58 | | | |
| | | | A-58 | | | |
| | | | A-59 | | | |
| | | | A-60 | | | |
| | | | A-61 | | | |
| | | | A-61 | | | |
| | | | A-61 | | | |
| | | | A-61 | | | |
| | | | A-62 | | | |
| | | | A-62 | | | |
| | | | A-62 | | | |
| | | | A-63 | | | |
| | | | A-63 | | | |
| | | | A-63 | | | |
| | | | A-64 | | | |
| | | | A-64 | | | |
| | | | A-64 | | | |
| | | | A-64 | | | |
| | | | A-65 | | | |
| | | | A-66 | | | |
| | | | A-66 | | | |
| | | | A-66 | | | |
| | | | A-66 | | | |
| | | | A-67 | | | |
| | | | A-67 | | | |
| | | | A-67 | | | |
| | | | A-67 | | | |
| | | | A-67 | | | |
| | | | A-68 | | | |
| | | | A-68 | | | |
| | | | A-68 | | | |
| | | | A-68 | | |
| | |
PAGE
|
| |||
| | | | A-68 | | | |
| | | | A-68 | | | |
| | | | A-69 | | | |
| | | | A-69 | | | |
| | | | A-69 | | | |
| | | | A-70 | | | |
ANNEXES | | | |||||
Annex A — Form of Newco Certificate of Incorporation | | | | | A-1 | | |
Annex B — Form of Newco Bylaws | | | | | B-1 | | |
Annex C — Voting and Support Agreement | | | | | C-1 | | |
Annex D — Sponsor Letter Agreement | | | | | D-1 | | |
Annex E — Backstop Agreement | | | | | E-1 | | |
Annex F — Form of Amended and Restated Registration Rights Agreement | | | | | F-1 | | |
Annex G — Certificate of Merger | | | | | G-1 | | |
Annex H — Form of Incentive Equity Plan | | | | | H-1 | | |
Annex I — Form of Employee Stock Purchase Plan | | | | | | | |
Annex J — Form of Letter of Transmittal | | | | | | | |
Annex K — Form of Lock up Agreement | | | | | | | |
| | | | DUDDELL STREET ACQUISITION CORP. | | |||
| | | | By: | | |
/s/ Manoj Jain
Name: Manoj Jain
Title: Director |
|
| | | | GRASSROOTS MERGER SUB, INC. | | |||
| | | | By: | | |
/s/ Manoj Jain
Name: Manoj Jain
Title: Director |
|
| | | | FISCALNOTE HOLDINGS, INC. | | |||
| | | | By: | | |
/s/ Timothy Hwang
Name: Timothy Hwang
Title: Chief Executive Officer |
|
By: |
|
| Signature of Subscriber: | | | Signature of Joint Subscriber, if applicable: | |
|
By:
Name:
|
| |
By:
Name:
|
|
| Title: | | | Title: | |
|
Name of Subscriber:
(Please print. Please indicate name and
Capacity of person signing above) |
| |
Name of Joint Subscriber, if applicable:
(Please print. Please indicate name and
Capacity of person signing above) |
|
|
Name in which securities are to be registered
(if different from the name of Subscriber listed directly above): |
| |
|
|
|
Subscriber’s EIN:
|
| |
|
| | Joint Subscriber’s EIN: | | |
|
|
| Business Address-Street: | | | Mailing Address-Street (if different): | |
|
|
| |
|
|
|
|
| |
|
|
|
City, State, Zip:
|
| | | | |
City, State, Zip:
|
| | | |
| Attn: | | | | | | Attn: | | | | |
|
Telephone No.:
|
| |
|
| |
Telephone No.:
|
| |
|
|
|
Facsimile No.:
|
| |
|
| |
Facsimile No.:
|
| |
|
|
|
|
| | | |
| Reason for Terminating Continuous Service | | | Option Termination Date | |
| (I) By the Company for Cause, or what would have been Cause if the Company had known all of the relevant facts, or due to Participant’s material breach of his or her unexpired employment agreement or independent contractor agreement with the Company. | | | All Options, whether or not vested, shall immediately expire effective on the date of termination of the Participant’s Continuous Service, or when Cause first existed if earlier. | |
| (II) Disability or death of the Participant during Continuous Service (in either case unless Reason I applies). | | | All unvested Options shall immediately expire effective as of the date of termination of the Participant’s Continuous Service, and all vested and unexercised Options shall expire twelve (12) months after such termination. | |
| (III) Any other reason. | | | All unvested Options shall immediately expire effective on the date of termination of the Participant’s Continuous Service. All vested and unexercised Options, to the extent unexercised, shall expire effective ninety (90) days after the date of termination of the Participant’s Continuous Service. | |
CLAUSE
|
| |
PAGE
|
| |||
| | | | 6 | | | |
| | | | 6 | | | |
| | | | 9 | | | |
| | | | 9 | | | |
| | | | 10 | | | |
| | | | 11 | | | |
| | | | 11 | | | |
| | | | 12 | | | |
| | | | 12 | | | |
| | | | 12 | | | |
| | | | 13 | | | |
| | | | 13 | | | |
| | | | 14 | | | |
| | | | 14 | | | |
| | | | 15 | | | |
| | | | 15 | | | |
| | | | 16 | | | |
| | | | 16 | | | |
| | | | 16 | | | |
| | | | 17 | | | |
| | | | 18 | | | |
| | | | 18 | | | |
| | | | 18 | | | |
| | | | 19 | | | |
| | | | 19 | | | |
| | | | 21 | | | |
| | | | 21 | | | |
| | | | 21 | | | |
| | | | 21 | | | |
| | | | 23 | | | |
| | | | 24 | | | |
| | | | 24 | | | |
| | | | 25 | | | |
| | | | 25 | | | |
| | | | 26 | | | |
| | | | 27 | | | |
| | | | 27 | | | |
| | | | 29 | | | |
| | | | 30 | | | |
| | | | 30 | | | |
| | | | 30 | | |
|
THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR”
PROPOSALS 1, 2, 3, 4, 5, 6, 7, 8 AND 9. |
| |
PLEASE MARK
YOUR VOTE AS INDICATE D IN THIS EXAMPLE |
|
|
☐ FOR
|
| |
☐ AGAINST
|
| |
☐ ABSTAIN
|
|
|
☐ FOR
|
| |
☐ AGAINST
|
| |
☐ ABSTAIN
|
|
|
☐ FOR
|
| |
☐ AGAINST
|
| |
☐ ABSTAIN
|
|
|
☐ FOR
|
| |
☐ AGAINST
|
| |
☐ ABSTAIN
|
|
|
☐ FOR
|
| |
☐ AGAINST
|
| |
☐ ABSTAIN
|
|
|
☐ FOR
|
| |
☐ AGAINST
|
| |
☐ ABSTAIN
|
|
|
☐ FOR
|
| |
☐ AGAINST
|
| |
☐ ABSTAIN
|
|
|
☐ FOR
|
| |
☐ AGAINST
|
| |
☐ ABSTAIN
|
|
|
☐ FOR
|
| |
☐ AGAINST
|
| |
☐ ABSTAIN
|
|
|
☐ Tim Hwang
☐ Gerald Yao ☐ Michael Callahan ☐ Key Compton ☐ Stanley McChrystal ☐ Keith Nilsson ☐ Anna Segdley ☐ Brandon Sweeney ☐ Conrad Yiu ☐ Manoj Jain ☐ [•] |
| | | | | | |
|
☐
Vote FOR all
nominees
|
| |
☐
Vote WITHHOLD
from all nominees
|
| |
☐
Vote FOR
all nominees except*
|
|
|
☐ FOR
|
| |
☐ AGAINST
|
| |
☐ ABSTAIN
|
|
|
☐ FOR
|
| |
☐ AGAINST
|
| |
☐ ABSTAIN
|
|
|
☐ FOR
|
| |
☐ AGAINST
|
| |
☐ ABSTAIN
|
|
|
☐ FOR
|
| |
☐ AGAINST
|
| |
☐ ABSTAIN
|
|
Exhibit
|
| |
Description
|
|
99.4* | | | | |
99.5* | | | | |
99.6* | | | | |
99.7* | | | | |
99.8* | | | | |
99.9* | | | | |
99.10* | | | | |
99.11* | | | | |
99.12*** | | | Consent of [•] to be named as a director nominee. | |
107** | | | |
| | | | DUDDELL STREET ACQUISITION CORP. | |
| | | |
By:
/s/ Allan Finnerty
Name: Allan Finnerty
Title: Chief Financial Officer |
|
|
Name
|
| |
Title
|
| |
Date
|
|
|
/s/ Manoj Jain
Manoj Jain
|
| |
Chief Executive Officer
(Principal Executive Officer) |
| |
February 14, 2022
|
|
|
/s/ Allan Finnerty
Allan Finnerty
|
| |
Chief Financial Officer
(Principal Financial and Accounting Officer) |
| |
February 14, 2022
|
|
|
/s/ Marc Holtzman
Marc Holtzman
|
| |
Director
|
| |
February 14, 2022
|
|
|
/s/ Mark Derrick Collier
Mark Derrick Collier
|
| |
Director
|
| |
February 14, 2022
|
|
|
/s/ Bradford Allen
Bradford Allen
|
| |
Director
|
| |
February 14, 2022
|
|
Exhibit 10.9
BACKSTOP AGREEMENT
Backstop Agreement (this “Agreement”), dated as of November 7, 2021, among (i) Duddell Street Acquisition Corp., a Cayman Islands exempted company (together with its successors, including the resulting Delaware corporation after the consummation of the Domestication, “DSAC”), and (ii) Maso Capital Investments Limited, a Cayman Islands exempted company (“MCIL”), Blackwell Partners LLC - Series A, a Delaware limited liability company (“Blackwell”), and Star V Partners LLC, a Tennessee limited liability company (“Star” and together with MCIL and Blackwell, collectively, the “Purchasers” and each, a “Purchaser”). For purposes of this Agreement, DSAC and the Purchasers are each a “Party” and collectively the “Parties.” Each capitalized term used and not otherwise defined herein has the meaning ascribed to such term in the Merger Agreement (as defined below).
WHEREAS, pursuant to and subject to the terms and conditions of that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated or otherwise modified from time to time, the “Merger Agreement”), among DSAC, Grassroots Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of DSAC (“Merger Sub”), and FiscalNote Holdings, Inc., a Delaware corporation (together with its successors, including the surviving corporation in the Merger (as defined below), the “Company”), among other matters, (i) DSAC will domesticate as a Delaware corporation in accordance with the DGCL and the Cayman Islands Companies Law, and (ii) the Company will merge with and into Merger Sub (the “Merger”), with the Company continuing as the surviving corporation;
WHEREAS, in connection with the entry into the Merger Agreement, the Purchasers have allocated and committed up to one hundred seventy five million dollars ($175,000,000) to subscribe for a number of shares of Newco Class A Common Stock, subject to the aggregate number of DSAC Ordinary Shares that are redeemed (and for which redemptions are not subsequently withdrawn in accordance with the DSAC Governing Document) by the Pre-Closing DSAC Holders pursuant to the DSAC Shareholder Redemption Right, if any (the “DSAC Redeemed Shares”); and
WHEREAS, the Purchasers are now entering into this Agreement with DSAC, whereby at the Closing under the Merger Agreement, the Purchasers will acquire, and DSAC will issue and sell to the Purchasers, shares of Newco Class A Common Stock, on a private placement basis, solely to the extent necessary to fund up to the DSAC Shareholder Redemption Amount (as defined below) on a share for share basis, on the terms and conditions set forth herein (the “Backstop Purchase Shares”).
NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:
1. Backstop Limit; Backstop Notice.
(a) Notwithstanding anything to the contrary in this Agreement, the Purchasers shall not be required to fund any amount pursuant to this Agreement that is greater than the product of the Redemption Price (as defined in the DSAC Governing Document), multiplied by the DSAC Redeemed Shares (the “DSAC Shareholder Redemption Amount”).
(b) DSAC shall deliver a written notice (the “Backstop Notice”) to the Purchasers at least ten (10) Business Days prior to the Closing Date setting forth:
(i) the total number of DSAC Redeemed Shares;
(ii) the Subscription Amount;
(iii) the resulting BPS Purchase Price (as defined below) (as calculated in accordance with Section 2(a)), which amount, for the avoidance of doubt, shall in no event be greater than the DSAC Shareholder Redemption Amount; and
(iv) DSAC’s wire instructions.
“Subscription Amount” means a number of Backstop Purchase Shares equal to that number of Backstop Purchase Shares, if any, that would be required to be sold hereunder, at a purchase price of $10.00 per share, such that the product of the number of the Backstop Purchase Shares multiplied by $10.00 shall equal the lesser of (i) the DSAC Shareholder Redemption Amount or (ii) $175,000,000. Notwithstanding the foregoing, for the avoidance of doubt, the “Subscription Amount” shall not include any shares of Newco Common Stock in respect of DSAC Ordinary Share redemptions that have been subsequently withdrawn in accordance with the DSAC Governing Document. Only one (1) Backstop Notice may be delivered hereunder.
2. Sale and Purchase.
(a) Subject to the terms and conditions hereof, following delivery of the Backstop Notice by DSAC to the Purchasers hereunder, DSAC shall issue and sell to the Purchasers, and the Purchasers shall purchase from DSAC a number of Backstop Purchase Shares equal to the Subscription Amount for an aggregate purchase price equal to the product of (x) $10.00 multiplied by (y) the number of Backstop Purchase Shares to be issued and sold hereunder (such aggregate purchase price, the “BPS Purchase Price”). The numbers of shares, per share amounts and purchase price of the Backstop Purchase Shares and the BPS Purchase Price, as applicable, shall be appropriately adjusted to reflect any stock split, stock dividend, stock combination, recapitalization or the like occurring after the date hereof. Each Purchaser’s obligations hereunder shall be joint and several with the obligations of the other Purchasers.
2
(b) The closing of the sale of the Backstop Purchase Shares (the “BPS Closing”) shall be held simultaneously with the closing of the PIPE Financing and immediately prior to the Effective Time. At the BPS Closing, DSAC shall issue to the Purchasers (or the funds, accounts and/or assignees designated by the Purchasers in accordance with this Agreement if so designated by the Purchasers, or its nominee in accordance with its delivery instructions) or to a custodian designated by any Purchaser, as applicable, in each case prior to the BPS Closing, the Backstop Purchase Shares, free and clear of any liens or other restrictions whatsoever (other than those arising under state or federal securities laws), which Backstop Purchase Shares, unless otherwise determined by DSAC, shall be uncertificated, with record ownership reflected only in the register of shareholders of DSAC (a copy of which showing the Purchasers and/or their designees as the owners of the relevant Backstop Purchase Shares on and as of the Closing Date shall be provided to the Purchasers on the Closing Date or promptly thereafter).
(c) The Purchasers shall enter into the Amended and Restated Registration Rights Agreement at Closing, and the Purchasers shall have certain registration rights with respect to the Backstop Purchase Shares as referenced therein (the “Registration Rights”).
3. Restriction on Sale of Backstop Purchase Shares.
(a) Each Purchaser hereby agrees and covenants that, such Purchaser will not, (i) during the period from the Closing Date and ending on the date that is 180 days following after the Closing Date (the “Initial Lock-Up Period”), Transfer any of the Backstop Purchase Shares (collectively, the “Restricted Securities”), and (ii) during the period from the date that is 180 days following after the Closing Date and ending on the first anniversary of the Closing Date (the “Subsequent Lock-Up Period” and together with the Initial Lock-Up Period, the “Lock-Up Period”), Transfer more than 50% of each type of the Restricted Securities (any Transfer prohibited under clause (i) or (ii) above, a “Prohibited Transfer”). If any Prohibited Transfer is made or attempted contrary to the provisions of this Agreement, such purported Prohibited Transfer shall be null and void ab initio, and DSAC shall refuse to recognize any such purported transferee of such Restricted Securities as one of its equity holders for any purpose. In order to enforce this Section 3, DSAC may impose stop-transfer instructions with respect to the Restricted Securities of Sponsor until the end of the Lock-Up Period, as well as include customary legends on any certificates for any of the Restricted Securities reflecting the restrictions under this Section 3.
3
(b) Notwithstanding the provisions set forth in Section 3(a), the following Transfers of Restricted Securities during the Lock-Up Period are permitted: (i) to DSAC’s officers or directors, or any Affiliates or family members of any of DSAC’s officers or directors; (ii) in the case of an individual, Transfers by gift to a member of the individual’s immediate family, or to a trust, the beneficiary of which is a member of the individual’s immediate family or an affiliate of such person, or to a charitable organization; (iii) in the case of an individual, Transfers by virtue of laws of descent and distribution upon death of the individual; (iv) in the case of an individual, Transfers pursuant to a qualified domestic relations order; (v) in the case of an entity, Transfers to a stockholder, partner, member or Affiliate of such entity; (vi) in the case of an entity, Transfers by virtue of the laws of the state of the entity’s organization and the entity’s organizational documents upon dissolution of the entity; (vii) transactions relating to Newco Common Stock or other securities convertible into or exercisable or exchangeable for Newco Common Stock acquired in open market transactions after the Closing, provided that no such transaction is required to be, or is, publicly announced (whether on Form 4, Form 5 or otherwise, other than a required filing on Schedule 13F, 13G or 13G/A) during the Lock-Up Period; (viii) the exercise of any options or warrants to purchase Newco Common Stock (which exercises may be effected on a cashless basis to the extent the instruments representing such options or warrants permit exercises on a cashless basis); (ix) Transfers to Newco or the Surviving Corporation to satisfy tax withholding obligations pursuant to the Surviving Corporation’s equity incentive plans or arrangements; (x) the entry, by the applicable holder of the Restricted Securities that is party hereto, at any time after the Closing, of any trading plan providing for the sale of Newco Common Stock by such holder, which trading plan meets the requirements of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended, provided, however, that such plan does not provide for, or permit, any Prohibited Transfer and no public announcement or filing is voluntarily made or required regarding such plan during the Initial Lock-Up Period; (xi) transactions in the event of DSAC’s completion of a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction which results in all of the equityholders of the Surviving Company or Newco, as applicable, having the right to exchange their equity interests of Newco for cash, securities or other property; (xii) Transfers by a party hereto in sell-to-cover transactions to satisfy tax obligations of such party in connection with such party’s receipt of Newco Common Stock following the vesting and settlement of Company RSUs, if applicable; provided, however, that, in the case of the foregoing clauses (i) through (vi) and (xii), for such Transfer to be effective, the transferee must enter into a written agreement with DSAC agreeing to be bound by this Section 3. The transferees with respect to any of the Transfers described in clauses (i) through (vi) of the preceding sentence are referred to herein as “Permitted Transferees.”
(c) For purposes of this Agreement, “Transfer” means the (i) sale or assignment of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Exchange Act, and the rules and regulations of the SEC promulgated thereunder with respect to, any security, (ii) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (iii) public announcement of any intention to effect any transaction specified in clause (i) or (ii).
(d) For purposes of this Section 3, “immediate family” shall mean a spouse, domestic partner, child, grandchild or other lineal descendant (including by adoption), father, mother, brother or sister of the Shareholder; and “affiliate” shall have the meaning set forth in Rule 405 under the Securities Act.
4
4. Representations and Warranties of Purchasers. Each Purchaser represents and warrants to DSAC as follows:
(a) Organization. Such Purchaser is duly organized, validly existing and in good standing (where applicable) under the laws of the jurisdiction in which it is incorporated, organized or constituted, and the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby are within such Purchaser’s corporate or organizational powers and have been duly authorized by all necessary corporate or organizational action on the part of such Purchaser.
(b) Authority. This Agreement has been duly executed and delivered by such Purchaser and, assuming the due authorization, execution and delivery hereof by DSAC and that this Agreement constitutes a legally valid and binding agreement of DSAC, this Agreement constitutes a legally valid and binding obligation of such Purchaser, enforceable against such Purchaser in accordance with the terms hereof (subject only to the effect, if any, of (i) applicable bankruptcy and other similar Applicable Law affecting the rights of creditors generally and (ii) rules of law governing specific performance, injunctive relief and other equitable remedies).
(c) Non-Contravention. The execution and delivery of this Agreement by such Purchaser does not, and the performance by such Purchaser of its obligations hereunder will not, (i) result in a violation of Applicable Law, except for such violations which would not reasonably be expected, individually or in the aggregate, to have a material effect upon such Purchaser’s ability to perform its obligations hereunder, (ii) conflict with or result in a violation of the governing documents of such Purchaser, or (iii) require any consent or approval that has not been given or other action (including notice of payment or any filing with any Governmental Authority) that has not been taken by any Person (including under any Contract binding upon such Purchaser), except where the failure to obtain such consents or to take such actions would not reasonably be expected, individually or in the aggregate, to have a material effect upon such Purchaser’s ability to perform its obligations under this Agreement or to consummate the transactions contemplated thereby.
(d) Legal Proceedings. There is no Action pending against, or to the knowledge of such Purchaser, threatened against such Purchaser or any of its Affiliates, by or before (or that would be by or before) any Governmental Authority or arbitrator that, if determined or resolved adversely in accordance with the plaintiff’s demands, would reasonably be expected, individually or in the aggregate, to prevent or enjoin such Purchaser’s performance of its obligations under this Agreement. None of such Purchaser or any of its Affiliates is subject to any Governmental Order that would reasonably be expected, individually or in the aggregate, to prevent or enjoin such Purchaser’s performance of its obligations under this Agreement.
(e) Restricted Securities. Such Purchaser understands that the sale of the Backstop Purchase Shares to such Purchaser has not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of such Purchaser’s representations as expressed herein. Such Purchaser understands that the Backstop Purchase Shares are “restricted securities” under applicable U.S. federal and state securities laws and that, pursuant to these laws, such Purchaser must hold the Backstop Purchase Shares indefinitely unless they are registered with the SEC and qualified by state authorities, or an exemption from such registration and qualification requirements is available. Such Purchaser acknowledges that DSAC has no obligation to register or qualify the Backstop Purchase Shares for resale, except pursuant to the Registration Rights.
5
(f) Accredited Investor. Such Purchaser is an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.
(g) Adequacy of Financing. Such Purchaser has, or will have at the BPS Closing, available to it sufficient clear funds to satisfy its obligations under this Agreement, without restriction or conditions on payment to DSAC except as provided hereunder.
(h) Purchaser’s Knowledge and Skill. Such Purchaser has knowledge, skill and experience in financial, business and investment matters relating to investments of this type and is capable of evaluating the merits and risks of such investment and protecting its interests in connection with the acquisition of Backstop Purchase Shares.
(i) No Other Representations or Warranties. Such Purchaser acknowledges that neither DSAC nor any of its representatives has made or makes any representation or warranty to such Purchaser in respect of DSAC, the Company or the transactions contemplated by the Merger Agreement other than, in the case of DSAC, the representations and warranties contained in this Agreement.
5. Representations and Warranties of DSAC. DSAC represents and warrants to each Purchaser as follows:
(a) Organization. DSAC is duly organized, validly existing and in good standing (where applicable) under the laws of the jurisdiction in which it is incorporated, organized or constituted, and the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby are within DSAC’s corporate or organizational powers and have been duly authorized by all necessary corporate or organizational action on the part of DSAC.
(b) Authority. This Agreement has been duly executed and delivered by DSAC and, assuming the due authorization, execution and delivery hereof by the Purchasers and that this Agreement constitutes a legally valid and binding agreement of the Purchasers, this Agreement constitutes a legally valid and binding obligation of DSAC, enforceable against DSAC in accordance with the terms hereof (subject only to the effect, if any, of (i) applicable bankruptcy and other similar Applicable Law affecting the rights of creditors generally and (ii) rules of law governing specific performance, injunctive relief and other equitable remedies).
6
(c) Non-Contravention. The execution and delivery of this Agreement by DSAC does not, and the performance by DSAC of its obligations hereunder will not, (i) result in a violation of Applicable Law, except for such violations which would not reasonably be expected, individually or in the aggregate, to have a material effect upon DSAC’s ability to perform its obligations hereunder, (ii) conflict with or result in a violation of the governing documents of DSAC, or (iii) require any consent or approval that has not been given or other action (including notice of payment or any filing with any Governmental Authority) that has not been taken by any Person (including under any Contract binding upon DSAC), except where the failure to obtain such consents or to take such actions would not reasonably be expected, individually or in the aggregate, to have a material effect upon DSAC’s ability to perform its obligations under this Agreement or to consummate the transactions contemplated thereby.
(d) Legal Proceedings. There is no Action pending against, or to the knowledge of DSAC, threatened against DSAC or any of its Affiliates, by or before (or that would be by or before) any Governmental Authority or arbitrator that, if determined or resolved adversely in accordance with the plaintiff’s demands, would reasonably be expected, individually or in the aggregate, to prevent or enjoin DSAC’s performance of its obligations under this Agreement. None of DSAC or any of its Affiliates is subject to any Governmental Order that would reasonably be expected, individually or in the aggregate, to prevent or enjoin DSAC’s performance of its obligations under this Agreement.
(e) Capitalization. As of the date hereof and as of immediately prior to the BPS Closing, the authorized share capital of DSAC consists of 180,000,000 Class A Ordinary Shares, 20,000,000 DSAC Class B Ordinary Shares and 1,000,000 preference shares, $0.0001 par value each.
(f) Valid Issuance of Backstop Purchase Shares. The Backstop Purchase Shares, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement and registered in the register of members of DSAC, will be validly issued, fully paid and nonassessable and free of all preemptive or similar rights, liens, encumbrances and charges with respect to the issue thereof and restrictions on transfer, other than restrictions on transfer specified under this Agreement, applicable state and federal securities laws and liens or encumbrances created by or imposed by such Purchaser.
(g) No General Solicitation. Neither DSAC, nor any of its officers, directors, employees, agents or shareholders has either directly or indirectly, including through a broker or finder, (i) engaged in any general solicitation, or (ii) published any advertisement in connection with the sale of the Backstop Purchase Shares.
(h) No Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties contained in this Section 5 and in any certificate or agreement delivered pursuant hereto, DSAC has not made, does not make and shall not be deemed to make any other express or implied representation or warranty with respect to DSAC, the sale and purchase of the Backstop Purchase Shares, the transactions contemplated by the Merger Agreement or a potential business combination, and DSAC disclaims any such representation or warranty. Except for the specific representations and warranties expressly made by such Purchaser in Section 4 and in any certificate or agreement delivered pursuant hereto, DSAC specifically disclaims that it is relying upon any other representations or warranties that may have been made by such Purchaser. Notwithstanding anything to the contrary in this Agreement, nothing in this Section 5(h) shall limit any claim or cause of action (or recovery in connection therewith) with respect to fraud.
7
6. Trust Account. Each Purchaser acknowledges that DSAC is a blank check company with the powers and privileges to effect a Business Combination. Each Purchaser further acknowledges that, as described in the Prospectus, substantially all of DSAC’s assets consist of the cash proceeds of DSAC’s initial public offering and private placements of its securities and substantially all of those proceeds have been deposited in the Trust Account for the benefit of DSAC, certain of its public shareholders and the underwriters of DSAC’s initial public offering. Each Purchaser acknowledges that, except with respect to interest earned on the funds held in the Trust Account that may be released to DSAC to pay its tax obligations, if any, the cash in the Trust Account may be disbursed only for the purposes set forth in the Prospectus. For and in consideration of DSAC entering into this Agreement, the receipt and sufficiency of which are hereby acknowledged, each Purchaser hereby irrevocably waives any right, title, interest or claim of any kind they have or may have in the future in or to any monies in the Trust Account and agree not to seek recourse against the Trust Account or any funds distributed therefrom as a result of, or arising out of, this Agreement, any Ancillary Agreement, and any negotiations, contracts or agreements with DSAC or any other Person; provided, however, that nothing in this Section 6 shall amend, limit, alter, change, supersede or otherwise modify the right of such Purchaser to (i) bring any action or actions for specific performance, injunctive and/or other equitable relief or (ii) bring or seek a claim for Damages against DSAC, or any of its successors or assigns, for any breach of this Agreement (but such claim shall not be against the Trust Account or any funds distributed from the Trust Account to holders of DSAC Ordinary Shares in accordance with the DSAC Governing Document and the Trust Agreement).
7. BPS Closing Conditions.
(a) The obligation of the Purchasers to purchase the Backstop Purchase Shares at the BPS Closing under this Agreement shall be subject to the fulfillment, at or prior to the BPS Closing of each of the following conditions, any of which, to the extent permitted by Applicable Laws, may be waived by the Purchasers:
(i) the transactions contemplated by the Merger Agreement shall be consummated substantially concurrently with, and immediately following, the purchase of the Backstop Purchase Shares;
(ii) all conditions precedent to Closing set forth in the Merger Agreement shall have been satisfied or waived (other than those conditions which, by their nature, are to be satisfied upon Closing); and
(iii) no provision of Applicable Law, and no judgment, injunction, order or decree of any applicable Governmental Authority, shall prohibit the consummation of the transactions contemplated hereby.
8
(b) The obligation of DSAC to sell the Backstop Purchase Shares at the BPS Closing under this Agreement shall be subject to the fulfillment, at or prior to the BPS Closing of each of the following conditions, any of which, to the extent permitted by applicable laws, may be waived by DSAC:
(i) the transactions contemplated by the Merger Agreement shall be consummated substantially concurrently with, and immediately following, the purchase of the Backstop Purchase Shares;
(ii) the representations and warranties of each Purchaser set forth in Section 4 shall have been true and correct as of the date hereof and shall be true and correct as of the BPS Closing, as applicable, with the same effect as though such representations and warranties had been made on and as of such date (other than any such representation or warranty that is made by its terms as of a specified date, which shall be true and correct as of such specified date), except where the failure to be so true and correct would not have a material adverse effect on such Purchaser or its ability to consummate the transactions contemplated by this Agreement;
(iii) Each Purchaser shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by such Purchaser at or prior to the BPS Closing; and
(iv) no provision of Applicable Law, and no judgment, injunction, order or decree of any applicable Governmental Authority, shall prohibit the consummation of the transactions contemplated hereby.
8. Termination. This Agreement may be terminated at any time prior to the BPS Closing:
(a) by written consent of each of DSAC, the Purchasers and the Company; or
(b) automatically:
(i) upon the consummation of the Merger without the sale to the Purchasers of any Backstop Purchase Shares (whether or not a Backstop Notice has been delivered); or
(ii) upon the termination of the Merger Agreement, as provided under the terms therein.
In the event of any termination of this Agreement pursuant to this Section 8, the BPS Purchase Price, if previously paid, and all Purchasers’ funds paid in connection herewith shall be promptly returned to the Purchasers in accordance with written instructions provided by the Purchasers to DSAC, and thereafter this Agreement shall forthwith become null and void and have no effect, without any liability on the part of the Purchasers or DSAC and their respective directors, officers, employees, partners, managers, members, or shareholders and all rights and obligations of each party shall cease; provided, however, that nothing contained in this Section 8 shall relieve either party from liabilities or damages arising out of any fraud or willful breach by such party of any of its representations, warranties, covenants or agreements contained in this Agreement. Section 6 shall survive termination of this Agreement.
9
9. General Provisions.
(a) Notices. Any notice or communication required or permitted hereunder shall be in writing and either delivered personally, emailed or sent by overnight mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, and shall be deemed to be given and received (i) when so delivered personally, (ii) when sent, with no mail undeliverable or other rejection notice, if sent by email, or (iii) three (3) Business Days after the date of mailing to the address below or to such other address or addresses as such person may hereafter designate by notice given hereunder:
(i) | If to the Purchasers, to: |
Maso Capital Investments Limited, Blackwell Partners LLC – Series A and Star V Partners LLC
8/F Printing House, 6 Duddell Street, Hong Kong
Attention: Manoj Jain, Chief Executive Officer
Email: manoj.jain@masocapital.com
with a copy (which shall not constitute notice) to:
Davis Polk & Wardwell LLP
The Hong Kong Club Building
3A Chater Road, Hong Kong
Attention: Miranda So
James Lin
Sam Kelso
Email: miranda.so@davispolk.com
james.lin@davispolk.com
sam.kelso@davispolk.com
(ii) | If to DSAC, to: |
Duddell Street Acquisition Corp.
8/F Printing House, 6 Duddell Street, Hong Kong
Attention: Manoj Jain, Chief Executive Officer
Email: manoj.jain@masocapital.com
10
with a copy (which shall not constitute notice), (1) if prior to Closing, to:
Davis Polk & Wardwell LLP
The Hong Kong Club Building
3A Chater Road, Hong Kong
Attention: Miranda So
James Lin
Sam Kelso
Email: miranda.so@davispolk.com
james.lin@davispolk.com
sam.kelso@davispolk.com
or (2) if following Closing to:
FiscalNote Holdings, Inc.
1201 Pennsylvania Avenue NW
Washington D.C. 20004
Attention: Josh Resnik,
SVP, General Counsel and Chief Content Officer
Email: josh.resnik@fiscalnote.com
with a copy (which copy shall not constitute notice) to:
Paul Hastings LLP
875 15th Street, NW Suite 10
Washington D.C. 20005
Attention: Brandon Bortner
James Shea
Steve Camahort
Email: brandonbortner@paulhastings.com
jamesshea@paulhastings.com
stevecamahort@paulhastings.com
(b) Entire Agreement. This Agreement constitutes the entire agreement, and supersedes all other prior agreements, understandings, representations and warranties, both written and oral, among the parties, with respect to the subject matter hereof, including any commitment letter entered into relating to the subject matter hereof.
(c) No Third Party Beneficiaries; Exception. Except to the extent expressly set forth in Sections 8(a), 9(e), 9(j) and 9(q), this Agreement shall be binding on, and inure solely to the benefit of, the Parties and their respective successors and assigns, and nothing set forth in this Agreement shall be construed to confer upon or give any Person, other than the Parties and their respective successors and permitted assigns, any benefits, rights or remedies under or by reason of, or any rights to enforce or cause DSAC to enforce, this Agreement; provided, however, that the Company is the intended third party beneficiary of this Agreement.
11
(d) Successors. All of the terms, agreements, covenants, representations, warranties, and conditions of this Agreement are binding upon, and inure to the benefit of and are enforceable by, the Parties and their respective successors and permitted assigns. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the Parties or their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.
(e) Assignments. Except as otherwise specifically provided herein, no Party may assign either this Agreement or any of its rights, interests, or obligations hereunder without the prior written consent of the other Parties and the Company. Notwithstanding the foregoing, any Purchaser may assign and delegate all or a portion of its rights, interests and obligations hereunder to one or more other persons upon prior written notice to DSAC and the Company; provided, that (i) such assignee(s) agrees in writing to be bound by the terms hereof, and upon such assignment by any Purchaser, the assignee(s) shall become a Purchaser hereunder and have the rights and obligations and be deemed to make the representations and warranties of a Purchaser provided for herein to the extent of such assignment, and (ii) no such assignment or delegation shall relieve such assigning Purchaser of its obligations hereunder (including its obligation to purchase the Backstop Purchase Shares) and each of the Company and DSAC shall be entitled to pursue all rights and remedies against such Purchaser in respect its obligations subject to the terms and conditions hereof. Any purported assignment or assumption of this Agreement or any right or obligation hereunder in contravention of this Section 9(e) shall be void ab initio.
(f) Counterparts. This Agreement may be executed in one or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other parties, it being understood that the Parties need not sign the same counterpart.
(g) Headings and Captions. The headings and captions of the various subdivisions of this Agreement are for convenience of reference only and shall in no way modify or affect the meaning or construction of any of the terms or provisions hereof.
(h) Governing Law. This Agreement, and all Actions based upon, arising out of, or related to this Agreement or the transactions contemplated hereby, shall be governed by, and construed in accordance with, Applicable Laws of the State of Delaware, without giving effect to principles or rules of conflict of laws to the extent such principles or rules would require or permit the application of Applicable Laws of another jurisdiction.
12
(i) Jurisdiction; WAIVER OF TRIAL BY JURY. Any Action based upon, arising out of or related to this Agreement or the transactions contemplated hereby shall be brought exclusively in the Delaware Chancery Court and any state appellate court therefrom within the State of Delaware (or, if the Delaware Chancery Court or such state appellate court shall be unavailable, any other court of the State of Delaware or, in the case of claims to which the federal courts have exclusive subject matter jurisdiction, any federal court of the United States of America sitting in the State of Delaware), and each of the Parties irrevocably submits to the exclusive jurisdiction of each such court in any such Action, waives any objection it may now or hereafter have to personal jurisdiction, venue or to convenience of forum, agrees that all claims in respect of the Action shall be heard and determined only in any such court, and agrees not to bring any Action arising out of or relating to this Agreement or the transactions contemplated hereby in any other court. Nothing herein contained shall be deemed to affect the right of any Party to serve process in any manner permitted by Applicable Law or to commence legal proceedings or otherwise proceed against any other Party in any other jurisdiction, in each case, to enforce judgments obtained in any Action brought pursuant to this Section 9(i). EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION BASED UPON, ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY, AND EACH OF THE PARTIES CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C) SUCH PARTY MAKES THIS WAIVER VOLUNTARILY AND (D) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 9(I).
(j) Modifications and Amendments. This Agreement may not be amended, modified, supplemented or waived except by an instrument in writing, signed by the party against whom enforcement of such amendment, modification, supplement or waiver is sought; provided, that the prior written consent of the Company shall be required for any material amendments, modifications, waivers or supplements (which shall include amendments which (1) create additional conditionality to the Purchasers’ obligation to purchase the Backstop Purchase Shares, (2) change the DSAC Shareholder Redemption Amount, (3) change the Company’s rights under this Agreement, or (4) or change the economics or delay the timing of any Backstop Notice (including changing the Threshold DSAC Redemptions Amount before which a Backstop Notice can be given under Section 1(b)).
(k) Waiver of Damages. Notwithstanding anything to the contrary contained herein, in no event shall any party be liable for punitive damages in connection with this Agreement; provided, however, that in no event shall the Purchasers be liable for any form of damages, whether such damages are consequential, special or exemplary, in connection with this Agreement in excess of the sum of the DSAC Shareholder Redemption Amount and any reasonable fees and expenses (including, without limitation, legal fees) associated with the collection of such damages.
(l) Severability. If any provision of this Agreement shall be invalid, illegal or unenforceable, the validity, legality or enforceability of the remaining provisions of this Agreement shall not in any way be affected or impaired thereby and shall continue in full force and effect.
13
(m) Expenses. The Parties will each be responsible for their costs and expenses incurred in connection with the preparation, execution and performance of this Agreement and the consummation of the transactions contemplated hereby, including all fees and expenses of agents, representatives, financial advisors, legal counsel and accountants. DSAC will be responsible for all fees and expenses incurred in connection with transfer agents, stamp taxes and all of The Depository Trust Company’s fees associated with the issuance and resale of the Backstop Purchase Shares and any securities issuable upon conversion or exercise of the Backstop Purchase Shares (in each case, if applicable).
(n) Construction. The Parties have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the Parties and no presumption or burden of proof will arise favoring or disfavoring any party hereto because of the authorship of any provision of this Agreement. Any reference to any federal, state, local, or foreign law will be deemed also to refer to law as amended and all rules and regulations promulgated thereunder, unless the context requires otherwise. The words “include,” “includes,” and “including” will be deemed to be followed by “without limitation.” Pronouns in masculine, feminine, and neuter genders will be construed to include any other gender, and words in the singular form will be construed to include the plural and vice versa, unless the context otherwise requires. The words “this Agreement,” “herein,” “hereof,” “hereby,” “hereunder,” and words of similar import refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited. The Parties intend that each representation, warranty, and covenant contained herein will have independent significance. If any party hereto has breached any representation, warranty, or covenant contained herein in any respect, the fact that there exists another representation, warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) which such party hereto has not breached will not detract from or mitigate the fact that such party hereto is in breach of the first representation, warranty, or covenant.
(o) Waiver. No waiver by any party hereto of any default, misrepresentation, or breach of warranty or covenant hereunder, whether intentional or not, may be deemed to extend to any prior or subsequent default, misrepresentation, or breach of warranty or covenant hereunder or affect in any way any rights arising because of any prior or subsequent occurrence.
(p) Confidentiality. Except as may be required by law, regulation or applicable stock exchange listing requirements, or upon the request of a Governmental Authority, unless and until the transactions contemplated hereby and the terms hereof are publicly announced or otherwise publicly disclosed by DSAC, the Parties shall keep confidential and shall not publicly disclose the existence or terms of this Agreement.
14
(q) Specific Performance; Enforcement. Each Purchaser agrees that irreparable damage may occur to DSAC and the Company in the event any provision of this Agreement is not performed by such Purchaser in accordance with the terms hereof and that DSAC and the Company shall be entitled to specific performance of the terms hereof, in addition to any other remedy at law or equity, without a requirement to post bond or any other security. Subject to the proviso in Section 9(c) and as provided in this Section 9(q), this Agreement may be enforced only by DSAC and the Purchasers, and none of DSAC’s direct or indirect creditors nor any other person that is not a party to this Agreement shall have any right to enforce this Agreement or to cause DSAC to enforce this Agreement.
(r) Further Assurances. Each party will, at the request of the other party, promptly take all actions, and execute and deliver all other agreements and documents, which may be reasonably required to give effect to the terms of and the transactions contemplated by this Agreement.
[Signature Page Follows]
15
IN WITNESS WHEREOF, the undersigned have executed this Agreement to be effective as of the date first set forth above.
DUDDELL STREET ACQUISITION CORP. | |||
By: | /s/ Manoj Jain | ||
Name: | Manoj Jain | ||
Title: | Director |
Maso Capital Investments Limited | |||
By: | /s/ Sohit Khurana | ||
Name: | Sohit Khurana | ||
Title: | Authorized Signatory |
Blackwell Partners LLC - Series A | |||
By: | /s/ Sohit Khurana | ||
Name: | Sohit Khurana | ||
Title: | Authorized Signatory |
Star V Partners LLC | |||
By: | /s/ Sohit Khurana | ||
Name: | Sohit Khurana | ||
Title: | Authorized Signatory |
[Signature Page to Backstop Agreement]
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of Duddell Street Acquisition Corp. on Amendment No. 2 to Form S-4 (File No. 333-261483) of our report dated March 31, 2021, except for the effects of the restatement discussed in Note 2 – Amendment 1, as to which the date is July 26, 2021 and Note 2 – Amendment 2, as to which the date is November 24, 2021, with respect to our audit of the financial statements of Duddell Street Acquisition Corp. as of December 31, 2020 and for the period from August 28, 2020 (inception) through December 31, 2020, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Marcum LLP
Marcum llp
Boston, MA
February 14, 2022
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Registration Statement on Amendment No. 2 to Form S-4, and related Prospectus, of Duddell Street Acquisition Corp. of our report dated November 11, 2021, relating to the consolidated financial statements of FiscalNote Holdings, Inc. and its subsidiaries, appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference of our firm under the heading “Experts” in such Prospectus.
/s/ RSM US LLP
McLean, Virginia
February 14, 2022
Exhibit 107
Calculation of Filing Fee Table
FORM S-4
(Form Type)
DUDDELL
STREET ACQUISITION CORP.
(Exact Name of Registrant as Specified in its Charter)
N/A
(Translation of Registrant’s Name into English)
Table 1: Newly Registered and Carry Forward Securities
Security Type |
Security
Class Title(2) |
Fee
Calculation or Carry Forward Rule |
Amount
Registered(1) |
Proposed
Maximum Offering Price Per Unit |
Maximum
Aggregate Offering Price |
Fee Rate |
Amount
of
Registration Fee(5) |
|||||||||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||||
Fees to Be Paid | Equity | Class A common stock, par value $0.0001 per share (9)(11) | Rule 457(c) and (f)(1) | 15,351,400 | $ | 9.90 | (4) | $ | 151,978,860.00 | (4) | 0.0000927 | $ | 14,088.44 | |||||||||||||
Fees Previously Paid | Equity | Class A common stock, par value $0.0001 per share(3)(9)(10) | Rule 457(c) and (f)(1) | 120,324,514 | $ | 9.90 | (4) | $ | 1,191,212,688.60 | (4) | 0.0000927 | $ | 110,425.42 | |||||||||||||
Equity | Redeemable warrants(6)(9) | Rule 457(c) and (f)(1) | 8,750,000 | $ | 1.43 | (7) | $ | 12,512,500.00 | (7) | 0.0000927 | $ | 1,159.91 | ||||||||||||||
Equity | Class B common stock, par value $0.0001 per share(8)(10) | Rule 457(c) and (f)(1) | 8,491,491 | $ | 9.90 | (4) | $ | 84,065,760.90 | (4) | 0.0000927 | $ | 7,792.90 | ||||||||||||||
Total Offering Amounts | $ | 1,439,769,809.50 | ||||||||||||||||||||||||
Total Fees Previously Paid | $ | 119,378.23 | ||||||||||||||||||||||||
Net Fee Due | $ | 14,088.44 |
1
(1) | Prior to the consummation of the business combination described in the proxy statement/prospectus forming part of this registration statement (the “proxy statement/prospectus”), Duddell Street Acquisition Corp., a Cayman Islands exempted company limited by shares (“DSAC”), intends to effect a deregistration under the Cayman Islands Companies Act (As Revised) and a domestication under Section 388 of the Delaware General Corporation Law, pursuant to which DSAC’s jurisdiction of incorporation will be changed from the Cayman Islands to the State of Delaware (the “Domestication”). As used herein, “New DSAC” refers to DSAC after the Domestication. All securities being registered will be issued by New DSAC, the continuing entity following the Domestication, or New FiscalNote, the continuing entity following the business combination described in this proxy statement/prospectus, which will thereafter be renamed “FiscalNote Holdings, Inc.”, as further described in the proxy statement/prospectus. As used herein, “New FiscalNote” refers to DSAC after the consummation of the business combination described in this proxy statement/prospectus. |
(2) | Pursuant to Rule 416(a) of the Securities Act, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. |
(3) | The number of shares of common stock being registered represents: (a) the number of Class A ordinary shares of DSAC (“DSAC Class A ordinary shares”) that were registered pursuant to the Registration Statement on Form S-1 (333-249207) (the “IPO Registration Statement”) and offered by DSAC in its initial public offering, all of which will be automatically converted by operation of law into shares of Class A common stock, par value $0.0001 per share, of New FiscalNote (“New DSAC Class A common stock” or “New FiscalNote Class A common stock”) in the Domestication; (b) the number of Class B ordinary shares of DSAC (“DSAC Class B ordinary shares”) outstanding immediately prior to the Domestication, all of which will be converted into DSAC Class A ordinary shares immediately prior to the Domestication and will automatically be converted by operation of law into shares of New DSAC Class A common stock in the Domestication; and (c) the maximum number of shares of New FiscalNote Class A common stock estimated to be issued in connection with the business combination described in the proxy statement/prospectus, which is based on the sum of: (x) 87,561,867 shares of New FiscalNote Class A common stock to be issued in connection with the merger described in the proxy statement/prospectus assuming the exercise of warrants held by certain investors in FiscalNote to purchase FiscalNote Class A common stock immediately prior to the consummation of the Business Combination, and (y) 10,887,647 shares of New FiscalNote Class A common stock to be reserved for issuance upon the exercise of options and restricted stock units (“RSUs”) to purchase New FiscalNote Class A common stock, which are currently options and RSUs of FiscalNote Holdings, Inc. (“FiscalNote”). |
(4) | Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low trading prices of the DSAC Class A ordinary shares on the Nasdaq Capital Market (“Nasdaq”) on November 30, 2021 ($9.90 per DSAC Class A ordinary share) (such date being within five business days of the date that this registration statement was first filed with the SEC). This calculation is in accordance with Rule 457(f)(1) of the Securities Act. For purposes of calculating the registration fee, shares of New FiscalNote Class A common stock and New FiscalNote Class B common stock (as defined below) are treated as having the same value as DSAC Class A ordinary shares, as each DSAC Class A ordinary share will become a share of New DSAC Class A common stock in the Domestication and DSAC Class B ordinary shares are treated as having the same value as DSAC Class A ordinary shares, as each DSAC Class B ordinary share is convertible into one DSAC Class A ordinary share in connection with the Domestication. |
(5) | Calculated pursuant to Rule 457 under the Securities Act by multiplying the proposed maximum aggregate offering price of securities to be registered by 0.0000927. |
(6) | The number of redeemable warrants to acquire shares of New DSAC Class A common stock being registered represents the number of redeemable warrants to acquire DSAC Class A ordinary shares that were registered pursuant to the IPO Registration Statement referenced in note (3) above and offered by DSAC in its initial public offering (“DSAC public warrants”). The DSAC public warrants automatically will be converted by operation of law into redeemable warrants to acquire shares of New DSAC Class A common stock in the Domestication (“New DSAC public warrants”). |
(7) | Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low trading prices of DSAC public warrants on Nasdaq on November 30, 2021 ($1.43 per warrant) (such date being within five business days of the date that this registration statement was first filed with the SEC). This calculation is in accordance with Rule 457(f)(1) of the Securities Act. |
(8) | Based on 8,491,491 shares of Class B common stock, par value $0.0001 per share, of New FiscalNote (“New FiscalNote Class B common stock”) estimated to be issued in connection with the business combination described in the proxy statement/prospectus. |
(9) | Pursuant to the Business Combination Agreement, at the closing of the Domestication, (A) each then issued and outstanding Class A ordinary share of DSAC will convert automatically into one share of New FiscalNote Class A common stock, (B) each then issued and outstanding Class B ordinary share of DSAC will convert automatically into one share of New FiscalNote Class A Common Stock, and (C) each then issued and outstanding common warrant of DSAC will convert automatically into one warrant to purchase one share of New FiscalNote Class A Common Stock. As such, the number of shares of New FiscalNote Class A common stock and the number of shares of New FiscalNote Class A common stock underlying the New FiscalNote warrants to be issued to existing securities holders of DSAC in connection with the Business Combination are calculated based on the number of DSAC securities held by such holders as of the date of the proxy statement/prospectus. |
(10) | The maximum numbers of New FiscalNote Class A and Class B common stock to be issued to existing FiscalNote security holders are calculated by dividing the quotient of (A) the sum of $1 billion (the Company Value as defined in the Business Combination Agreement) plus the aggregate exercise price payable with respect to vested FiscalNote options and FiscalNote warrants, (assumed to be approximately $9 million), divided by (B) the total number of issued and outstanding FiscalNote shares, (assumed to be 83,679,199), taking into account the total number of shares issued or issuable as a result of any exercise or conversion of all FiscalNote equity securities outstanding immediately prior to the effective time of the Merger, by $10.00 (the “Exchange Ratio”). The resulting Exchange Ratio is approximately 1.2, which we believe remains consistent as of January 10, 2022. Each share of FiscalNote ClassA common stock (other than dissenting shares) will be cancelled and converted into the right to receive shares of Newco Class A Common Stock as determined pursuant to the Exchange Ratio, (ii) each share of FiscalNote Class B common stock (other than dissenting shares) will be cancelled and converted into the right to receive the applicable portion of the merger consideration comprised of Newco Class B Common Stock, as determined pursuant to the Exchange Ratio, (iii) all of the warrants to purchase shares of FiscalNote Class A common stock or FiscalNote preferred stock outstanding and unexercised or unconverted, as applicable, immediately prior to the Business Combination will be deemed automatically exercised or converted into the right to receive a number of shares of New FiscalNote Class A common stock determined pursuant to the Exchange Ratio, (iv) all options to purchase shares of Class A common stock of FiscalNote, vested or unvested, will convert into stock options to purchase shares of New FiscalNote Class A Common Stock determined in accordance with the Exchange Ratio, (v) all of the vested restricted stock units to acquire shares of Class A common stock of FiscalNote will be automatically deemed settled and converted into the right to receive that number of shares of New FiscalNote Class A Common Stock determined pursuant to the Exchange Ratio, and (vi) all of the unvested restricted stock units to acquire shares of Class A common stock of FiscalNote outstanding immediately prior to the Business Combination will be automatically assumed and converted into restricted stock units relating to shares of Newco Class A Common Stock, subject to substantially the same terms and conditions as were applicable immediately before the Business Combination. |
(11) | Based on the maximum number of shares of New FiscalNote Class A common stock estimated to be issued as earnout considerations in connection with the business combination described in the proxy statement/prospectus. Such maximum number of shares of New FiscalNote Class A common stock represents up to 15,351,400 shares of New FiscalNote Class A common stock (including shares reserved for issuances upon separation of RSUs) to be issued to certain holders of FiscalNote securities as earnout considerations pursuant to the Business Combination Agreement (as defined in the proxy statement/prospectus) upon occurrence of certain triggering events set forth thereunder. |
2